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ABSTRACT 
Brucellosis is a serious disease of cattle in many countries of the world, including 
Mediterranean and Middle Eastern countries. The study outlined in this thesis was 
conducted to investigate the epidemiology of brucellosis in the Sultanate of Oman. Thirty 
of 1267 holdings tested in the Sultanate contained seropositive animals for brucellosis 
(herd prevalence 2.4%, 95% CI 1.6, 3.4%). The southern governorate (Dhofar) had 
significantly more seropositive holdings (n = 20, 8.6%, 95% CI 5.3, 13) than did the 
northern governorates (n = 10, 0.97%, 95% CI 0.5, 1.8) (p < 0.001) highlighting the 
endemic nature of the disease in Dhofar.  
Although there were no significant differences between the herd seroprevalence for 
individual species, the highest herd level seroprevalence was reported in cattle (4.9%) 
followed by camels (2.3%), goats (1.4%) and sheep (0.6%). The overall individual animal 
seroprevalence of brucellosis in Oman was generally at a low level (0.4%; 95% CI 0.2, 
0.5). The individual seroprevalence level in the different species was also low, being 0.4%, 
0.4%, 0.4% and 0.1% in cattle, camels, goats and sheep, respectively. The practice of 
moving animals without testing between governorates is likely to have allowed the spread 
of infection throughout Oman. The active importation of live animals from other countries 
in the Horn of Africa, without prior monitoring of their brucellosis status, inter-species 
contact, sharing of common pasture, large herd size and the presence of poor 
biosecurity/unhygienic conditions in herds in the southern governorate may have facilitated 
the spread of brucellosis in the Dhofar region and from here infection may have been 
transmitted to other governorates.  
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A logistic-regression analysis was undertaken to identify risk factors for disease. This 
analysis indicated associations of breed, age, herd size and production system with 
seropositivity. A higher seroprevalence was found in imported animals (OR 3.71, 95% CI 
0.68, 20.43), and the seroprevalence increased with age. The latter finding is possibly 
because of a higher risk of contracting the disease after puberty through increased contacts 
with potentially infected animals. 
Only Brucella melitensis was cultured from different species of animals and biotype 1 was 
the only type identified in Oman by molecular means and phage typing. Sequencing of 
DNA revealed that all isolates had a very similar pattern.  
In the current study although there was no significant difference observed in the 
seroprevalence detected by different diagnostic assays (cELISA, iELISA and RBPT), the 
ELISAs were capable of detecting more positive samples than the RBPT and Rapid test. 
This may reflect the better sensitivity of the ELISAs and it is recommended that these tests 
be used in the control and eradication of brucellosis in Oman, where vaccination is 
undertaken. 
In Oman, human brucellosis was first reported in 1979 in the southern Dhofar governorate. 
A retrospective analysis of human brucellosis data sourced from the Ministry of Health, 
Oman from 1995 to 2012 was conducted. Information regarding location, age, gender, 
nationality of patients and year were included in the analysis. During this period, 2737 
human cases of brucellosis were reported, with 96.7% of these in Dhofar. The incidence of 
disease was highest in young individuals (0-10 years of age), highlighting that these 
subjects were more at risk of acquiring brucellosis. The incidence of brucellosis was 
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slightly higher in males (56%) than females (44%). Most of the positive patients were 
Omani nationals, most likely because of more opportunity for contact with infected 
animals on privately owned farms.  
The failure of disease control programmes in the southern region (2003 until 2012) could 
be due to a lack of information, inappropriate planning or administrative issues. With the 
information gathered from this study, it is considered there is a need to build a strategy to 
control the disease throughout Oman, rather than restricting control to the Dhofar 
governorate. However it is recommended that the control program adopted in the southern 
region (Dhofar), where the seroprevalence is high, be different to that implemented in the 
northern regions, where the disease prevalence is lower and more manageable. In the 
southern region, implementing a vaccination programme, along with individual animal 
identification and disease screening with a plan of intensive involvement and extension in 
the community, should be considered. In contrast in the northern region a test and slaughter 
program could be implemented. 
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CHAPTER ONE 
INTRODUCTION 
1.1 Background 
Brucellosis is a zoonotic disease (Huddleson, 1943; Boschiroli et al, 2001; Hendricks et al, 
1995; Godfroid et al, 2005; Corbel et al, 2006) affecting a wide range of mammalian 
species, including humans (Hall, 1989; Brinley and Corbel, 1990; Capasso, 2002; Glynn 
and Lynn, 2008), fresh water fish (El-Tras et al, 2010), sea mammals (Brew, 1999; Bricker 
et al, 2003a; McDonald et al, 2006) and wildlife (Thorpe et al, 1965; Godfroid, 2002; 
Godfroid et al, 2010; Van Campen and Rhyan, 2010). In 1887 Colonel David Bruce, a 
physician in the Royal Army, isolated Brucella for the first time (Hall, 1989). The 
organism was detected in the spleen of British soldiers on the island of Malta, and 
consequently the disease was known as Malta fever (Hardy et al, 1930; Godfroid et al, 
2005). Subsequently Brucella melitensis and Brucella abortus were isolated from these 
patients (Glynn and Lynn, 2008). The first documented case of brucellosis in animals was 
reported in cattle (Meyer, 1990). The causative agent was subsequently isolated in 1895 by 
Bernhard Bang, and hence the disease was known as Bang’s disease (Sutherland, 1980; 
Hoffman and Houle, 1995). The organism was initially called Micrococcus melitensis 
(Moreno and Moriyon, 2002), however it was later renamed Brucella melitensis (Spink, 
1956).  
Brucellosis is distributed widely, particularly in the Middle East (Hadad and Al Azawy, 
1991; Pappas et al, 2006). Meyer and Shaw in 1920 confirmed the relationship between 
bovine brucellosis and human brucellosis and diagnosed the first human cases in the 
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United States of America (USA) (Buchanan et al, 1974). The World Health Organization 
(WHO) reported that brucellosis was a significant health and economic problem 
(Boschiroli et al, 2001). It is well accepted today that nearly every case of human 
brucellosis has an animal origin and, therefore, control is primarily a veterinary problem 
(Nicoletti, 2002). 
Brucellosis is a herd/flock problem (Corbel, 1989; Corbel, 1997 a,b) and is mainly spread 
through the ingestion of contaminated material (Corbel, 1989; Crawford et al, 1990). In 
females the initial infection is often followed by abortion and subsequent delays in 
conception or even permanent infertility (Cotton and Buck, 1931; Brinley-Morgan and 
Corbel, 1990; Enright, 1990, Singh et al, 1994). Infected animals shed organisms in 
colostrum, milk or uterine discharges following abortion or parturition (FAO, 2003). 
Humans become infected through ingestion of raw milk and other dairy products (EFSA, 
2013), or following direct contact with contaminated tissue, blood, urine, vaginal 
discharges, aborted foetuses (Sahin et al, 2008) or placentas (Flynn, 1983; Hall, 1989; 
Bercovich, 1998). Airborne infection in laboratories and abattoirs has also been recorded 
(Hartigan, 1997; FAO, 2003). 
Brucellosis can have a major impact on livestock productivity and results in major losses 
for international trade (Beveridge, 1983; Bridges and Halling, 1994). 
1.2 Oman overview 
1.2.1 Location and administrative classification: 
Oman is located in the south-eastern quarter of the Arabian Peninsula and covers a total 
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land area of 309,500 square kilometres. The country contains several topographical 
features with valleys and deserts accounting for 82%, mountain ranges 15% and coastal 
plain 3% of the land mass. The coast is 1,700 km long, running from the Strait of Hormuz 
in the north to the border with the Republic of Yemen. Oman is surrounded by seas: the sea 
of Oman, Arabian Sea and Arabian Gulf. The country borders the United Arab Emirates 
(UAE) to the west, the Republic of Yemen to the south and the Strait of Hormuz and the 
Arabian Sea to the east (Figure 1.1). 
Oman is extremely hot and dry throughout the year, with the exception of Dhofar 
Governorate, which has a light monsoon climate and receives cool winds from the Indian 
Ocean. The country is characterized by high summer temperatures, scanty and irregular 
rainfall, and a high rate of evaporation, high relative humidity and persistent winds from all 
directions. The hottest months are July and August with mean temperatures reaching 45°C, 
while December, January and February are the coldest, averaging 17°C (Meteorological 
Affairs, 2012). 
Administratively, the Sultanate is divided into 11 governorates namely: Muscat 
Governorate in which the affiliated wilayats are Muscat, Muttrah, Al Amerat, Baushar, 
Seeb and Qurrayat. The centre of this governorate is the Wilayat of Muscat; Batinah South 
Governorate which contains the affiliated wilayats of Al Rostaq, Al Awabi, Nakhl, Wadi al 
Maawil, Barka and Musannah. The centre of this governorate is the Wilayat of Rostaq; 
Batinah North Governorate which includes the wilayats of Sohar, Shinas, Liwa, Saham, Al 
Khabourah and Al Suwaiq. The centre of this governorate is the Wilayat of Sohar; 
Musandam Governorate with the affiliated wilayats of Khasab, Diba, Bukha and Madha. 
The centre of this governorate is the Wilayat of Khasab; Al Buraimi Governorate which 
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contains the affiliated wilayats of Al Buraimi, Mahdha and Al Sinaina. The centre of this 
governorate is the Wilayat of Al Buraimi; Al Dakhiliyah Governorate which includes the 
wilayats of Nizwa, Bahla, Manah, Al Hamra, Adam, Izki, Samayil and Bid Bid. The centre 
of this governorate is the Wilayat of Nizwa; Al Sharqiyah South Governorate containing 
the affiliated wilayats of Sur, Al Kamil W’al Wafi, Jaalan Bani Bu Hassan, Jaalan Bani Bu 
Ali and Masirah. The centre of this governorate is the Wilayat of Sur; Al Sharqiyah North 
Governorate that includes the wilayats of Ibra, Al Mudhaibi, Bidiya, Al Kabil, Wadi Bani 
Khalid and Dima W’attayeen. The centre of this governorate is the Wilayat of Ibra; Al 
Dhahirah Governorate including the affiliated wilayats of Ibri, Yankul and Dhank. The 
centre of this governorate is the Wilayat of Ibri; and Al Wusta Governorate which contains 
Haima, Mahout, Al Duqm and Al Jazir wilayats. The centre of this governorate is the 
Wilayat of Haima. Dhofar Governorate, with the affiliated wilayats of Salalah, Taqah, 
Murbat, Dhalkut, Rakiout, Thumrayt, Shaleem, Sadah, Muqshin and Mazyounah has its 
centre in the Wilayat of Salalah. 
According to the 2010 census, the total human population of Oman was 2,773,479, with 
1,957,336 Omanis and 816,143 expatriates (NCSI, 2010). The agricultural census of 
2004/2005 revealed that about 30% of the population was working in the agricultural 
sector (MAF, 2005). 
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Figure 1.1 Map of Oman  
 
1.2.2 Livestock in Oman 
Agriculture, livestock and fisheries are among the oldest and most important sectors of the 
Omani economy. These play a vital part in feeding the population, providing employment 
for large numbers of Omanis and the economy. The Batinah Region has the most date 
palms, mango and lime trees, while the Governorate of Dhofar has the most coconut 
palms. Agricultural advice and guidance programmes have been adopted to promote the 
use of high-quality fertilizers and seeds, modern irrigation systems have been introduced 
on the farms and barriers have been built to provide protection against floods. 
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Livestock play an important role in most national economies through food production, 
generation of cash returns for urban and rural populations, means of transportation, 
providing by-products and making employment opportunities for the population (FAO, 
1996). Livestock form a major capital reserve for farming households (FAO, 2003). 
However livestock production is under continuous threat by existing and emerging 
diseases that may result in direct and indirect losses to the livestock owner as well as to the 
national economy (FAO, 1996). 
According to the agricultural census, the total number of livestock (sheep, goats, cattle and 
camels) in the sultanate was estimated at 2,327,071 and these were raised on 154,146 
holdings (Table 1.1) (MAF, 2005). Following the completion of the camel counting and 
numbering project in the Governorate of Dhofar, a national strategy was introduced to 
reduce the number of camels by 50%. This was developed to restore the balance between 
the number of camels and the natural pastures and to increase the amount of water 
available by reducing the area used for the production of animal fodder. 
1.3 Issues 
Brucellosis is one of the most economically important worldwide contagious zoonotic 
diseases. Globally, the disease is endemic in many regions including the Middle East, Sub-
Saharan Africa, India, China, Peru, Mexico, central and southwest Asia and the 
Mediterranean region. Only a few countries are free of the disease including Australia, 
New Zealand, Japan and Canada (OIE, 2012). 
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Table 1.1 Number of livestock present in the Governorates of the Sultanate (MAF, 2005, Agriculture Census) 
Governorates Sheep Goats Camels Cattle 
No. of 
animals 
No. of 
holdings 
No. of 
animals 
No. of 
holdings 
No. of 
animals 
No. of 
holdings 
No. of 
animals 
No. of 
holdings 
Muscat 13855 1699 47713 3424 52 21 4447 1073 
Batinah 110572 8183 430005 23891 5626 1273 66411 14426 
Musandam 5609 470 67977 2057 38 12 325 76 
Al Dhahirah 95047 4517 243596 8234 15641 1333 22553 4953 
Al 
Dakhiliyah 
43499 4073 203057 8756 6730 1064 19245 5547 
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Governorates Sheep Goats Camels Cattle 
Al Sharqiyah 60012 8073 322858 16885 12779 3585 14642 6347 
Al Wusta 14867 1040 71819 2043 22906 1572 43 20 
Dhofar 7605 343 170123 4650 53527 6087 173892 8419 
Total 351066 28398 1557148 69940 117299 14947 301558 40861 
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In 1986, a study conducted by Ismaily et al. (1988) revealed that the seroprevalence of 
brucellosis in Oman was 2.9, 0.9, 1.6 and 3.6% in cattle, goats, sheep and camels, 
respectively. However, by 2003 a study conducted in the southern region revealed that the 
seroprevalence had risen to 3.67 and 4.5% in cattle and small ruminants, respectively but 
had decreased in camels to 1.07% (MAF, 2003b). In contrast the northern region was 
considered to be free from disease since no disease had been reported since 1986. To 
confirm this a pilot serological study was conducted by the Central Veterinary Laboratory 
(CVL) in 2006 and 1007 samples were collected from small ruminants (306 sheep and 701 
goats) in the main areas of the northern region (Batinah, Al Dakhiliyah, Al Dhahirah and 
Al Sharqiyah). Of these samples 13 were positive (1 sheep from Batinah, 2 samples (1 
sheep, 1 goat) from Al Dakhiliyah and 10 samples from goats from Al Dhahirah region). 
No positive samples were found from the Al Sharqiyah region (MAF, 2006). 
Historically the reports for brucellosis in the southern region varied from 1997 until 2001 
as shown in Table 1.2. In contrast, during the period 1998 until 2002 between 133 and 316 
human cases were reported in Oman (both the southern and northern region of the 
Sultanate) (MOH, 2003). Most cases were in humans living in the southern region (Table 
1.3). 
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Table 1.2 Passive Seroprevalence (%) of brucellosis in different animals from 1997 to 
2001 (MAF, 2001) 
Year Sheep Goats Cattle Camels Total 
1997 0.0  8.3  16.7  0.0  9.6  
1998 0.0  18.2  14.3  0.0  13.3  
1999 0.0  24.3  14.3  18.2  19.2  
2000 0.0  19.2  6.9  9.1  11.8  
2001 0.0  8.3  0.0  7.1  4.8  
 
An observational study examining three years of data by the Dhofar Hospital revealed that 
63% of cases were due to consumption of raw milk, especially from cattle or camels, and 
83% of patients had a history of contact with live animals. The source of infection in 4.5% 
of cases was unknown. Most (91%) patients had a fever and 70% had arthritis (MOH, 
2003). 
In Oman, B. melitensis biovar-1 is the only type that has been isolated from cattle, camels, 
sheep and goats in the southern region (MAF, 2003b). However a comprehensive 
epidemiological study on the strains and types of Brucella infecting animal and humans in 
the Sultanate has not yet been undertaken.  
In 2003, a national program to control brucellosis in animals was approved by the 
government. This 12 year program was divided into four phases each of 3 years. The first 
phase concentrated on vaccination of cattle and small ruminants using the rev-1 vaccine. 
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The vaccine was administered at the dose recommended by the FAO (1995) (single dose 
for young animals at 4-8 months of age and a repeated reduced dose for adults). The aim of 
the program was to vaccinate 70% of the total population each year. Camels were not 
included in the program due to a lack of knowledge on the vaccine’s efficacy in this 
species and uncertainty over the safety of milk after vaccination. 
In conclusion, brucellosis was reported by Mackinnon in 1979 in the southern region of 
Oman (Nicoletti, 1986) with both animal and human cases being reported. The highest 
number of human cases was reported in 1998 with around 300 cases recorded (MOH, 
1998). 
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Table 1.3 Brucellosis reported in humans (1998 – 2002) (MOH, 2003) 
Governorate 
Year 
1998 1999 2000 2001 2002 
Dhofar 
305 
(99.3%) 
309 
(97.8%) 
302 
(98.4%) 
159 
(98.1%) 
127 
(95.4%) 
Muscat 1 2 2 1 3 
N. Batinah 1 3 0 0 0 
S. Batinah 0 0 0 1 0 
Al Dakhiliyah 0 2 0 0 1 
N. Al Sharqiyah 0 0 0 1 1 
S. Al Sharqiyah 0 0 0 0 0 
Al Dhahirah 0 0 2 0 0 
Musandam 0 0 0 0 0 
Al Wusta 0 0 1 0 1 
Total 307 316 307 162 133 
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This study was designed to investigate the epidemiology of brucellosis in Oman from both 
an animal and human point of view in order to determine the prevalence of disease, to 
identify the risk factors associated with disease and to type the strains of Brucella present 
in Oman. 
1.4 Objectives: 
The general aim of this project was to undertake a study on brucellosis using different 
diagnostic tools to determine the distribution of disease in Oman and to identify putative 
risk factors for disease. 
The specific aims of the project outlined in this thesis were to: 
1- Map the distribution of disease in Oman using geographical information systems 
(GIS). 
2- Determine the seroprevalence of brucellosis in Oman and to establish the types of 
Brucella present in Oman recently and previously isolated and their genetic 
relationship. 
3- Determine the susceptibility of Brucella to the currently available antibiotics. 
4- Evaluate different diagnostic tests for the diagnosis of brucellosis in Oman. 
 
In the following chapter the key literature on Brucella relevant to the aims of this project is 
reviewed. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Etiologic Agent of Brucellosis 
Brucellosis is caused by a gram-negative coccobacillus organism which belongs to the 
family Brucellaceae (Meyer, 1990; Bridges and Halling, 1994). Brucellae are small, non-
motile, non-sporing, gram-negative coccobacilli short rods. They grow rather slowly on 
ordinary nutrient media while their growth is improved by the addition of serum or blood. 
They are aerobic and there is no growth under strictly anaerobic conditions (Alton et al, 
1975a). The Brucella species are intracellular parasites of humans and animals and can 
usually be found in the reticuloendothelial and reproductive systems. Typically Brucella 
spp. occur as small gram-negative coccobacilli, but coccal and bacillary forms also occur. 
The cells are short and slender; the axis is straight; the ends are rounded; and the sides may 
be parallel or convex outwards. In length they vary from about 0.5 - 0.7 μm, in breadth 
vary from 0.5 - 1.5 μm occurs in single form (Ray and Steel, 1979) and commonly are 
found in pairs and rarely in groups (Alton et al, 1975a). 
All Brucellae are fastidious organisms which usually grow in nutrient-rich media within 
48-72 hours of incubation at 37ºC in a 5% CO2 atmosphere. The organisms are aerobic, 
non-encapsulated and catalase and oxidase positive. They do not ferment carbohydrates 
and have variable urease activity (Young, 1995).  
Brucella species have a strong host preference, which is evident in their ability to establish 
chronic infection in individuals and maintain transmission and infection in populations of 
specific animal species (Glynn and Lynn, 2008). However, almost all Brucella spp. can 
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infect mammalian species other than their preferred host; for example, both B. melitensis 
and B. suis are capable of colonizing bovine udders and therefore contaminating cows' 
milk (Ewalt et al, 1997; Kahler, 2000). Brucella are facultative intracellular organisms, 
classified according to the presence or absence of lipopolysaccharide (S-LPS), which is a 
major component of virulence and is used for differentiating strains into smooth or rough 
types. The smooth strains of B. melitensis, B. abortus and B. suis are serious pathogens 
infecting both humans and other animals (Ko and Splitter, 2003). Species which are free of 
or have little S-LPS, such as B. ovis, B. canis and B. neotomae are classified as rough 
strains of low virulence. A high level of homology has been identified among Brucella 
species by molecular characterization (Paulsen et al, 2002; Halling et al, 2005). Brucellae 
are coccoid if culture is undertaken directly from fresh aborted material, however they are 
pleomorphic on subculture or if culture is delayed. On MacConkey agar the colonies 
appear in two forms and are 0.1 to 0.2 mm in diameter. The smooth form is glistening, 
translucent and bluish-green in colour while the rough form has a granular appearance and 
is yellowish-white in colour. The organism is oxidase, catalase and urease positive and can 
reduce nitrate to nitrite (Alton et al, 1988; Moyer et al, 1991). The number of species has 
increased to 10 over recent years as several new Brucella species have been isolated from 
marine mammals, voles, rodents, and from an infected human breast implant (Foster et al, 
2007; Scholz et al, 2008c, 2010). Brucella melitensis, B. abortus and B. suis are the three 
species generally associated with human disease. Rare cases of human infection with B. 
canis have been reported, while human cases of B. ovis and B. neotomae infection have not 
been reported. Little is known about the capacity of the new Brucella species to cause 
infection. One possible laboratory-acquired infection with a marine mammal isolate has 
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been reported (Brew et al, 1999) and one specific sequence type (ST27) has been 
associated with three human infections in Peru and New Zealand (Whatmore et al, 2008). 
Interestingly, these patients had no contact with marine mammals; however contact with 
raw fish was a common feature. Recently, there has been a report of B. melitensis biovar 2 
found in catfish in Egypt, suggesting that fish may constitute a novel source of infection 
(El-Tras et al, 2010). 
2.2 History and Zoonotic Importance of Brucellosis 
The infectious agent of brucellosis was first isolated by David Bruce from the spleen of 
soldiers dying of Mediterranean fever on the Island of Malta in 1887 (Alton, 1990a). Bruce 
named the agent Micrococcus melitensis. In domestic animals, brucellosis has been 
commonly known as enzootic abortion or bovine contagious infection, epizootic abortion, 
infectious abortion, contagious abortion, slinking of calves, Bang’s disease and ram 
epididymitis. Human brucellosis is also known as undulant fever, Malta fever, 
Mediterranean fever, gastric fever, Mediterranean gastric fever, Gibraltar-Rock fever, 
Cyprus fever, Neapolitan fever, intermittent gastric fever, intermittent typhoid fever and 
pseudotyphus (Ray and Steel, 1979). 
Brucellosis is potentially a serious zoonosis and, with few exceptions, infections in humans 
result from direct or indirect contact with animals or animal products. The main source of 
infection for the general population is dairy produce prepared from infected milk with B. 
melitensis representing the greatest hazard. The milk of infected sheep and goats may 
contain large numbers of viable organisms, which become concentrated in products such as 
soft cheese (Ongör et al, 2006). Soft cheese has been recognized as one of the major 
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vehicles of infection in Turkey (Turgut et al, 2006). Direct contact with livestock is a well 
documented source of infection. Infection may occur through cuts and abrasions on the 
skin, via the conjunctiva and by inhalation. These routes of infection are important for 
farmers, veterinarians and butchers, who are all at increased risk of infection through 
contact with animals and animal products. In 1971, Ogutman carried out a sero-
epidemiological study on 2626 individuals in Erzurum, a city in eastern Turkey. In this 
study 1.5% of people who had been in close contact with animals but who displayed no 
evidence of clinical brucellosis were seropositive compared with 1.3% in people who had 
not been in contact with animals and had no evidence of clinical brucellosis, 18% of 
individuals who had been in close contact with meat or meat products and who had no 
clinical evidence of brucellosis, 7.4% of individuals who had not been in contact with 
animals or meat or meat products with brucellosis but who consumed large amounts of 
milk or milk products, 11.7% of workers who slaughtered cattle and 39.9% of workers 
who slaughtered sheep (Ogutman, 1972). The overall proportion of individuals 
seropositive to brucellosis was 13.3%. Another seroprevalence study was carried out in 
different occupational groups of veterinarians and veterinary assistants, slaughterhouse 
workers and controls in Kocaeli, a city in northwest Turkey. Serum samples were 
evaluated using the Rose Bengal Plate test (RBPT), ELISA and standard agglutination 
tests. The ELISA showed a significantly higher brucellosis seroprevalence (4.8%) in the at-
risk groups compared to 0% in the control group. All positive samples were from vets. The 
highly infectious nature of Brucella makes laboratory-acquired brucellosis a common 
problem in diagnostic and research laboratories. At the Ankara Numune Education and 
Research Hospital, when 48 healthcare workers with a professional risk of infection were 
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questioned, 12 were found to have had brucellosis, giving an infection risk of 8% per 
employee year (Ergonul et al, 2004). The main reasons for these infections were the 
absence of appropriate safety equipment and poor laboratory practices. 
The situation of human brucellosis was reviewed in 1995 and findings are summarised in 
Table 2.1 (Abdou, 1996). 
2.3 Taxonomy of Brucellae 
The taxonomy of genus Brucellae as a single monospecific genus or multiple species has 
been a cause of controversial debate among scientists. The biochemical characteristics and 
host preference differences led to the classification of the genus initially into six species. 
However, DNA-DNA hybridization studies have revealed a great level of homogeneity 
between all species and they may be considered as a single species of B. melitensis (Verger 
et al, 1987). 
Based on DNA homology, it has been proposed that all six members of the genus are 
actually biovars of a single species (Halling et al, 2005). Four members of the genus, B. 
abortus, B. suis, B. canis, and especially B. melitensis are able to cause infection in humans 
(Young, 1995). 
According to their host specificity and phenotypic characters, the genus Brucella contains 
a group of very closely related bacteria. Brucella melitensis primarily affects sheep and 
goats (Sahin et al, 2008; Corbel and Brinley-Morgan, 1984), Brucella abortus primarily 
affects cattle, Brucella suis primarily affects pigs, Brucella ovis affects rams and ewes, 
Brucella neotomae affects desert wood rats, and Brucella canis affects male dogs and 
19 
 
bitches (Corbel and Brinley-Morgan, 1984; Verger et al, 1985; Alton et al, 1988; Corbel 
and Macmillan, 1998b). However, recently, four more species have been identified B. ceti 
(cetacean), B. pinnipedialis (pinnipeds) (Blasco and Molina, 2011), B. microti (vole) and 
B. inopinata (humans) (Scholz et al, 2008c; Godfroid et al, 2011) and 17 biovars have 
been characterized (Osterman, 2006). (Moved from Etiologic agent) 
Common genetic fingerprinting methods, such as pulsed-field gel electrophoresis and 
multilocus sequence typing analyses, have revealed little variability between isolates of a 
given species. However, multilocus sequence typing has been useful in identifying the 
relationship between species and among biovars within a species, and in general, the 
findings support the classification of Brucella into the 6 known species, with at least 1 new 
species representing the newer marine strains of Brucella (Whatmore et al, 2007). The 
genus Brucella belongs to the family Brucellaceae within the order Rhizobiales of the 
class Alphaproteobacteria. The closest phylogenetic neighbour of the genus Brucella is the 
genus Ochrobactrum, a saprophyte that occasionally infects humans. Until 1985, the genus 
Brucella consisted of 6 species, B. melitensis, B. abortus, B. suis, B. canis, B. neotomae 
and B. ovis, known as the six classical species. All these species are genetically highly 
related. In 1985, it was proposed combining the six species into a single species, B. 
melitensis, with the other species to be recognised as biovars (e.g., B. melitensis biovar 
Abortus 1) (Verger et al, 1985). In 2003, however, the Subcommittee on the Taxonomy of 
Brucella unanimously agreed on a return to the pre-1986 taxonomic nomenclature of the 
genus Brucella, implying re-approval of the six classical Brucella nomenspecies with their 
corresponding biovars (Osterman, 2006). Since 2007, B. ceti and B. pinnipedialis, which 
preferentially infect cetaceans and pinnipeds, respectively, have been recognized as new 
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Brucella species (Foster et al, 2007). In 2008, Brucella microti was first isolated from the 
common vole (Microtus arvalis) (Scholz et al, 2008 a,b,c) and recently B. inopinata was 
isolated from an infected breast implant in a woman displaying clinical signs of brucellosis 
(Scholz et al, 2010). This latter species is the only one that has yet to have been isolated 
from an animal reservoir. Prospective Brucella species have also been isolated from three 
native rat species in Australia (Tiller et al, 2010) and from two cases of stillbirth in non-
human primates (Schlabritz-Loutsevitch et al, 2009). The preferential hosts and the 
pathogenicity for humans of the 10 recognized Brucella species are depicted in Table 2.1. 
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Table 2.1 Brucella species, preferred host and pathogenicity for humans (Godfroid
 
et al, 2011). 
Brucella species Biovars Preferential host(s) Pathogenicity for humans 
B. melitensis 1–3 Sheep, goat High 
B. abortus 1–6, 9 Cattle High 
B. suis 
1, 3 Pig High 
2 Wild boar, hare No 
4 Reindeer, caribou High 
5 Rodents No 
B. neotomae – Desert wood rat No 
B. ovis – Ram No 
B. canis – Dog Moderate 
B. ceti – Cetaceans Unknown 
B. pinnipedialis – Pinnipeds Unknown 
B. microti – Soil, vole, fox Unknown 
B. inopinata – Unknown High 
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The organisms continue to affect human populations living in rural areas in the 
Mediterranean Basin (Portugal, Spain, Southern France, Italy, Greece, Turkey, North 
Africa), South and Central America, Eastern Europe, Asia, Africa, the Caribbean, the 
Middle East, and Latin American countries where the organisms are endemic (Gotuzzo et 
al, 1986; Shehabi et al, 1990; Yagupsky, 1994).  
2.3.1 Brucella abortus 
Brucella abortus, initially named as Bacillus abortus by Bang in 1897 and eventually 
renamed in 1920, is the etiological agent of bovine brucellosis, an infection that leads to 
spontaneous abortion, premature calving, and infertility in cattle. Most species of Brucella 
are primarily associated with certain hosts; however, infections can also occur in other 
species, particularly when they are kept in close contact. Maintenance hosts for B. abortus 
include cattle, bison (Bison spp.) water buffalo (Bubalus bubalus) (Longo et al, 2009), 
African buffalo (Syncerus caffer), elk (Jensen et al, 1995) and camels (Musa and Shigidi, 
2001). A feral pig population has recently been reported to maintain B. abortus. A variety 
of other species can become "spill-over" hosts in areas where this organism is enzootic. 
Brucella abortus has also been reported in horses, sheep, Rocky Mountain bighorn sheep, 
goats, chamois, pigs, raccoons, opossums, dogs, coyotes, foxes, wolves and other species. 
Moose and llamas can be infected experimentally (Forbes and Tessaro, 1996).  
In animals, B. abortus is usually transmitted by contact with the placenta, fetus, fetal fluids 
and vaginal discharges from infected animals. Many infected cattle become chronic 
carriers and In utero infections may also occur (Ray and Steel, 1979; Beveridge, 1983; 
Alton et al, 1988). Venereal transmission seems to be uncommon, however, transmission 
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by artificial insemination is reported to occur when contaminated semen is deposited in the 
uterus (WHO, 2006b). Millions of organisms are shed in the afterbirth and in fluids 
associated with calving and abortions. The disease is spread when cattle ingest 
contaminated feed or lick calves or aborted fetuses from infected cattle (Alton et al, 1988; 
Hall, 1989; Crawford et al, 1990b).This species is able to cross the species barrier affecting 
other livestock and humans (Young, 1995).  
2.3.2 Brucella melitensis 
Brucella melitensis, the first species in the genus Brucella to be described, causes abortions 
in female goats and sheep, unilateral orchitis in males and Malta fever in humans (Alton, 
1990a). Sir David Bruce, a British army surgeon, discovered the organism in 1887 as the 
causative agent of Mediterranean or Malta fever (Moreno and Moriyon, 2002). The 
organism now bears his name coupled with “melitensis,” which is Latin for Malta. 
Brucella melitensis is prevalent in Mediterranean and Middle Eastern countries through 
Central Asia to China and southern areas of the former Soviet Union. Some areas of Africa 
and India, as well as Central and South America, are also affected. This species’ natural 
hosts are goats and sheep; however the organism is the least species-specific of the 
Brucellae (Alton, 1990a). Sheep and goats and their products are the main source of 
infection, although B. melitensis in cattle has emerged as an important problem in some 
southern European countries, Israel, Kuwait, and Saudi Arabia. The disease in goats 
resembles the disease in B. abortus-infected cattle (Enright, 1990). Brucella melitensis 
infection is particularly problematic because B. abortus vaccines do not effectively protect 
against the infection. Consequently bovine B. melitensis infection is emerging as an 
increasingly serious public health problem in some countries with the spread of the disease 
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through unpasteurized dairy products.  
The organism is highly pathogenic for humans, making it one of the most serious zoonoses 
in the world. A vaccine has not yet been developed in humans, and animal vaccines are 
pathogenic to humans. Although rarely fatal for humans, it is highly contagious, difficult to 
treat, and easily transmitted, making it ideal for use in bioterrorism (CDC, 2008). 
2.3.3 Brucella suis 
Brucellosis caused by B. suis was first described by Traum in 1914 in swine herds in 
Indiana. It was initially thought to be a pathogenic B. abortus but was later named B. suis 
by Huddleson (Alton, 1990b). Comparison of the closely-related B. suis and B. melitensis 
genomes revealed a set of genomic variations that could be responsible for the differences 
in virulence and host preference between these organisms (Paulsen et al, 2002). Domestic 
and feral swine are natural hosts of B. suis (Norton and Thomas, 1976; Becker et al, 1978). 
Brucellosis caused by B. suis is considered to be a venereal disease with the infected boar 
passing the disease on to uninfected sows (Alton, 1990b). Contraction of the human 
disease is primarily limited to the occupational hazards of farmers and abattoir workers. 
Brucella suis was the first bio-weapon developed by the U.S.A. military during the 1950s. 
It is seen as a potential bioterrorism threat that could be used to target military personnel, 
civilians or food supplies (Paulsen et al, 2002). 
2.3.4 Brucella ovis 
A rough form of Brucella, B. ovis is the primary cause of brucellosis in sheep. Brucella 
ovis was first isolated in New Zealand and Australia (Blasco, 1990). It has also been found 
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in the USA, Mexico, Canada, South Africa and parts of Asia, Europe and South America 
(Blasco, 1990). 
Brucella ovis may be transmitted venereally via an infected ewe. It can also be passed from 
one ram to another ram by direct contact, sharing of pens or through shearing wounds 
(Blasco, 1990). Ewes rarely show symptoms and only a small percentage of them actually 
abort (Grilló et al, 1999). However, some ewes may develop placentitis as a result of 
exposure to the organism which may result in the birth of weak lambs (Thoen et al, 1993). 
In sexually-mature rams, B. ovis causes epididymitis, orchitis and infertility. Only 
approximately 40% of rams with low antibody titers shed the organism, in contrast to 
100% of high titer reactors (West et al, 2002). 
2.3.5 Brucella canis 
Brucella canis was first recognized in the late 1960s as a cause of abortions and 
reproductive failure, and it has since been documented in several countries (Carmichael, 
1990). It is especially common in Mexico, Central and South America and in the southern 
states of the USA. It has been diagnosed in commercial or research breeding beagle 
kennels in several other countries, including Japan and more recently in The People's 
Republic of China. The disease has been reported sporadically in Europe (Wanke, 2004). 
Humans may be infected; however, dogs and other canine species are believed to be the 
only true hosts. Although canine brucellosis does not typically end in an animal’s death it 
does result in reproductive failure (Hollett, 2006). 
Brucellosis in dogs is mainly transmitted through sexual contact. In the female dog, B. 
canis survives in the vaginal and uterine tissues and is often excreted for life. The infected 
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female is frequently clinically healthy, although she can spread the bacteria through urine, 
aborted fetuses or most commonly through the act of breeding. Semen from infected males 
usually contains large numbers of abnormal sperm and inflammatory cells, especially 
during the first three months following infection. Chronically-infected males may have no 
sperm or reduced numbers of immature sperm. Infected males harbor organisms in the 
prostate gland and epididymides (Wanke, 2004). 
2.3.6 Brucella neotomae 
Brucella neotomae was isolated from the desert wood rat, Neotoma lepida, by Stoenner 
and Lackman in 1957 (Cameron and Meyer, 1958). It was identified as a new species of 
Brucella on the basis of conventional genus speciation, including the organism’s behavior 
on differential dye media, CO2 requirements and H2S production. The organism was found 
to be distinctly different from the three main species, B. abortus, B. melitensis, and B. suis, 
and all sub-classifications within the species (Huddleson et al, 1957; Cameron and Meyer, 
1958). 
2.3.7 Marine Mammal Species 
Recently, a number of Brucella isolates have been described whose properties do not 
closely agree with the descriptions of the recognized species. The status of most of these 
strains has not been finalised, and it is possible that some or all of them will eventually be 
identified as atypical cultures of existing species or biovars. These new Brucella species 
have been isolated from marine mammals, predominantly seals and cetaceans and an otter, 
from Scotland and the coast around northern England and from a bottle-nosed dolphin 
from California (Ewalt et al, 1994). Identification of these organisms has been based on 
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serology, staining, metabolic phenotype, culture characteristics and phage typing (Jahas et 
al, 1997; Clavareau et al, 1998; Vizcaino et al, 2004). Characterization of these strains has 
failed to assign them to a known species of Brucella, and questions have been raised 
concerning the prevalence of infection, distribution and possible pathogenicity and 
zoonotic potential of these species (Ewalt et al, 1994; Foster et al, 1996).  
2.4 Clinical picture in animals and humans 
The incubation period varies with the species and stage of gestation at infection. In cattle, 
reproductive losses typically occur during the second half of the pregnancy with abortions 
or stillbirths occurring two weeks to five months after infection. In pigs, abortions can 
occur at any time during gestation whilst in dogs they occur approximately 7 to 9 weeks 
during pregnancy, however early embryonic deaths have also been reported after 2 to 3 
weeks. Generally, brucellosis is a chronic infectious disease of the reproductive tract 
leading to abortion, reduced fertility, retained foetal membranes, orchitis, epididymitis 
and/or impaired fertility in cattle (Huddleson, 1943; Cunningham, 1977; Ray and Steel, 
1979; Enright et al, 1984; Acha and Szyfres, 1987; Enright, 1990; Cheville et al, 1993). 
Abortion storms can occur with up to 80% of pregnant infected cows aborting 
(Cunningham, 1977). Subsequently the number of abortions usually decreases, as cows 
which have aborted in one year may deliver normal calves in subsequent years (Huddleson, 
1943; Berman, 1981; Stevenson and Hughes, 1988). Crawford et al. (1990) reported that 
3% of infected females would lose their calves in subsequent years. 
Although much has been written about bovine brucellosis, little has been written about the 
gross pathological lesions seen in naturally infected animals. Cheville et al. (1992) stated 
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that field infections were typically subclinical in calves and non-pregnant cattle. Palmer et 
al. (1996b) and Cheville et al. (1996) failed to observe lesions in aborted foetuses or calves 
that died within 1 to 2 days of birth after experimental challenge of cows with B. abortus 
strain RB51 and strain 2308. However in the study of Palmer et al. (1996a) large numbers 
of bacteria were isolated from the lung, lymph nodes, allantoic fluid and rectal swabs of 
foetuses. They observed that 8 of 10 pregnant cattle which were experimentally infected 
with 1 x 10
10
 colony forming units (cfu) of B. abortus strain RB51 were febrile 
(temperature 39.1 to 41.1

C) during the first 24 to 48 hours after challenge, although no 
signs of depression or loss of appetite were apparent. In contrast, Cheville et al. (1992) 
demonstrated that after calves were challenged with 5 – 7 x 109 cfu of B. abortus strain 
2308, no calves developed fever or other clinical signs, even though they developed high 
levels of persistent antibody titres. 
Retained placentas are frequently reported in cows following abortion (Huddleson, 1943; 
Beveridge, 1983). Cunningham (1977) considered that this was a result of the prematurity 
of the parturition rather than from uterine infection. Nevertheless Payne (1959), Mollelo et 
al. (1963) and Palmer et al. (1996a) demonstrated that B. abortus had a tropism for the 
bovine placental trophoblasts and could induce placentitis resulting in premature birth. 
Cheville et al. (1993) reported severe acute diffuse purulent placentitis and necrosis with 
cloudy placental fluid in artificially infected cattle. 
In cattle, brucellosis is primarily a disease of females but entire males can also be infected, 
but they do not readily spread the disease. The organism localizes in the testicles of the 
bull, resulting in orchitis. In the female, the organism is prevalent in the udder, uterus and 
lymph nodes adjacent to the uterus. The infected cows exhibit signs which may include 
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abortion during the last trimester of pregnancy, retained afterbirth and birth of weak calves 
(Enright, 1990). Typically, infected cows usually abort only once and subsequent calves 
may be born either weak or healthy. Some infected cows will not exhibit any clinical signs 
of disease and may give birth to normal calves. 
Acha and Szyfres (1987) considered that the presence of metritis following abortion could 
result in permanent infertility and Huddleson (1943) observed that some infected females 
subsequently failed to show signs of oestrus. Subclinical mastitis has also been reported 
and the bacterium may be found in the milk (Beveridge, 1983). 
Although infection of male cattle with B. abortus often fails to lead to the development of 
clinical signs (Beveridge, 1983), seminal vesiculitis, epididymitis and orchitis can occur 
(Huddleson, 1943; Acha and Szyfres, 1987; Stevenson and Hughes, 1988) leading to 
reduced libido and fertility (Plant et al, 1976; Acha and Szyfres, 1987). 
Hygromas have been reported in infected cattle (Huddleson, 1943; Beveridge, 1983) and 
Van der Schaff and Roza (1940) reported that they were common in Zebu cattle in Java, 
Indonesia. Brucella abortus has been isolated from such lesions (Van der Schaff and Roza, 
1940; Tounkara et al, 1994). 
Brucella melitensis mainly causes abortions, stillbirths, the birth of weak offspring and 
retained foetal membranes. Sheep and goats usually abort only once, but reinvasion of the 
uterus and shedding of organisms can occur during subsequent pregnancies. Milk yield is 
significantly reduced in animals that abort, as well as in animals whose udder becomes 
infected after a normal delivery. However, clinical signs of mastitis are uncommon. Acute 
orchitis and epididymitis can occur in males, and may result in infertility. Arthritis is seen 
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occasionally in both sexes. Many non-pregnant sheep and goats remain asymptomatic 
(Acha and Szyfres, 1987).  
Infection with B. melitensis mainly causes abortions, stillbirths, the birth of weak offspring 
and retained foetal membranes. Sheep and goats usually abort only once, but reinvasion of 
the uterus and shedding of organisms can occur during subsequent pregnancies. The milk 
yield is significantly reduced in animals that abort, as well as in animals whose udder 
becomes infected after a normal birth, however mastitis is rare. Acute orchitis and 
epididymitis can occur in males, and may result in infertility. Arthritis is occasionally seen. 
Many non-pregnant sheep and goats remain asymptomatic (European Commission, 2001). 
Moved from B. melitensis 
Brucella canis can cause abortions and stillbirths in pregnant dogs. Most abortions occur 
late, particularly during the seventh to ninth week of gestation. Abortions are usually 
followed by a mucoid, serosanguinous or gray-green vaginal discharge that persists for up 
to six weeks. Early embryonic deaths and resorption have been reported a few weeks after 
mating, and may be mistaken for failure to conceive. Some pups are born alive but weak 
and most die soon after birth. Epididymitis, scrotal edema, orchitis and poor sperm quality 
may be seen in males. Scrotal dermatitis can occur due to self-trauma. Unilateral or 
bilateral testicular atrophy can be seen in chronic infections, and some males become 
infertile (Carmichael, 1990). The bacteria also can infect the developing fetuses resulting 
in abortion after 45-55 days of gestation, perinatal mortality and subsequent infertility 
(Carmichael and Joubert, 1988). In males, the bacteria survive in the testicles and seminal 
fluids with bacteria spread via the urine or semen (Moore and Kakuk, 1969). Infected 
males often display no clinical signs except in advanced cases where epididymitis, 
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testicular atrophy, scrotal dermatitis and infertility may be observed (Carmichael, 1990) 
moved from B. canis 
In sows, abortion is the primary indicator of disease, which occurs at any stage of the 
pregnancy. An infected sow may deliver some healthy live piglets and have some born 
dead or die shortly after birth. Mastitis may also be observed. In boars, there may be 
Brucellae present in the semen without any visual indications of disease. There may also 
be unilateral swelling and atrophy of the epididymes and testes usually resulting in 
infertility. Reports of lameness; swollen joints, bursae and tendons; and paralysis because 
of abscess formation near the spine have also been documented (Alton, 1990b). Moved 
from B. Suis 
In common, the major clinical sign of brucellosis in animals is infectious abortion as a 
result of the bacteria invading the placenta and fetus. The infected animals effectively 
remain carriers for the rest of their lives, even though they may abort only once. During 
this time they excrete large numbers of organisms in their milk, as well as in the products 
of subsequent, apparently normal, parturitions. Infection in humans can occur through the 
ingestion of raw milk or milk products, or by handling infected animals, especially around 
the time of parturition. Pasteurization effectively protects the urban population in most 
regions, but stockowners and their families often drink raw milk and are at risk from direct 
contact with infected animals (Davies and Casey, 1973, Castell et al, 1996; Anon, 2014). 
Horses are also attacked with B. abortus which commonly results in inflammation of the 
atlantal bursa (poll evil) and paraspinosus bursa (fistulous withers) (Hinton et al, 1977; 
O’Sullivan, 1981; Acha and Szyfres, 1987). Cohen et al. (1992) reported that nine (37.5%) 
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of 24 horses with fistulous withers were seropositive to B. abortus. Although abortion has 
been recorded in horses (McCaughey and Kerr, 1967), Denny (1973) assumed that 
subclinical infection was the most common form of brucellosis in this species. 
There is little information on the effects of brucellosis in marine mammals but Brucella has 
been isolated from the reproductive organs of some marine species. In rare cases, 
infections have also been linked to lesions or clinical disease. Brucella-associated 
abortions and placentitis have been reported in two captive bottlenose dolphins and a wild 
Atlantic white-sided dolphin. Recently, Brucella has also been isolated from a dead Maui’s 
dolphin calf in New Zealand. Brucella-associated epididymitis has been reported in 
porpoises, and orchitis, suspected to be brucellosis, has been reported in minke whales 
(Clavareau et al, 2009).  
Brucella-associated meningoencephalitis has been reported in three stranded striped 
dolphins and other signs of Brucella-associated systemic disease have been seen in 
Atlantic white-sided dolphins with lesions of hepatic and splenic necrosis, lymphadenitis 
and mastitis. Brucella has also been identified as a possible secondary invader or 
opportunistic pathogen in debilitated seals, dolphins and porpoises. It has been isolated 
from several subcutaneous abscesses. In addition, this organism has been found in organs 
with no microscopic or gross lesions, and in apparently healthy animals (Palmer et al, 
1996a). Moved from Marine Brucellosis 
The infection in humans manifests initially as an acute febrile illness or undulant fever 
(Pappas et al, 2005). However, the clinical signs in humans are not pathognomonic for the 
disease (Young, 1989a, b), and include fever, chills, weakness, general aches and pains, 
33 
 
neck pain, sweating, headaches, weight loss, anorexia, constipation, nervousness and 
mental depression (Ray and Steel, 1979; Stevenson and Hughes, 1988). Stevenson and 
Hughes (1988) considered that, because of the non-specific nature of the symptoms, 
patients often delayed seeking medical attention and consequently diagnosis was often 
delayed. Young (1983) considered that fever and lymphadenopathy were the most common 
clinical signs presented in patients suffering from brucellosis. However the variable 
symptoms and the occurrence of subclinical and atypical infections in both the acute and the 
chronic stages make the clinical diagnosis of human brucellosis difficult (Matar et al, 1996). 
In contrast to cattle, abortion in women from brucellosis is uncommon and this may be due 
to a lack of erythritol in their placenta and uterus (Ruben et al, 1991). Local skin lesions 
have also been described in humans at the site of accidental inoculations with B. abortus 
strain 19 vaccine (Corbel, 1989). 
A substantial proportion of patients present with splenomegaly and/or hepatomegaly. 
When the disease becomes chronic, a wide range of pathological conditions may occur 
including spondylitis, endocarditis and meningoencephalitis (Young, 1995; Pappas et al,
 
2005). The recommended treatment is a long course (at least 6 weeks) of combinations of 
antibiotics, notably rifampin plus tetracycline or gentamicin or (parenteral) streptomycin 
(Solera, 1997b; Ariza et al, 2007). 
2.5 Necropsy findings and microscopic lesions 
Granulomatous inflammatory lesions are frequently seen in affected organs and lymphoid 
tissues (Payne, 1959; Berman, 1981), although lesions such as necrotizing placentitis, 
testicular alteration, necrotizing orchitis and epididymitis which may be present are not 
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pathognomonic for brucellosis (Danks, 1943; Lambert et al, 1964; Crawford et al, 1990b; 
Cheville et al, 1993). In ruminant fetuses, the spleen and/or liver may be enlarged, and the 
lungs may exhibit pneumonia and fibrous pleuritis (Cheville et al, 1993). Abortions caused 
by Brucella spp. are typically accompanied by placentitis. The cotyledons may be red, 
yellow, normal or necrotic. In cattle and small ruminants, the intercotyledonary region is 
typically leathery, with a wet appearance and focal thickening (Huddleson, 1943).  
In adults, granulomatous to purulent lesions may be found in the male and female 
reproductive tracts, mammary glands, supramammary lymph nodes and other lymphoid 
tissues, bones, joints and other tissues and organs (Runells and Huddleson, 1925; Enright, 
1990). Mild to severe endometritis may be seen after an abortion (Palmer et al, 1996a), and 
males can have unilateral or bilateral epididymitis and/or orchitis (Danks, 1943; Lambert et 
al, 1964; Crawford et al, 1990b). In B. abortus-infected cattle, hygromas may be found on 
the knees, stifles, hock, angle of the haunch, and between the nuchal ligament and the 
primary thoracic spines (Bracewell and Corbel, 1980). 
  
2.6 Epidemiology of the disease 
Among the Brucellae, B. abortus, B. melitensis, and B. suis are not host-specific (Bridges 
and Halling, 1994; Corbel, 1997; FAO, 2003) being capable of infecting a wide range of 
host species, including humans (Alton et al, 1988). Brucella grows intracellularly, 
producing a variable bacteraemic phase followed by localization to the tissues of the 
genital tract and the mammary gland. Abortion is typically the first clinical sign of the 
pregnant female, with orchitis and epididymitis in males (Huddleson, 1943; Cunningham, 
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1977; Enright et al, 1984; Acha and Szyfres, 1987; Cheville et al, 1993; Corbel, 1998a). In 
particular, female animals that have reached sexual maturity are most susceptible to 
infection displaying abortions if pregnant (England et al, 2004). 
Most species of Brucella are maintained in a limited number of reservoir hosts including 
cattle, bison (Bison spp.) (Meagher and Meyer, 1994), water buffalo (Bubalus bubalus), 
African buffalo (Syncerus caffer), elk and camels (Ray and Steel, 1979; Beveridge, 1983; 
Alton et al, 1988; Hall, 1989; Crawford et al, 1990b), and feral pigs. Brucella suis contains 
more diverse isolates than other Brucella species, and these isolates have broader host 
specificity (Priadi et al, 1985). Biovars 1 and 3 are found in both domesticated pigs (Sus 
scrofa domesticus) and wild pigs, while biovar 2 has been isolated from domesticated pigs, 
wild boar (Sus scrofa scrofa) and European hares (Lepus capensis). Biovar 4 is maintained 
in caribou and reindeer (Rangifer tarandus and its various subspecies) and biovar 5 is 
found in small rodents. 
Other species can become accidental hosts, particularly for B. abortus, B. melitensis and B. 
suis (Hinton et al, 1977; Acha and Szyfres, 1987; Corbel, 1989), and can include buffalo 
(Ray and Steel, 1979), sheep, goats (Enke et al, 1959; Shaw, 1976; Luchsinger and 
Anderson, 1979), camels (Obied et al, 1996), pigs, moose, chamois, alpine ibex, raccoons, 
opossums (Tessaro, 1986), dogs, coyotes, foxes and wolves (Tessaro, 1986).  
2.6.1 Worldwide distribution 
Although brucellosis is widely distributed in the world (Figure 2.1), information on its 
distribution in many parts of the world is minimal (Beveridge, 1983; Crawford et al, 
1990b; Corbel, 1997), primarily due to its insidious nature and a lack of resources to 
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investigate the disease when compared with more spectacular diseases , such as foot-and-
mouth disease, sheep pox, Rift Valley fever and peste des petits ruminants. 
The disease appears to be endemic in the Mediterranean region (Al-Majali, 2005), central 
Asia (Baluyut and Dugui-Es, 1977; FAO, 1986), the Arabian Peninsula (Ibrahim, 1986; 
Qubain, 1986; Corbel, 1997) and as far east as Mongolia. Mexico, Peru and northern 
Argentina are also seriously affected in Latin America (Corbel, 1997). The disease has also 
been reported in Africa (Fassi-Fehri, 1975; Johnson et al, 1984; FAO, 1986; Corbel, 1989) 
and India (Corbel, 1989; FAO, 1986; Corbel, 1997). Most of North America is believed to 
be free of disease as are many countries in Northern Europe (Crawford et al, 1990b; 
Corbel, 1997; OIE, 2012). New Zealand and Australia are also considered free (Corbel, 
1997). Brucella melitensis biovar 3 is the predominant type in Mediterranean and Middle 
East, with biovar 1 predominant in Latin America. In Southern Europe, both biovars 1 and 
2 have been reported. 
Human brucellosis is endemic in Mediterranean countries and in 2003 more than 50,000 
human cases were reported in these countries (Pappas et al, 2006). An annual incidence of 
up to 78 cases/100,000 people has been reported in Middle Eastern and Mediterranean 
countries (Hartigan, 1997). However the true incidence of human brucellosis throughout 
the world is not known precisely and it would be expected to vary between areas (Alton, 
1990). Humans are dead-end hosts and the disease is generally restricted to specific 
occupational groups including veterinarians, farmers, laboratory technicians, abattoir 
workers and individuals who work with animals and their products. Fresh dairy products, 
aborted fetuses, placenta and uterine excretions are considered the major source of 
organism. Therefore, the most dangerous period for disease transmission is during lambing 
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or kidding period. For groups without occupational contact with animals, dairy products 
are the critical source of infection, especially cheese made from unpasteurized sheep and 
goat milk (FAO, 1995). During the manufacture of cheese most of the organisms are 
trapped within the clot and hence are concentrated in the cheese. The number of cases 
contracted from milk and milk products is seasonal and reaches a peak soon after lambing 
or kidding. Handling of raw wool has also been identified as a potential source of human 
infection (FAO, 1995). The epidemiology of brucellosis among humans reflects the 
epidemiology among populations of animals and the public health and economic impact of 
the disease remains of particular concern in developing countries throughout Africa, West 
Asia and some parts of Latin America (Glynn and Lynn, 2008). 
  
Figure 2.1 Global distribution of Animal Brucellosis (OIE, 2012) 
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Almost all affected countries have attempted to combat animal brucellosis using different 
strategies with varying levels of success. While disease prevalence is steadily decreasing in 
some countries, a dramatic increase in the prevalence has been reported in the Gulf and 
southern Mediterranean countries. Although brucellosis is a notifiable disease in many 
countries, the prevalence is likely to be underestimated due to underreporting or 
misdiagnosis (Hartigan, 1997). 
Animal brucellosis poses a barrier to trade of animals and animal products and could 
seriously impair the socio-economic development of a community, especially for livestock 
owners. The importance of this disease was evident in the commitment of over half of the 
total European Commission funding for animal disease control measures in 1997 to the 
control of brucellosis (Hartigan, 1997). 
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Table 2.2 Annual incidence of human brucellosis in some countries 
Country Year Survey area 
Sample 
size 
Type of data 
Frequency (%)–
incidence/100.000 
Algeria 1988–
1990 
   
36–67/100.000 
Tunisia Recent National 
  
40/100.000 
Lebanon 1984–
1986 
   
69.6/100.000 
Egypt 
1991 
Four 
governorates 
2720 All types 10.5 
1994 
 
747 Fever cases 43.2 
2000 
 
2236 
 
7 
Jordan 1986–
1991 
 
730 
  
Iraq 1988 
 
1187 
 
7.2/100.000 
Palestine 1996 Gaza 
  
8/100.000 
Turkey 1984–
1987 
 
8383 
 
13.9/100.000 
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Country Year Survey area 
Sample 
size 
Type of data 
Frequency (%)–
incidence/100.000 
Iran 
1988 
 
71051 
 
132.4/100.000 
1996 
 
30000 
  
Saudi 
Arabia 
1988 
   
79.6/100.000 
Kuwait 
1985 
 
1168 
 
68.9/100.000 
1997 
 
112 Bedouins 545.7/100.000 
Oman 1997 Dhofar 
  
200/100.000 
 
The seroprevalence in the southern part of Jordan was reported to be significantly higher 
than that of the central or northern parts. The high level in the southern regions could be 
due to either a lack of implementation of an effective control program or a high level of 
uncontrolled animal movement from Saudi Arabia (Al-Majali et al, 2007). In Jordan, the 
incidence of abortions in goat herds from brucellosis was significantly higher than that in 
sheep flocks (Al-Talafha et al, 2003). Brucella melitensis biotype 3 was the most prevalent 
isolate from the cultured aborted fetuses, although B. abortus biotype 9 has also been 
isolated from the lung of one fetus (Aldomy et al, 1992; Al-Talafha et al, 2003).  
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2.6.3.1 Age, Species and breed 
Brucellosis is commonly a disease of adult animals (sexually mature females and males). 
Young animals may contract the infection but display no clinical signs, although a transient 
and weak serological response may be detected. The susceptibility increases with 
pregnancy and after sexual maturity (Corbel et al, 2006). 
Goats seem to be the principal host for B. melitensis, with few sheep infected (Corbel & 
Brinley-Morgan, 1984); however in some areas the disease is more important in sheep 
(Corbel, 2006). Different breeds of sheep shows a great variation in their susceptibility to 
infection, with milking breeds being more susceptible than meat breeds (Corbel & Brinley-
Morgan, 1984). The Maltese breed and other breeds from South America appear to have 
strong resistance to infection. However Awassi’s are very susceptible and act as an 
important reservoir of infection for humans. Consequently for most countries bordering the 
Mediterranean Sea and in Southwest Asia, brucellosis is mainly focused on sheep, while in 
Latin America goats are the predominant species (European Commission, 2001). The 
behavioral patterns of sheep, including gathering at lambing time or during the evening, 
may play a role in disease transmission (Alton, 1982). 
There is significant evidence suggesting the high susceptibility of camels to B. melitensis 
and consequently consuming raw camel milk is regarded a major risk factor for humans 
(European Commission, 2001). Cattle and pigs are also susceptible to infection, especially 
where these are in contact with infected small ruminants (Garin-Bastuji and Hars, 2000). 
Carnivores, such as, cats, dogs and foxes, can also transmit the infection mechanically. 
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2.6.3.2 Mode of infection and disease transmission 
Two major modes of infection are recognized. The direct mode occurs through the 
ingestion of the bacterium, transmission via contaminated semen or infected embryos or 
through inhalation in aerosols (European Commission, 2001). Dogs can act as mechanical 
and biological vectors (FAO/WHO Expert Committee on Brucellosis, 1986). The 
organisms are rarely spread through waterways (European Commission, 2001). The 
number of bacteria excreted in milk is low but is sufficient to infect lambs and kids and 
humans (Philippon et al, 1971). Although the majority of infections are acquired through 
consumption of colostrum and milk, a small proportion of lambs and kids may be infected 
in utero. These animals then may subsequently shed the bacterium in their faeces. 
However a self-curing mechanism has been suggested resulting in the animals being 
subsequently susceptible to infection when they reach sexual maturity (Grilló et al, 1997). 
Immunotolerance to infection with B. melitensis has been reported and this may account, in 
part, to the difficulty in eradicating the disease (Dolan, 1980).  
In vaccinated animals, infection may be rapidly eliminated and sheep are reported to have 
a strong resistance to reinfection following recovery from infection with B. melitensis 
(Alton, 1990a). Long lasting immunity has also been demonstrated in experimentally 
infected sheep (Durán-Ferrer, 1998). 
Placenta, foetal fluids and vaginal discharges expelled by infected ewes after abortion are 
the primary route of dissemination of bacteria (European Commission, 2001; Corbel, 
2006) with a large number of organisms shed at the time of parturition or abortion (Alton, 
1990a, Durán-Ferrer, 1998). Aborted goats shed the organisms for a prolonged period (2-3 
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months). In contrast the organism is discharged by sheep for a maximum of three weeks 
after abortion or parturition. The organisms can also be shed from milk, colostrum and 
semen and may be isolated from various tissues, including lymph nodes and arthritic 
lesions. Infection of the mammary glands or supramammary lymph nodes may result in 
intermittent or continuous shedding of the pathogen (European Commission, 2001). 
The environmental conditions and type of husbandry greatly influence the dispersal of the 
disease such as, lambing in enclosures and an overcrowded environment. The disease is 
most likely introduced to a previously free area through the introduction of infected 
animals (European Commission, 2001). Communal grazing and the practice of 
transhumance are strongly correlated with disease (Corbel, 2006).  
2.6.3.3 Host-Parasite interactions 
Within mammalian hosts, Brucella spp. are intracellular organisms and infect phagocytes. 
The VirB operon, a type IV secretion pathway that is induced on phagosomal acidification, 
plays a key role in intracellular parasitism and is essential for pathogenicity (O’Callaghan 
et al, 1999; Ugalde, 1999; Boschiroli et al, 2002). Brucella spp. resist different 
environmental stresses within the phagocytic cells, modify their intracellular trafficking 
(the ability to modulate and evade fusion with lysosomes) and eventually reach their 
replicative niche (Kohler et al, 2002). Brucella spp. survive and multiply in dendritic cells, 
resulting in interference with their maturation so that antigen processing is impaired 
resulting in a compromised host immune response (Roop et al, 2009). Brucella spp. 
prevent apoptosis within macrophages and their long-term survival in the 
reticuloendothelial system of the spleen, liver and bone marrow results in chronic infection 
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(Gorvel and Moreno, 2002). During gestation, Brucella spp. replicate in large numbers in 
placental trophoblasts. The integrity of the placenta may be disrupted and abortion 
induced. The pregnant uterus is an immunological privileged site and the local immune 
response is modulated to prevent rejection of the fetus. However this may allow the 
Brucellae to replicate extensively (Neta et al, 2010). The Brucella lipopolysaccharide 
(LPS) is a weak inducer of the host inflammatory cytokines IL-1β, IL-6 or TNF-α 
compared to LPS molecules from many other Gram-negative bacteria (Roop et al, 2009). 
Although Brucella LPS stimulates TLR4, it has lower immunostimulatory activity 
compared to other Gram-negative bacteria such as Salmonella enterica serotype 
Typhimurium (Rittig et al, 2003). IFN-γ is a key cytokine controlling Brucella infection. 
One of its major functions is the stimulation of Brucella-killing effector mechanisms in 
phagocytic cells (Baldwin and Parent, 2002). 
The global picture emerging from what is known about Brucella virulence is an extremely 
efficient adaptation to shield itself from immune recognition and to manipulate key aspects 
of host cell physiology (apoptosis, vacuolar trafficking) (Gorvel and Moreno, 2002; 
Letesson et al, 2002; Gorvel, 2008). It is evident that one of the in vivo adaptation 
keystones is the ability to fine tune metabolism according to the various nutrients 
encountered during the infectious cycle (Brown et al, 2008; Lamontagne et al, 2010). 
Quorum sensing (QS) is also known to be involved in the regulation of Brucella virulence 
determinants mostly linked to the cell surface (type IV secretion system, flagellum, Omps 
and exopolysaccharide) (Letesson et al, 2002; Weeks et al, 2010). Both the BvrR/BvrS 
TCS and the QS system could contribute to the adaptation of the metabolic network during 
the nutrient shift faced by Brucella along its intracellular trafficking. Furthermore the 
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phosphoenolpyruvate phosphotransferase system (PTS) of B. melitensis senses the 
metabolic state of the cell leading to a coordinated regulation of C and N metabolisms, and 
as well as some key virulence genes, e.g., the virB operon (Dozot et al, 2010) and flagellar 
genes (Fretin et al, 2005). 
In the placenta, Brucella invade trophoblasts and utilize iron for their replication which 
may lead to placental disruption resulting in abortion or weak offspring. Erythritol is also 
assumed to play a major role to determine tissue tropism for Brucella (Williams et al, 
1964; Keppie et al, 1965; Acha and Szyfres, 1987) and this may be linked with iron 
acquisition for virulence in ruminants. Most Brucella species are highly virulent, causing 
an acute infection in both their natural and accidental hosts. The bacterium has a reputation 
for being a ‘stealth pathogen’ that can infect without inducing a massive inflammatory 
response. Its ability to survive and multiply in host cells, such as macrophages in the 
reticuloendothelial system and trophoblasts in the placenta, is a key aspect of its virulence. 
Over the last 20 years, considerable advances have been made in understanding the 
genetics and cell biology of Brucella virulence, and these have been reviewed recently 
(Roop et al, 2009; Martirosyan et al, 2011). The bacteria enters cells via lipid rafts, which 
help in the avoidance of defense mechanisms. The bacterium's lipopolysaccharide and 
periplasmic cyclic β-glucan are essential for the first steps in the establishment of an 
intracellular replication niche, in which Brucella survives and multiplies. Acidification of 
the phagosome induces the expression of several virulence factors including the VirB type 
IV secretion system. The VirB system is thought to translocate effectors' proteins into the 
host cell, which modulate host cell biology to create the intracellular replication niche. 
Brucella creates its replication vacuole by capturing membrane vesicles at endoplasmic 
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reticulum exit sites, a tactic used by some other intracellular pathogens, including 
Legionella (O’Callaghan et al, 1999; Kohler et al, 2002). 
Compared to other non-sporing bacteria, B. melitensis has a relatively higher ability to 
persist outside the host (European Commission, 2001). Favourable environmental 
conditions include high humidity with a pH>4, low temperatures and the absence of direct 
sunlight. The infectivity of the organisms may persist for several months in contaminated 
water, aborted materials, liquid manure, wool, hay, contaminated equipment and clothes. 
Under dry conditions, B. melitensis may remain viable in dust and soil (European 
Commission, 2001). Contaminated equipment and utensils can be sterilized by autoclaving 
at 121°C and liquid manure treated by xylene and calcium cyananaide for 2 to 4 weeks. 
Caustic soda, 2% formaldehyde and 2.5% sodium hypochlorite can destroy the organisms 
on contaminated surfaces (European Commission, 2001). In milk and dairy products, 
survival of Brucella depends on the type and age of products, their pH, humidity, 
temperature and storage conditions (Carrère et al, 1960). Prolonged boiling and 
pasteurization inactivates the bacteria (Davies and Casey, 1973). In fermented cheese, 
Brucella do not survive for long, however the optimal time of fermentation to ensure safety 
is not exactly known although it has been estimated to be around three months (Nicoletti, 
1989). In acidified soft cheeses the survival time of Brucella is enhanced, hence the only 
means to ensure their safety is pre-processing pasteurization of the milk (European 
Commission, 2001). Radiation of colostrum by gamma rays is effective in inactivating 
Brucella (Garin-Bastuji et al, 1990). In contrast to dairy products, the life span of Brucella 
in meat is short due to the lower pH that occurs post mortem.  
Disinfectants, including phenol (10 g/l), formaldehyde and xylene (1ml/l), are effective in 
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inactivating the bacterium. For exposed skin, ethanol, diluted hypochlorite solution and 
iodophores are used for decontamination. On pasture Brucella can survive for up to 4 days 
if there is direct sunlight and up to 6 days in the shade (WHO, 1986). 
2.7 Laboratory diagnosis 
Generally, brucellosis can be diagnosed by serological tests, culture and PCR assays. 
Brucella species and biovars are usually identified by phage-lysis, biochemical criteria and 
molecular techniques. 
2.7.1 Serodiagnosis 
Serological tests have been used widely to detect the humoral response in cattle with B. 
abortus infection, although false positive and false negative reactions, associated with a 
specificity and sensitivity less than 100%, can be a problem. False positive reactions have 
been reported in animals infected with other microorganisms including Yersinia 
enterocolitica 0:9 as their O-chain in the LPS are identical. Animals exposed to other 
bacteria, such as E. coli O:157, Streptomonas maltophilia, vibrio cholera O:1, Francisella 
tularensis, E. hermani and Bordetella bronchiseptica, can also produce conflicting 
serological results (Weynants et al, 1996b). False positive reactions arising from antibodies 
induced by vaccination and the failure to develop an immune response until animals 
become pregnant are further diagnostic challenges. Interferon gamma tests and indirect 
ELISAs using rough strain antigen have been reported to be promising tools to 
differentiate brucellosis from diseases caused by other cross-reacting microorganisms 
(Nielsen et al, 1989; Weynants et al 1996a).  
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No serological test has been developed solely for B. melitensis. Diagnostic assays 
developed for detecting infection of cattle with B. abortus have been used to detect B. 
melitensis infection in small ruminants. Accordingly, the RBPT and the CFT are the most 
widely used tests for the serological diagnosis of brucellosis in sheep and goats 
(MacMillan, 1990). These tests detect antibodies raised against the smooth 
lipopolysaccharide (S-LPS) (OIE, 2008). However, the sensitivity of the CFT test is poorer 
than that of both the RBPT and the indirect ELISAs in small ruminants (Blasco et al, 
1994a; Blasco et al, 1994b). In addition, both the RBPT and CFT tests lack specificity 
when used for testing sera from sheep and goats recently vaccinated with Rev-1, the only 
available vaccine against B. melitensis (Fensterbank, et al, 1982; De Bagués et al, 1992;
 
Díaz-Aparicio et al, 1994). Although this issue is less if the Rev-1 vaccine is applied via 
the conjunctival route (De Bagués et al, 1992;
 
Díaz-Aparicio et al, 1994). 
2.7.1.1 Rose Bengal Plate Test (RBPT) 
In ruminants the RBPT is often used to screen entire herds for evidence of infection with 
brucellosis (Alton et al, 1975b; Sutherland, 1980; Alton et al, 1988; MacMillan, 1990). 
The principle of the test depends on an antigen-antibody reaction resulting in agglutination. 
Smooth Brucella culture stained with Rose Bengal dye is mixed in a buffered acidic 
suspension and mixed with an equal volume (drops) of serum (Sutherland, 1980; Alton et 
al, 1988). The acidic buffer is used to decrease problems associated with non-specific 
agglutination (Corbel, 1972). One studied tested the sera of 300 cows that had aborted and 
which had been cultured for B. abortus with the RBPT, CFT and SAT. Of the sera 91.4%, 
92.7% and 66.9% were positive, respectively (MacMillan, 1990). Sutherland and Searson 
(1990) reported that the sensitivity of the RBPT was 78% and the specificity 71%. In 
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contrast, MacMillan (1990) reported a sensitivity and specificity of 97 and 92.7%, 
respectively in an automated RBPT. Koh and Morley (1981) reported a specificity of 97.9 
to 99.1% in vaccinated and non-vaccinated herds. As a consequence of this specificity, the 
RBPT is not recommended for testing individual animals (Alton et al, 1988).  
Similar to other serological tests, the RBPT can give incorrect results and cannot 
distinguish between vaccinated and infected cases (Brinley-Morgan et al, 1969; Alton et 
al, 1975b; Sutherland, 1980; Alton et al, 1988). Furthermore the lower specificity of the 
test may result in more false positive reactions, which are test negative on other assays 
(Brinley-Morgan et al, 1969; Mylrea, 1972; Browne, 1974). The RBPT may be interfered 
by infection with Salmonella, E. coli O:157 (Nielsen et al, 1980) and Y. enterocolitica O:9 
(Mittal and Tizard, 1979).  
The RBPT primarily detects immunoglobulin G (IgG) (Corbel, 1972) however it can also 
detect IgM (Allan et al, 1976). The high sensitivity of the test is one of its key features 
with only 0.4 to 1.8% of RBPT seronegative animals testing positive on the CFT (Mylrea, 
1972; Brinley-Morgan et al, 1978). False negative results can occur to the RBPT during 
the first weeks of infection (MacMillan, 1990).  
2.7.1.2 Compliment Fixation Test (CFT) 
The CFT has been stated to be the most accurate and definitive of the serological tests 
(Sutherland, 1980). It has been widely used in control and eradication programs (Alton et 
al, 1988; MacMillan, 1990). The test usually utilizes the whole cell of B. abortus 
(MacMillan, 1990). Several authors have revealed that compliment fixing antibodies in 
infected animals are mostly IgG and IgM (Anderson et al, 1964; Brinley-Morgan et al, 
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1969). However, several authors have reported that IgM has reduced ability to fix 
compliment when sera is heated at 56°C which may restrict the early detection of infection 
(Sutherland, 1980; Alton et al, 1988). The prozoning phenomenon is also an obstacle 
associated with sera where the ratio of the two types of IgG (IgG1 and IgG2) is high in sera. 
This may result in blocking the fixation of compliment (Hobbs, 1985; Alton et al, 1988). 
The sensitivity of the CFT is high compared with culture and this test has been considered 
to be the most superior serological test (Nicoletti, 1969; Alton et al, 1975b). Furthermore 
the CFT’s specificity is high compared with the SAT (serum agglutination test), RBPT, 
and Indirect ELISA (Dohoo et al, 1986). Huber and Nicoletti (1986) reported that in adult 
vaccinated cows, the CFT had the highest sensitivity and specificity compared with the 
rivanol and milk ring tests. The CFT is very sensitive to changes, is not easy to perform 
requiring experienced and skilled scientists, may exhibit prozone and anticomplimentary 
reactions and can fail to detect latent carrier infections (Christie et al, 1968). False negative 
reactions may occur as the test only can detect antibody at least two weeks after infection 
(Sutherland, 1980). 
2.7.1.3 Enzyme linked Immunosorbent Assay (ELISA) 
The ELISAs are dependent upon the detection of antibodies in the serum of infected or 
vaccinated animals; however they can detect all antibody isotypes (Hobbs, 1985). For over 
two decades, ELISAs have been used to supplement other serological tests for the 
diagnosis of B. abortus (Engvall and Perlmann, 1971). The tests may utilize whole cell 
antigen, crude and semi purified LPS or non-LPS antigens (Letesson et al, 1997). Several 
ELISA types have been developed including the direct, indirect and competitive forms. 
ELISA’s have also been used to detect antibodies in milk (Thoen et al, 1995; Nielsen et al, 
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1996), and have been evaluated in naturally infected animals, vaccinated animals (Abalos 
et al, 1996; Uzal et al, 1996) and in humans (AlShamahy and Wright, 1998). 
Although the ELISA is not a cheap test, several authors have highlighted several 
advantages in using this assay. Firstly, it has high sensitivity and specificity (Saunders and 
Clinard, 1976; Cargill et al, 1985; Sutherland et al, 1986). Secondly, and unlike the CFT, 
the ELISA is not affected by haemolysis, prozone and anticomplimentary effects 
(Reynolds, 1987) and finally the technique is not complicated and is commercially 
available.  
The sensitivity and specificity of the ELISA has been found to be much better than the 
Milk Ring Test (MRT) when testing milk for evidence of infection in lactating cows. It 
also has a higher sensitivity and specificity than the CFT (Sutherland et al, 1986). 
Although Cargill et al. (1985) reported that the ELISA and CFT had similar specificities. 
Nicoletti and Tanya (1993) reported that the ELISA was an efficient test for the early 
detection of brucellosis, although its use for field diagnosis was not as efficient.  
Although cross-reactions have been highlighted with Y. enterocolitica O:9, use of a 
competitive ELISA with monoclonal antibody to B. abortus LPS eliminates this problem. 
Depending on its sensitivity and its ease of performance, Nielsen et al. (1995) concluded 
that the ELISA is the most suitable assay for the diagnosis of brucellosis in individual 
animals. However, as with other assays, caution must be taken with its use in areas where 
vaccination has been undertaken.  
In an investigation carried out by Hornitzky and Searson (1986), the usefulness of the 
ELISA was highlighted in cattle that were culture positive, non-vaccinated RBPT negative 
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reactors or low CFT titer animals. Heck et al. (1984) reported that the ELISA and 
Haemolysis In Gel Test (HIGT) were able to detect antibodies in 92 to 96% of animals, 
respectively, within four weeks of experimental challenge of vaccinated cows, and almost 
100% were detected ten weeks after inoculation. However with the SAT, CFT and rivanol 
tests, less than 88.6% were positive after 24 weeks of infection. In contrast, in non-
vaccinated challenged cows, 93 and 90% were positive on the ELISA and HIGT, 
respectively, four weeks post infection while less than 62% were positive by other tests. 
In general, the indirect ELISAs are good tests for surveillance purposes in countries in the 
latter phases of eradication where vaccination is no longer used. However, these ELISAs 
lack specificity when used in vaccinated animals, particularly when Rev-1 is used in adult 
animals. In these conditions, only the Native Hapten (NH) gel precipitation test is useful 
for determining infection in vaccinated animals (Díaz, et al, 1979; OIE, 2008). Although 
the competitive ELISA is promising, this test also lacks specificity in vaccinated animals 
and those infected with Y. enterocolitica O:9 (Marín et al, 1999; Muñoz et al, 2005). The 
World Health Organization has recently classified brucellosis among the 7 top neglected 
zoonoses, a group of diseases that are simultaneously a threat to human health and a cause 
of poverty perpetuation (Maudlin and Weber, 2006). 
2.7.1.4 The Serum Agglutination Test (SAT) 
The SAT was used as a standard test for the diagnosis of brucellosis before the RBPT was 
developed (Brinley-Morgan, 1967; Davies, 1971; Alton, 1977a, b; Sutherland, 1980; 
Nicoletti, 1969). The test was found to detect IgM more efficiently than IgG1, and 
consequently was reported to be more effective in the early detection of infection (Allan et 
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al, 1976). In cattle vaccinated with strain 19, SAT was also found to detect more IgM than 
IgG antibody and it was recommended by Alton (1977 a, b) to take this feature into 
account when using the SAT in areas where strain 19 had previously been used. However, 
several disadvantages with using the SAT have been demonstrated. These include the 
prozone phenomenon which can result in false negative reactions, especially where the 
IgG1 concentration is high (MacMillan, 1990). Cross-reaction with Y. enterocolitica O:9 
and E. coli O:157 have also been reported (Mittal and Tizard, 1980; MacMillan, 1990). In 
culture positive animals Sutherland and Searson (1990) demonstrated that the SAT had a 
sensitivity and specificity of 70% and 95%, respectively. As a consequences of these 
limitations, several countries test samples with confirmatory tests such as the CFT 
(Sutherland, 1980). In contrast, Jiwa et al. (1996) recommended the use of the SAT as it is 
a simple, inexpensive technique that can be performed by untrained personnel. 
2.7.1.5 Milk Ring Test (MRT) 
The milk ring test is a simple test that can detect antibodies in the milk of infected cows 
(Beveridge, 1983; MacMillan, 1990). It detects antibodies attached to fat globules of the 
milk by using whole cell haematoxylin-stained killed Brucella antigen (MacMillan, 1990). 
The antigen is added to the milk sample and the antigen-antibody complex rises to the 
surface of the milk forming a ring in the cream layer (Sutherland, 1980; MacMillan, 1990). 
The sensitivity of the test has been reported to be high (Beveridge, 1983), however false 
negative reactions have been described (Christie et al, 1968; Brinley-Morgan et al, 1978), 
although testing of bulk milk samples from dairy farms helps decrease the false negative 
reactions. Thoen et al. (1995) reported that the MRT was less useful in areas where the 
prevalence of brucellosis was low and Cunningham (1968) reported that the test was also 
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less effective where animals had been vaccinated with strain 19 and in animals with 
mastitis. 
Although the MRT has several disadvantages, it is a simple, inexpensive test which can be 
used for screening dairy herds by non-skilled personnel (Sutherland, 1980; Beveridge, 
1983; Nielsen et al,1996). 
2.7.1.6 Rivanol Test 
The Rivanol test uses rivanol dye to precipitate serum protein, other than gamma globulins 
(Brinley-Morgan, 1967). The test has been shown to be promising in differentiating 
infected from vaccinated cattle (Nicoletti et al, 1978a, b; Alton et al, 1988). However, false 
negative reactions have been reported, especially when animals are vaccinated at a young 
age (Huber and Nicoletti, 1986). Many authors have studied the sensitivity and specificity 
of the test, although the results have been variable (Nicoletti, 1969; Anczkyowski and 
Murat-Skwarek, 1972). In a study undertaken by Huber and Nicoletti (1986) which 
involved testing over 1000 culture–positive adult cows, 99.3% were positive on the rivanol 
test, however only 24.8% of 2,417 culture-negative adult vaccinated cows were negative 
by this test. Nicoletti (1969) reported that the test had a good specificity (80%) and high 
sensitivity (96%) and as a result of the low false positive rate it was concluded that the test 
was useful for detecting infected cows. Nevertheless, the sensitivity of the rivanol test is 
lower than the CFT and is time-consuming and not easy to perform or interpret (Brinley-
Morgan, 1967). 
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2.7.1.7 Other tests 
The Mercapto-ethanol Test (ME Test), Coombs Test and The Indirect Haemolysis 
Test (IHLT) 
The mercapto-ethanol test is based on inactivation of IgM by mercapto-ethanol and then 
detection of IgG only. However it requires experienced technicians and the results can be 
difficult to interpret and hence it is rarely used today (Brinley-Morgan, 1967). 
Coombs test has mainly been used as an assay to detect brucellosis in humans and has also 
been called the Antihuman globulin test (AHG). It also has been used to confirm the results 
of the CFT in cattle (Sutherland, 1980). Although, the test has been demonstrated to be 
effective in detecting chronic carriers, it can have a high percentage of false positive 
reactions in vaccinated animals (Brinley-Morgan, 1967). Sutherland (1980) also reported 
that the test was not easy to perform or interpret. 
In the indirect haemolysis test (IHLT), LPS sensitized erythrocytes are used to overcome 
the prozone phenomenon (Plackett et al, 1976; Sutherland, 1980). Corner et al. (1983) 
stated that the IHLT was characterized by low sensitivity (47%) when compared with the 
CFT (89.5%) and RBPT (89.5). In one study, 54% of culture negative cattle were positive 
on the CFT, 45% to the RBPT and 68% to the IHLT. This was assumed to be associated 
with the low specificity of the IHLT, leading to a high proportion of false positive 
reactions (Sutherland and MacKenzie, 1983).  
2.7.2 Antigen detection 
Bacterial culture is a useful tool for confirming brucellosis, as well as differentiating 
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bacteria for taxonomic purposes and producing vaccines. Brucella can be isolated from 
several sources including foetal membranes and tissues (spleen, lungs, testes, stomach 
contents and liver), aborted materials, vaginal excretions, hygromas, testes, lymph nodes 
(supramammary and iliac lymph nodes in particular), uterine cotyledons, mammary glands 
and colostrum and milk (Alton et al, 1975a). Isolation of the bacterium from udder 
secretions was suggested to be a method to differentiate field strains from vaccinal strains 
(Huber and Nicoletti, 1986). Although Alton et al. (1975a) were able to isolate Brucella 
for up to six weeks post partum, others were unable to isolate the organism five days after 
abortion. In a study undertaken by Hornitzky and Searson (1986), B. abortus was isolated 
from the supramammary lymph nodes of 79.6% of the culture-positive cows, and the 
detection proportion increased to 89.8% when the results for culturing of the prescapular 
lymph nodes were included with those of the supramammary lymph node. Including the 
retropharyngeal lymph nodes increased this to 93.9% and 100% when the results for the 
submandibular and iliac lymph nodes were included in the results. Weynants et al. (1995) 
isolated B. abortus from lymph nodes adjacent to the inoculation site after challenging 10 
cattle, highlighting the role of the lymph nodes in filtering the bacterium. 
Although bacterial culture is considered the definitive diagnosis (Cunningham, 1977; 
Crawford et al, 1978; Hornitzky and Searson, 1986; Huber and Nicoletti, 1986; Mayfield 
et al, 1990; OIE, 2009) it has many disadvantages. Firstly contamination can make 
successful culturing difficult. Secondly it takes time, reagents and equipment and hence 
requires significant laboratory experience and it is expensive. Thirdly the infected 
materials or culturing process may expose personnel to the agent (Mikhail et al, 1983; 
Alton et al, 1988; Gaviria-Ruiz and Cardona-Castro, 1995; Ouahrani-Bettache et al, 1996). 
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Consequently serological assays are key for successful eradication and control programmes 
(Sutherland, 1980). 
2.7.2.1 Culturing of Brucella on media 
Although several media have been developed for culturing Brucellae (Mayfield et al, 
1990), standard basal medium is considered to be the ideal medium for this pathogen. 
Corbel and Brinley-Morgan (1984) found that the primary isolation of Brucella could be 
accelerated by adding 5-10% normal serum to the medium. Atmospheric conditions 
required for growth is 10% CO2, except for strain 19, at 37°C, although growth can be seen 
between 20 and 40°C. The optimal pH range for growth is between 6.6 and 7.4 (Corbel and 
Brinley-Morgan, 1984). 
Farrell’s medium, a selective medium containing antibiotics such as bacitracin, 
cycloheximide, nalidixic acid, nystatin, polymixin B and vancomycin with 5% horse serum 
has been used for the isolation of Brucella from contaminated tissues. Culturing on solid 
media limits the interference by faster growing microbes as the media discourages 
dissociation which facilitates the recognition of colonies. Alton et al. (1988) reported that 
colonies were visible on nutrient agar after three days of incubation, although routinely 
examination is not undertaken until the fourth or fifth day of culturing. Brucella colonies 
appear transparent or pale honey colored on serum dextrose agar. The colonies are raised 
and convex with a smooth, shiny surface.  
Alton et al. (1988) demonstrated that the growth of Brucella in liquid medium was poor 
and culturing on static liquid medium accelerated the dissociation of smooth to non-smooth 
forms. Furthermore culturing in liquid medium has reported to require a longer incubation 
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period (Mayfield et al. 1990). 
Biphasic medium of Farrell’s medium and a liquid phase of Bordie Sinton’s medium are 
commonly used as additional media for the isolation of Brucella from heavily 
contaminated samples. It has been found that culturing on biphasic medium increases 
detection (positive cultures) by 64.8%, compared to isolation on solid medium (Corner et 
al, 1985; Hornitzky and Searson, 1986). 
2.7.2.2 Biotyping of brucellosis 
The importance of biotyping Brucella is to provide epidemiological information, to 
establish the agent’s characteristics and to facilitate control programmes (Luchsinger et al, 
1973; Crawford et al, 1990). Each type of Brucella consists of several biovars or biotypes. 
Brucella abortus is composed of eight biovars and B. melitensis nine (Corbel and Brinley-
Morgan, 1984). Each biovar may contain many different strains. Biovar 1 of B. abortus is 
the most prevalent biovar in cattle but is also found in other species including sheep and 
goats, buffalo, horses, camels, and humans (Kerr et al, 1966; Hendricks and Meyer, 1975; 
Shaw, 1976; Crawford et al, 1990). Biovar 2 has also been isolated from cattle in New 
South Wales (Hornitzky and Searson, 1986).  
The two common ways for biotyping are phage typing, which depends on lysis of the 
bacterium by phages, and a comparison of oxidative metabolic profiles on selected amino 
acids and carbohydrate substrates (Alton et al, 1988). However the latter method can be 
hazardous, time consuming and requires specific facilities. Biovars of B. abortus can also 
be differentiated by their utilization of CO2, production of H2S, growth on media with dyes 
and reactions with monospecific antisera (Corbel et al, 1983; Crawford et al, 1990). 
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Corbel and Brinley-Morgan (1984) demonstrated a significant amount of DNA homology 
in species within the genus and similar polynucleotide sequences have been detected. As a 
result, the usual biotyping tests may not always reveal the full extent of differences 
between biovars, especially where the differences rely upon a single characteristic. Aldrick 
(1968) highlighted the importance of biotyping isolates as soon as possible after culturing 
due to the unstable nature of colonies which may not be visible after repeated subculturing.  
2.7.2.3 Molecular detection and identification 
Classically the detection and identification of Brucella spp. has been based on cultural and 
phenotypic analysis (biotyping). Although providing valuable information, biotyping is a 
highly specialized and time-consuming approach requiring experienced staff using well-
optimized non-commercial reagents which is ideally conducted in a securely biological 
contained laboratory (Bridges and Halling, 1994; Mercier et al, 1996).  
The polymerase chain reaction (PCR) is a common diagnostic tool used worldwide. The 
technique has been used to detect Brucella DNA, to differentiate between species and 
strains and to study the epidemiology of the disease (Allardet-Servent et al, 1988). In 
contrast with other conventional techniques, the PCR has several advantages. It takes less 
time with the results being available within a few hours; it minimizes the need to handle 
potentially infectious samples; it can be automated; and it is not expensive. 
Initial PCR methods were based on the 16S rRNA and bcsp31 genes (Baily et al, 1992; 
Herman and Deridder, 1992). PCR methods based on the 16S rRNA amplify a DNA 
fragment common to all Brucella species; however the method cross-reacts with members 
of the closely related genus Ochrobactrum (Velasco et al, 1998; Scholz et al, 2008a). The 
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IS711 molecular element has become the preferred target for general identification 
purposes due to its restricted occurrence in Brucella and the presence of multiple copies, 
allowing for unparalleled sensitivity and direct testing on clinical samples (Halling et al, 
1993; Ouahrani-Bettache et al, 1993). Other molecular markers such as recA (Scholz et al, 
2008a), omp2 (Leal-Klevezas et al, 1995) and 16S–23S intergenic transcribed sequence 
(Rijpens et al, 1996) can also be used to correctly identify members of the genus Brucella. 
Until recently the most popular PCR assay developed for differentiating Brucella at the 
species level was the AMOS PCR (Bridges and Halling, 1994). This technique is based on 
the insertion site of the IS711 element which is species-specific and results in a unique 
PCR profile for Brucella strains belonging to each of the B. abortus, B. melitensis, B. ovis 
and B. suis species (hence the name AMOS). However, B. canis, B. neotomae, some 
biovars of B. abortus and B. suis and the Brucella species isolated from marine mammals 
cannot be detected by the AMOS PCR Novel IS711. Chromosomal locations specific to 
marine mammal Brucella isolates have been identified allowing their identification and 
classification based on the same principle as AMOS PCR (Cloeckaert et al, 2003; Maquart 
et al, 2008; Zygmunt et al, 2010). Real-time PCR assays, based on some of the genetic 
markers described above, have been developed to identify Brucella species (Al Dahouk et 
al, 2007b), although these tests have the same limitations regarding B. suis and B. abortus 
detection. AMOS-PCR has provided the basis for other multiplex PCR assays, such as the 
Bruce-ladder-PCR which is able to successfully discriminate between isolates of the six 
classical species and the marine mammal Brucellae (Lopez-Goni et al, 2008; Mayer-Scholl 
et al, 2010). These tests, which are remarkably robust and require no expensive laboratory 
equipment, display specificity at the species level, except for some strains belonging to the 
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closely related B. canis and B. suis species (Koylass et al, 2010). For many years, most 
epidemiological data was based on the division of the three most significant species, B. 
melitensis, B. abortus and B. suis, into a number of biovars. Several other molecular 
techniques have been used to divide isolates into molecular groups such as PFGE, IS711 
fingerprinting, omp typing, IRS-PCR and AFLP that corresponded well with the classical 
species divisions (Vizcaino et al, 2000; Moreno et al, 2002; Whatmore, 2009). However, 
none of these techniques has significant resolution at the subspecies level. The use of 
multilocus sequence analysis (MLSA) opens the way to detailed characterization of the 
global population structure of Brucella (Whatmore et al, 2007). These analyses confirmed 
the status of the classical species as distinct genetic entities, allow indexing of intra-species 
diversity and relating this to historical biovar designations, and have provided a framework 
for the placement of atypical or emerging Brucella isolates (De et al, 2008; Schlabritz-
Loutsevitch et al, 2009; Tiller et al, 2010). Furthermore, these analyses and the availability 
of more robust phylogenetic histories, have allowed the identification of canonical single 
nucleotide polymorphisms (SNPs) that could be exploited as the basis of rapid diagnostic 
tests. A number of SNP-based assays have recently been described that can rapidly identify 
Brucella isolates to the species level (Foster et al, 2008; Gopaul et al, 2008; Gopaul et al, 
2010), identify vaccine strains (Gopaul et al, 2010) or even identify the biovar (Fretin et al, 
2008). A further major recent genome-driven advance has been the identification and 
exploitation of tandem DNA repeats as typing tools. These repeats have been exploited in 
many bacteria to develop a new generation of Variable Number of Tandem Repeat 
(VNTR) based typing approaches but are likely to prove particularly valuable in Brucella 
which previously lacked any epidemiological tools with adequate resolution to facilitate 
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reliable epidemiological trace-back (Bricker et al, 2003; Le Flèche et al, 2006; Whatmore 
et al, 2006). Both MLSA and VNTR based analyses question the validity of some of the 
biovars established by classical microbiological typing, particularly those of B. melitensis 
(Al Dahouk et al, 2007a; Whatmore et al, 2007). Such analyses applied to local 
epidemiological scenarios shall allow progress in a number of areas previously hampered 
by the lack of tools with adequate discriminatory capacity. Application of these approaches 
should ultimately allow rapid detection of nationally or internationally dispersed clusters, 
detection of transmission chains, detection of new and emerging strains and trace-back to 
sources of outbreaks. The ability of VNTR analysis to link genotypes to background 
epidemiological data should also facilitate the identification of risk factors and help 
understand differential virulence or pathogenic properties of individual genotypes. VNTR 
has recently proven highly efficient in confirming laboratory or other professionally 
acquired infections (Marianelli et al, 2008; Valdezate et al, 2010), in distinguishing relapse 
from re-infection (Al Dahouk et al, 2005a; Kattar et al, 2008), in characterizing outbreaks 
(Valdezate et al, 2007; Lucero et al, 2010), in identifying associations of different 
genotypes with different pathogenic profiles (Nöckler et al, 2009), and in assessing the 
stability of vaccine preparations (Garcia-Yoldi et al, 2007). 
Although Bridges and Halling (1994) reported that the sensitivity of the PCR could be 
reduced by contamination, Da Costa et al. (1996) considered that its sensitivity was its 
main advantage. However the assay has to be performed under strict standardized 
conditions which are not always available in laboratories.  
Pulsed field gel electrophoresis (PFGE) is a restriction endonuclease analysis that has been 
used to study the relationship between strains of Brucella species. The technique has been 
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found to be helpful in classifying the genus as it detects differences between DNA 
fingerprints of species and biovars. Unlike other techniques which produce a large number 
of small DNA segments, Tcherneva et al. (1996) demonstrated that the PFGE could split 
DNA into a small number of large segments. The enzymes (Xho I) and (XbaI) have been 
shown to divide the DNA into more than 25 bands of different intensities (Allardent-
Servent et al, 1988). After digestion by XbaI, Brucella can be clearly differentiated into 
species based on their unique DNA fingerprints. However, the technique was unable to 
clearly differentiate biovars (Allardent-Servent et al, 1988). However in the study by 
Jensen et al. (1995) it was demonstrated that the PFGE could distinguish field isolate of B. 
abortus biovars 1, 2 and 4 from that of RB51 vaccine strain. 
Although PFGE has several advantages, it suffers from the disadvantage that the 
concentration of DNA cannot be altered after the agarose is prepared and therefore the 
migration of the DNA molecules is influenced by the total DNA concentration (Li et al, 
1989). Consequently the technique has been modified by immersing cells in agarose prior 
to lysis. This keeps the large DNA molecules intact during the diffusion of the detergent 
and protease (Schwartz and Cantor, 1984). 
2.7.2.4 Skin Delayed-Type Hypersensitivity (SDTH) 
The skin delayed-type hypersensitivity (SDTH) test has been used widely for the diagnosis 
of brucellosis, especially in ruminants, and it is a valuable addition to serological tests. 
Similar to the tuberculin test for tuberculosis, the principle is to evaluate the cell-mediated 
immunity after inoculation of 0.1 ml of crude extract of B. (brucellin) abortus 
intradermally into the neck. In a positive result a hypersensitivity reaction is observed 24 to 
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72 hours after injection. The degree of skin swelling reveals the intensity of the reaction 
and an increase in the thickness of the skin fold by 2 mm or more is considered a positive 
reaction (Bercovich et al, 1993). 
The SDTH can also detect latent carriers and can confirm the status of false negative 
results arising from serological tests. A purified protein brucellin (P39) produced negative 
results in cattle infected with other microorganisms, such as Y. enterocolitica O:9, and E. 
coli. This confirms the high specificity of this test (Denoel et al, 1997). In contrast another 
study by Cheville et al. (1994) demonstrated that vaccinated heifers reacted to standard 
brucellin, and consequently it was concluded that the test was unable to distinguish 
between vaccinated and naturally infected animals. In a study undertaken by Bhongbhibat 
et al. (1970), allergenic fractions of Brucella species were purified and could distinguish 
between infections with B. abortus and B. melitensis. 
However the test is time-consuming, animals need to be handled twice and the results are 
not easy to interpret. Weynants et al. (1995) highlighted that the SDTH could alter the 
animal’s immune status if used repeatedly and this may interfere with subsequent 
serological tests. Consequently an interval of seven weeks after the SDTH test is 
recommended before testing with serological tests (Muskens et al, 1995, 1996).  
2.7.2.5 Gamma Interferon Assay (IFN-¥) 
The gamma interferon assay was developed as an in vitro alternative to the SDTH 
(Weynants et al, 1995). It involves mixing cytoplasmic protein from B. melitensis B 115 
with whole blood from cattle. The test offers the advantage of being able to distinguish 
between true and false positives, although like most tests it cannot distinguish between 
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vaccinated and infected animals. 
 
2.8 Treatment, prevention and control of Brucellosis 
2.8.1 Treatment 
As an intracellular bacterium, the treatment of animal brucellosis is challenging (Metcalf et 
al, 1994). Although there is no effective treatment for bovine or swine brucellosis, canine 
brucellosis has been treated successfully through the administration of combinations of 
antibiotics. Streptomycin with sulphadiazine and oxytetracycline are the commonly used 
antibiotics. Infusing the udder of infected cattle with these antibiotics has also been 
attempted, although the infection was not successfully eliminated (Corbel, 1977; Radostits 
et al, 1994). Few authors have demonstrated the efficacy of oxytetracycline and 
streptomycin to cure animals from natural infection with B. abortus or B. melitensis (de 
Bagues et al, 1991; Radwan et al, 1993). Nicoletti et al. (1987) found that giving an oral 
subtherapeutic dose of chlortetracycline in parallel with injection of strain 19 (S19) vaccine 
did not interfere with the formation of antibodies. However, others have demonstrated the 
positive effect of oxytetracycline when administered with S19 (Smith et al, 1983; Nicoletti, 
1990). In conclusion, treatment of infected animals is not practical or feasible from an 
economic point of view unless the animals have significant value. 
Two treatment regimens are recommended in humans: a combination of oral doxycycline 
100 mg twice a day and rifampicin 600–900 mg/day (15 mg/kg/day) in a single oral dose 
over a 6-week course; and a combination of streptomycin 1 g intramuscularly once a day 
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for 2 weeks or an alternative aminoglycoside, instead of the administration of rifampicin. 
The latter regime has the advantage of lower relapse rates (Corbel, 2006; Ariza et al, 
2007). For a successful therapy of focal complications and chronic disease, combination of 
three or four of the antimicrobial drugs listed previously and longer treatment courses (>45 
days) are recommended (Robson et al, 1993; Hendricks et al, 1995; Solera et al, 1997a; b; 
Ariza, 1996; Solera, 1997b; Ariza et al, 2007).  
2.8.2 Prevention and control of animal brucellosis 
The live-attenuated B. melitensis Rev-1 vaccine is the only vaccine available for B. 
melitensis, and this vaccine has been shown to be effective in preventing brucellosis in 
sheep and goats (Blasco, 1997). However, when administered by the classic subcutaneous 
route (individual doses of 1×10
9–2×109 cfu), a long-lasting serological response is induced, 
which makes an eradication program based on test and slaughter impractical. When the 
same vaccine is administered by the conjunctival route (at the same dose but in a smaller 
volume), the immunity conferred is similar to that induced by the classic subcutaneous 
method, although the serological response is significantly reduced making it suitable for 
use in an eradication program (Blasco, 1997). However, this type of program is still out of 
the reach of many countries that have only elementary veterinary services and limited 
economic resources. In these cases, a mass vaccination campaign is the only reasonable 
alternative to control brucellosis. Unfortunately, the vaccination of pregnant animals with 
Rev-1 subcutaneously can result in abortions and the excretion of Rev-1 strain in milk 
(Blasco, 1997). Reduction of the Rev-1 dose (10
3
 to 10
6
 cfu administered subcutaneously) 
has been reported to avoid these significant adverse reactions while still inducing effective 
protection (Al Khalaf et al, 1992). However, field and experimental data suggests 
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otherwise, and reduced doses of Rev-1 should not be recommended as an alternative to 
vaccination with standard doses (Fensterbank et al, 1982; Blasco, 1997). Due to the risk of 
abortion, there is no entirely safe strategy for mass vaccination. Even conjunctival 
vaccination is not safe enough to be applied regardless of the pregnancy status of the 
animals (Blasco, 1997). It is recommended that Rev-1 should not be used in mid-gestation 
animals, the main critical period for abortions. However, this is impractical under field 
conditions, and some of the risks have to be assumed if the objective is to control the 
disease. Conjunctival vaccination of animals before the start of the mating season, during 
the late stages of the lambing season, or during lactation are the safest approaches to 
performing a whole-flock/herd vaccination program (Blasco, 1997). This modified-live 
vaccine also has a very slight chance of infecting humans (Blasco and Díaz, 1993) as well 
as being resistant to streptomycin which, in combination with doxycycline, constitutes the 
most effective treatment of brucellosis in humans (Ariza et al, 2007). 
Accordingly some biosafety measures (wearing protective glasses and gloves) and 
educational campaigns are needed to reduce the risk of infection in humans. In the case of 
accidental injection with Rev-1, a combined doxycycline-gentamicin (or doxycycline-
rifampin) treatment should be administered (Blasco and Diaz, 1993; Ariza et al, 2007). 
One of the key disadvantages of vaccination is the potential interference with serological 
assays. The diagnostic epitopes involved are located in the O-polysaccharide section (a 
homopolymer of N-formylperosamine) of the B. melitensis S-LPS immunodominant 
surface antigen (González et al, 2008). Research to improve the vaccines by removing 
these S-LPS epitopes (ie, to develop rough—R—vaccines) has been conducted. Among the 
live rough Brucella strains obtained by classic attenuation methods, is the B. abortus RB51 
68 
 
vaccine. However, its efficacy and safety with regard to bovine brucellosis is questionable 
(Moriyón et al,2004; Mainar-Jaime et al, 2008) and it is not effective against B. melitensis 
or B. ovis infections in sheep (Moriyón et al, 2004). Finally, Other research efforts in 
developing R vaccines have resulted in candidates of low overall efficacy (Moriyón et al, 
2004; Barrio et al, 2009). Whereas, R candidate vaccines do not interfere with the classic 
serological tests (RBPT and CFT) this is not the case for the ELISAs. Using S-LPS or its 
hydrolytic polysaccharides as antigens, a proportion of ewes vaccinated with R candidates 
have been classified as seropositive to an indirect ELISA (Barrio et al, 2009). This result is 
not unexpected, because R mutants elicit antibodies to the core epitopes also present in the 
wild-type S-LPS and its hydrolytic polysaccharides. Core epitopes are not readily 
accessible on the whole S Brucellae (used as antigen in the RBPT and CFT), but they can 
become exposed on adsorption to ELISA plates and, therefore, prevent a clear-cut 
distinction of the antibody responses to S and R Brucellae. This problem is likely to affect 
all R vaccines (Mainar-Jaime et al, 2008). In conclusion, the potential advantages for R 
vaccines are questionable and there is increasing evidence demonstrating that these 
vaccines interfere in S-LPS–based ELISAs, are not safe in pregnant animals, may be 
excreted in the milk of vaccinated animals, may infect humans and have reduced efficacy 
when compared with the Rev-1 and S19 vaccines in small ruminants and cattle
 
(Moriyón et 
al,2004). 
Other approaches to develop new-generation vaccines, such as the construction of 
recombinant strains with missing relevant diagnostic proteins or DNA-based vaccines, are 
also being investigated (Blasco, 2006). In fact, the Rev-1 vaccine strain with a deletion of 
the gene coding for BP26 protein (that can be used as a differential marker) has been 
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shown to induce the same protective efficacy as Rev-1 in sheep (Jacques et al, 2007). It 
also showed efficacy against B. ovis infection in rams, however evaluation of the 
performance of the BP26-based differential diagnostic test is limited (Grilló et al, 2009). 
However none of the new-generation vaccines have been shown to have improved efficacy 
and safety over the classic Rev-1 vaccine and it has been recommended that Rev-1 should 
remain the reference vaccine for the prevention of brucellosis in sheep and goats (Blasco, 
2006). 
Independent of their origin, the Rev-1 vaccine and the tests used to diagnose the disease 
should always be submitted for quality control to internationally recognized laboratories, 
and should fulfill the minimal requirements described by the World Organization for 
Animal Health (OIE, 2008). A country’s veterinary services must select a control or 
eradication approach compatible with the socioeconomic conditions and infection status of 
that country. The effect of brucellosis on both the livestock economy and human health as 
well as the costs of the different strategies must be evaluated as part of this practice. 
Several aspects, such as knowledge of livestock management and breeding practices, the 
habits of the community and the availability of adequate human resources to carry out the 
program, must also be evaluated. Moreover, cooperation between all related stakeholders is 
of paramount importance and should be promoted. Collaboration between the public health 
and veterinary services has to be encouraged through the establishment of a national 
zoonoses body (Metcalf et al, 1994). 
Although vaccination can interfere with serological testing, this strategy is central to 
protect susceptible livestock. However, this interference is minimized when animals are 
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vaccinated at a younger age. In endemic countries, several strategies have been designed to 
eradicate and or control the disease. The implementation of any sanitary strategy requires 
considerable technical training, and an awareness campaign aimed at farmers and the 
general population. The most common strategies to control infection with B. melitensis in 
small ruminants include blanket whole-flock/herd vaccination or testing and slaughtering 
with or without vaccination. In both cases, the use of adequate vaccination procedures and 
diagnostic tests is of paramount importance (Blasco and Molina, 2011). 
The use of vaccination to increase disease resistance in herds is important in these 
strategies and it has been demonstrated that, in cattle, vaccination was the most effective 
control measure. In California the prevalence in dairy and beef herds was nearly 87% 
lower after vaccination for ten years (Nelson, 1977). However, a study has shown that for 
any successful prevention, 70% of a herd’s population needs to be immunized (Berman, 
1981). However Metcalf et al. (1994) reported that vaccination alone, without the adoption 
of any other control measures, was of doubtful value. Consequently other measures, 
including movement restrictions and management changes, are also required to be adopted 
in conjunction with a vaccination campaign.  
Numerous attempts to eradicate B. melitensis infection or, at least, to reduce its prevalence 
to an “acceptable” level have been made in several countries within the region. In Algeria, 
an approach based on test-and-slaughter of goats was initiated in 1995, however it was 
replaced after a 3-year period with a mass vaccination campaign. In Tunisia, mass 
vaccination with Rev-1 by the conjunctival route, irrespective of age, was implemented 
throughout the country in order to stop the spread of the 1991 epizootic. A similar 
programme was implemented in eastern Morocco in 1996. Simultaneously, an 
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epidemiological survey was conducted and confirmed the absence of brucellosis in small 
ruminants in the rest of the country (Benkirane, 2006). In Iran, sheep and goats raised 
under an intensive husbandry system were individually identified and tested with the 
RBPT and SAT in 1983. Positive animals were then slaughtered and compensation paid to 
their owners. Following this campaign young animals were vaccinated with Rev-1. This 
resulted in a dramatic drop of infection from 3.2 to 0.5% between 1983 and 1996. For 
flocks raised under an extensive husbandry system young animals were vaccinated with 
Rev-1, although seropositive animals were not removed. In this group the proportion of 
seropositive animals had decreased from 3% in 1994 to 2.2% in 1998. Kuwait also initiated 
an annual mass vaccination campaign in 1993, using a reduced dose (1/50) of Rev-1, 
administered subcutaneously (Al-Khalaf et al, 1992; Crowther et al, 1977). Between 1993 
and 1997 the proportion of animals vaccinated each year had increased to 75%. 
Several vaccines have been produced to protect cattle, sheep and goats and swine against 
infection with Brucella. In endemic areas, RB51 and S19 are the most common vaccines to 
control B. abortus infection while Rev-1 vaccine is mostly used to control infections with 
B. melitensis. 
2.8.2.1 Control of B. melitensis 
Although the application of a test and slaughter strategy can be an effective way for the 
control and eradication of B. melitensis, this method is not always applicable in areas 
where the prevalence of disease is high and where socio-economic obstacles exist to the 
diseases control. Consequently control programs based on vaccination are suitable to 
reduce the prevalence of disease to an acceptable level prior to implementing an 
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eradication campaign. It is now recommended that a combination of vaccination of young 
animals and culling of infected adults is the most practical way to control B. melitensis 
(Blasco and Moriyon, 2005). 
2.8.2.1.1 Classical B. melitensis REV-1 vaccine 
Rev-1 is an attenuated strain of virulent B. melitensis obtained in the 1950’s (Elberg and 
Faunce, 1957) and is reported to be the best isolate of B. melitensis for incorporation into a 
vaccine (Blasco, 2006). Alton and Elberg (1967) have demonstrated the efficacy of the 
vaccine after vaccination of cattle 3 to 6 months of age, as well as in adult animals. The 
vaccine has been shown to induce a high and durable immune response (Blasco, 1997). 
The vaccine can be administered via the subcutaneous (S/C) or conjunctival route in both 
young and adult animals. However the S/C vaccination of young animals (3 to 6 months of 
age) with a standard full dose can result in persistent infection which interferes with the 
interpretation of results of serological assays (Fensterbank et al, 1982). However, this is 
not an issue if the aim is to induce the highest level of immunity in animals and not 
eradication of infection. In contrast vaccination via the conjunctival route confers adequate 
protection in young animals without interfering with serological assays (Marin et al, 1999).  
Although Rev-1 has some advantages it can result in infection of humans if accidentally 
inoculated (Blasco and Diaz, 1993) and has the potential to infect rams (European 
Commission, 2001). The vaccine may also induce abortions in sheep and goats if animals 
are vaccinated during pregnancy (Blasco, 1997). Even reduced doses of Rev-1 are not 
totally safe and may not induce effective protection in sheep (Fensterbank et al, 1982). 
Blasco (1997) recommended the use of a standard (full) dose via the conjunctival route to 
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minimize the risk of abortion (Blasco, 1997). 
In conclusion, vaccines (S19 and Rev1) are useful for the control of Brucella melitensis, 
especially if used in young animals (3 to 6 months) in countries with a high prevalence and 
limited resources (Blasco, 1997). However the level of protective immunity developed, 
safety issues in males and females, interference with serological assays, duration of 
immunity and the standardization of the vaccine are potential areas of concern with 
brucellosis vaccines. 
2.8.2.2 Vaccines of B. abortus 
2.8.2.2.1 Strain 19 vaccine (S19) 
Strain 19 is the mostly widely used vaccine against B. abortus in the world and it is 
considered the reference vaccine to which all other vaccines are compared. It was initially 
produced in the USA in 1939 and has been used in the field since 1941. The vaccine 
contains a live attenuated strain that was initially cultured from milk and then subcultured 
19 times (Nicoletti 1990). Jones et al. (1965) and Sangari et al. (1996) demonstrated that 
the S19 isolated could not grow in the presence of erythritol, was highly immunogenic, 
was less virulent than field strains and retained its viability during lyopholisation. 
Normally the vaccine is administered as a single subcutaneous injection containing 5-8 x 
10
10
 cfu to female calves 3 to 6 months of age. In contrast adult cattle receive a lower 
disease of 3 x 10
8-9 
cfu also through the subcutaneous route. It has also been reported that 
the vaccine can be administered to any age group through the conjunctival route at the 
reduced dose (3 x 10
9 
cfu). The conjunctival route has the advantages over the 
subcutaneous route in that there is a lower risk of abortion, it stimulates protection without 
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the presence of persistent antibodies which may interfere with the interpretation of 
serological tests and is not excreted in the milk.  
Reduced dose S19 can induce a similar immune response to that of full dose in adult cattle 
(Corner and Alton, 1981) and consequently has been recommended in areas where the 
disease is severe. However Bartone and Lomme (1980) considered that care has to be 
taken when handling the vaccine to ensure sufficient viable organisms were present to 
stimulate immunity in the vaccinated animals.  
Although S19 has many advantages, several limitations have been documented. Firstly, the 
vaccine may result in infection if given late in pregnancy (Crawford et al, 1978; Nicoletti 
et al, 1978a). Secondly, Breitmeyer et al. (1992) reported that the organism could be 
excreted in the milk of vaccinated cattle, resulting in increased probability of transmission 
to humans or other animals. Thirdly, persistent infections can occur after vaccination 
(Nicoletti, 1977; Corner and Alton, 1981). Although Crawford et al. (1978) cultured the 
organism from the milk of one of 245 dairy cattle five months after vaccination; the 
organism was not cultured from the lymph nodes of vaccinated adult beef cattle. Finally, 
administration of S19 in pregnant cows by the subcutaneous route may result in abortions 
(Nicoletti, 1977; Beckett and MacDiarmid, 1985). However, others failed to detect an 
influence on the pregnancy level in vaccinated animals (Corner and Alton, 1981). 
The side effects after using S19 are believed to be as a result of erythritol tolerant mutants 
derived from the vaccine strain culture. These mutants are believed to cause persistent 
infection or abortions after inoculation into pregnant cattle. Although a few cases of 
abortion may result from vaccination with S19, several authors have recommended that 
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S19 can be used at any stage of gestation as the benefits gained from vaccination outweigh 
any adverse effects or abortion risk (Barton and Lomme, 1980; Nicoletti, 1976).  
Another limitation of S19 is the presence of persistent antibodies which may interfere with 
serological assays. Nicoletti (1985) reported that the presence of these antibodies was 
influenced by the age and pregnancy status of the animal at vaccination and the dose 
administered. Alton et al. (1980) found that approximately 0.5% of animals vaccinated at a 
young age developed persistent antibodies. However, Beckett and MacDiarmid (1985) 
demonstrated that cattle vaccinated as calves had lower titres than did those vaccinated as 
adults. As a consequence of these persistent antibodies, false positive reactions must be 
considered when interpreting the results of serological surveys. Therefore, Nicoletti 
(1990b) recommended a reduction in the number of bacteria in the vaccine in order to 
decrease these undesirable antibodies. Several authors have demonstrated that the antibody 
level decreases six months post-vaccination eventually reaching non-detectable levels. 
Consequently it is recommended that the time of vaccination be accounted for when 
considering serological results and that all vaccinated animals should be identified 
(Worthington et al, 1973; Nicoletti et al, 1978a). 
The pathogenicity of S19 vaccine for humans is also a disadvantage of the vaccine as it can 
lead to necrosis and swelling of infected tissues. It also causes orchitis in male cattle during 
the first 10 days of vaccination and post vaccinal arthritis in calves. However the protective 
nature of S19 has been highlighted by many authors (Alton 1978; Erasmus 1995) if 
administered at 4 to 8 months of age. 
In conclusion, although S19 has some limitations, the vaccine is ideal for the control of 
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bovine brucellosis and it is relative safe, easy to use and has high immunogenicity leading 
to stimulation of immunity in a range of animals. 
2.8.2.2.2 Strain RB51 vaccine 
RB51 is an O-antigen deficient mutant of a virulent strain of B. abortus (S2308). The 
vaccine was proposed to overcome the disadvantages of S19 and has been officially used 
in several countries to prevent brucellosis in cattle. However there have been conflicting 
results about the vaccine’s efficacy. Schuring et al. (1995) and Palmer et al. (1996a) 
demonstrated that this vaccine resulted in fewer abortions when compared with S19. The 
immunity induced by RB51 is mostly cellular, resulting in fewer false positive reactions 
with serological tests. Furthermore the lack of antibodies against O-antigen enables 
differentiating between naturally infected and vaccinated cases. 
The route of administration and the dose used has varied from country to country. In the 
USA, the vaccine has been used mainly in calves at 4 to 12 months of age and injected 
subcutaneously with a dose of 1-3 x 10
10 
cfu. However, in other countries both calves and 
adult cattle have been vaccinated with two doses one year apart to boost the animal’s 
immunity. Vaccination with RB51 can result in the organisms being detected in milk, and 
abortions have been reported in cattle and bison post-vaccination (Palmer et al, 1996b). As 
a result, vaccination of early pregnant cattle is not recommended, unless the dose is 
reduced. Although vaccination with reduced dose during late stage pregnancy has resulted 
in no side effects, the pathogen can still be shed by a significant proportion of the 
vaccinated animals. 
Although studies on the effect of RB51 in humans are limited, it is likely that RB51, like 
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S19, can induce infection in humans. The diagnosis of humans infected with RB51 
requires a specific test and it is not easy to treat as RB51 is resistant to rifampicin 
(Villarroel et al, 2000). 
2.8.2.2.3 Brucella abortus strain 45/20 vaccine 
The inactivated vaccine 45/20 was initially made through dissociation of a rough strain 
after passaging strain 45 in guinea pigs. Although the vaccine has good immunogenicity, it 
is not widely used due to several drawbacks. Firstly, the vaccine organism can revert to a 
smooth form resulting in infections. Secondly, non-agglutinating antibodies play a role in 
blocking the antigen of smooth strains resulting in delayed clearance and increasing the 
likelihood of chronic cases developing. Finally, a lesion can develop at the injection site. 
After the priming vaccination no serologically response is detectable, although low levels 
of antibodies are stimulated within 10 days of administering a second dose (Hall et al, 
1976). The vaccine can be used at any age and during pregnancy (Alton, 1978). 
2.8.2.3 Other preventive measures 
Brucellosis is usually introduced to a herd through contact with infected animals and or 
semen of infected males. To prevent its introduction new animals should be purchased 
from Brucella-free herds and new animals should be isolated and screened before they are 
added to the herd. Semen also should be evaluated or collected from disease free bulls 
before it is used for artificial insemination. However managing the disease in endemic 
areas where animals co-graze can be difficult unless a vaccination program is also 
implemented. 
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Understanding the epidemiology of the disease in a country, in particular the distribution of 
the disease is critical prior to developing or assessing a disease control program. In the 
following chapter the results of a cross-sectional study are reported to further the 
knowledge on brucellosis in livestock in Oman. 
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CHAPTER THREE 
SEROPREVALENCE OF BRUCELLOSIS: CROSS-SECTIONAL STUDY 
3.1 Introduction  
As outlined in Chapter 1 brucellosis was detected in small percentage of animals in 1986 
but the seroprevalence subsequently increased (Ismaily et al, 1988; MAF 2003b) and 
evidence of infection in humans was evident (Nicoletti, 1986). However a thorough study 
on the seroprevalence in animals had not been undertaken in Oman. A cross-sectional 
serological study was undertaken in Oman to better understand the epidemiology of 
brucellosis in the country. The results of that study are reported in this chapter.  
3.2 Materials and Methods 
3.2.1 Samples 
3.2.1.1 Sampling plan for Seroprevalence: 
A cross-sectional serological study was undertaken to determine the prevalence of 
brucellosis in cattle, sheep, goats and camels in the Sultanate. Past reports indicated the 
presence of brucellosis in the southern Dhofar governorate (prevalence approximately 6%), 
however the status of brucellosis in the northern areas was unknown. 
The Sultanate was divided into two areas South (Dhofar with known expected prevalence 
of brucellosis) and North (Batinah, Al Buraimi, Al Dhahirah, Al Dakhiliyah, Al Sharqiyah, 
Al Wusta, Musandam and Muscat Governorates where the expected prevalence was 
unknown). A two stage sampling plan was adopted. The number of herds selected for 
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sampling from the north of Oman (387 herds) was based on an expected herd prevalence of 
50% (95% desired absolute precision - DAP) and a 5% margin of error. Within these 
herds, animals were randomly selected on the basis of the minimum sample size to detect 
the disease at an expected prevalence of 50% with the probability of finding at least one 
infected animal at a 95% confidence limit. Since there were some previous studies 
available for the seroprevalence (less than 10%) of brucellosis in different animals species 
in Dhofar, 138 herds were randomly selected based on an expected herd prevalence of 10% 
(95% DAP) and 5% error. Animals from Dhofar were randomly selected by assuming the 
expected percentage of the diseased animals to be 10% at a 95% confidence limit and 5% 
margin of error (Thrusfield, 2005).  
The number of samples thus calculated was subjected to the following formula for the 
estimation of required sample size (nadj):  
nadj  = (N x n) ÷ (N + n) 
Where: 
N  = total population  
n  =  calculated sample size through formula  
The sampling units were stratified and selected in proportion to the livestock population in 
the selected areas based upon the Agricultural Census in 2004/2005 (MAF, 2005). Random 
selection methods were used for the selection of areas to be sampled (random village 
selection through Survey Toolbox available at 
http://www.ausvet.com.au/content.php?page=software#st) within each Wilayat. The 
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selection of individual animals was also conducted through simple random sampling on-
site by either tossing a dice to determine which animal to sample or by using random 
number allocation. 
The minimum number of animal holdings required were 525 cattle, 529 sheep, 527 goat 
and 525 camel farms from all the governorates of Oman (Table 3.1 to Table 3.4). The 
number of individuals sampled at each holding varied according to the population of the 
species present at each holding. Number of herds to be sampled from a governorate was 
selected according to the population proportion of respective livestock species. No data 
were available regarding the animal population of two newly constituted wilayats [Al 
Sinainah (Al Buraimi Governorate) and Mazyounah (Dhofar Governorate)]. The sampling 
plan for these was made after acquiring animal population information from local animal 
health representatives and after interviewing livestock owners. 
3.2.1.2 Collection of samples and epidemiological information 
Field sampling was carried out between July 2009 and April 2010 throughout the 
Sultanate. For the data collection and mapping ArcPad™ (ESRI, USA) on Juno™ SB 
Handheld computers (Trimble Navigation Limited, USA) were used (Figure 3.1). In case 
of the herds belonging from the Dhofar governorate, the possible vaccination status of the 
animal was determined (ear-tagged or not / history of vaccination of herd from local 
veterinary staff) and only non-vaccinated animals were selected for sampling.  
Information regarding the husbandry (management and cohorts), animal characteristics 
(age, breed, gender and physical examination) and history (abortion, still birth at individual 
and herd level) was recorded on a predesigned proforma (Appendix 2). A herd was 
82 
 
categorized as positive for abortion history if any of the sampled animals or non-sampled 
cohorts had abortion history. Most of the sampled livestock was kept under the mixed 
management system where two or more species were kept together at same location with 
extensive or limited contact. Coding on the basis of presence of different cohorts was 
performed as single / alone (when only one species was found at a location), or multiple 
species contact (with camel, with cattle, with goats, with sheep or with other ruminants). 
Samples were collected into labeled sterile vacutainers. To produce serum, blood was 
drawn into a 10mL clot activator vacutainer without anticoagulant. Samples were 
transported to the Veterinary Research Center (VRC) for further processing while 
observing the critical temperature requirements (4°C). Upon arrival each sample was given 
a unique identity (VRC Number) and serum was removed. Later these samples were stored 
at -20°C until further testing was performed. 
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Table 3.1 Sampling plan to determine the seroprevalence of brucellosis in cattle in 
Oman 
Governorate 
Total 
Population 
(Heads) 
% of total 
population 
Herds selected 
for sampling 
Adjusted No. of 
herds sampled 
Muscat 4447 3.48 13.38 14 
Batinah 66411 52.02 199.75 200 
Musandam 325 0.25 0.98 1 
Al Buraimi 5971 4.68 17.96 18 
Al Dhahirah 16582 12.99 49.88 50 
Al Dakhiliyah 19245 15.07 57.89 58 
Al Sharqiyah 14642 11.47 44.04 45 
Al Wusta 43 0.03 0.13 1 
Total for 
North of 
Oman 
127666 42.33 
384 @ 50% 
expected 
prevalence & 
95% CI & 5% 
error 
387 
Total for 
South of 
Oman 
(Dhofar) 
173892 57.66 
138 @ 10% 
expected 
prevalence & 
95% CI, 5% error 
138 
Grand Total 301558 
  
525 
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Table 3.2 Sampling plan to determine the seroprevalence of brucellosis in sheep in 
Oman 
Governorate 
Total 
Population 
(Heads) 
% of total 
population 
Herds selected 
for sampling 
Adjusted 
number of 
herds sampled 
Muscat  13855 4.03 15.49 16 
Batinah  110572 32.19 123.62 125 
Musandam  5609 1.63 6.27 7 
Al Buraimi  54005 15.72 60.38 61 
Al Dhahirah 41042 11.95 45.89 47 
Al Dakhiliyah 43499 12.66 48.63 50 
Al Sharqiyah 60012 17.47 67.09 68 
Al Wusta  14867 4.33 16.62 17 
Total for North of 
Oman 
343461 97.83 384 @ 50% 
expected 
prevalence & 
95% CI & 5% 
error 
391 
Total for South of 
Oman (Dhofar) 
7605 2.17 138 @ 10% 
expected 
Prevalence & 
95% CI, 5% 
error 
138 
Grand Total 351066 - - 529 
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Table 3.3 Sampling plan for seroprevalence of brucellosis in goats of Oman 
Governorate Total Population 
(Heads) 
% of total 
population Herds selected 
for sampling 
Adjusted 
number of herds 
sampled 
Muscat  47713 3.44 13.21 14 
Batinah  430005 31 119.05 120 
Musandam  67977 4.9 18.82 19 
Al Buraimi  95202 6.86 26.36 27 
Al Dhahirah 148394 10.69 41.08 42 
Al Dakhiliyah 203057 14.64 56.22 57 
Al Sharqiyah 322858 23.28 89.38 90 
Al Wusta  71819 5.18 19.88 20 
Total for North 
of Oman 
1387025 89.07 384 @ 50% 
expected 
prevalence & 
95% CI & 5% 
error 
389 
Total for South 
of Oman 
(Dhofar) 
170123 10.92 138 @ 10% 
expected 
Prevalence & 
95% CI, 5% error 
138 
Total 1557148 - - 527 
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 Table 3.4 Sampling plan for seroprevalence of brucellosis in camels of Oman 
 
Governorate 
Total 
Population 
(Heads) 
% of total 
population 
Herds selected 
for sampling 
Adjusted 
number of 
herds 
sampled 
Muscat  52 0.08 0.31 1 
Batinah  5626 8.82 33.88 34 
Musandam 38 0.06 0.23 1 
Al Buraimi  6947 10.89 41.83 42 
Al Dhahirah 8694 13.63 52.35 53 
Al Dakhiliyah  6730 10.55 40.52 41 
Al Sharqiyah 12779 20.04 76.95 77 
Al Wusta  22906 35.92 137.96 138 
Total for North of 
Oman 
63772 54.37 384 @ 50% 
expected 
prevalence & 
95% CI & 5% 
error 
387 
Total for South of 
Oman (Dhofar) 
53527 45.63 138 @ 10% 
expected 
Prevalence & 
95% CI, 5% 
error 
138 
Total 117299 - - 525 
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Figure 3.1 ArcPad (ESRI, USA) ArcPad™ (ESRI, USA) mounted Juno™ SB 
Handheld computer (Trimble Navigation Limited, USA) used for the field data 
collection and mapping 
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3.2.1.3 Population dynamics of samples 
In this study, to determine the seroprevalence of brucellosis in livestock from the 
Sultanate, 10697 serum samples were collected from all governorates of Oman. These 
samples were collected from 1479 geographically marked animal holdings (Figure 3.7) 
distributed throughout the Sultanate. Sera were collected from 2209 cattle, 2457 sheep, 
3776 goats and 2255 camels. Although the aim of the study was to sample herds not 
previously vaccinated against brucellosis, a lack of cooperation by farmers in the 
brucellosis endemic region (Dhofar governorate) prevented reaching the desired number of 
unvaccinated herds to sample. Herds containing any vaccinated animals were excluded 
from the analyses. Consequently data from 1267 unvaccinated herds comprising 1704 
cattle, 2215 sheep, 3308 goats and 2250 camels were used in the final analyses. 
All samples were collected according to the proportion of livestock present in each 
governorate as shown in Figure 3.2 and the distribution of the livestock sampled is 
presented in Table 3.7. In total 442 (29.8% of those available) holdings were sampled in 
the Dhofar governorate. Animals sampled in these holdings included 703 cattle, 554 sheep, 
1676 goats and 909 camels. The vaccination histories of the herds and animals were 
examined carefully and 232 (18.3% of unvaccinated) herds comprising 198 cattle, 312 
sheep, 1208 goats and 904 camels were confirmed not to have been vaccinated against 
brucellosis. From the north of Oman, 274 herds (21.6%) were sampled from Batinah 
governorate (753 cattle, 659 sheep, 676 goats and 118 camels) followed by 179 (14.1%) 
from Al Sharqiyah governorate (172 cattle, 272 sheep, 406 goats and 247 camels), 172 
(13.6%) from Al Wusta governorate (4 cattle, 98 sheep, 105 goats and 547 camels), 164 
(12.9%) from Al Dakhiliyah governorate (260 cattle, 278 sheep, 367 goats and 138 
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camels), 101 (7.9%) holdings from Al Dhahirah governorate (152 cattle, 212 sheep, 232 
goat and 135 camels), 90 (7.1%) holdings in Al Buraimi governorate (81 cattle, 267 sheep, 
146 goats and 140 camels), 30 (2.4%) holdings from Muscat governorate (69 cattle, 82 
sheep, 73 goats and 15 camels) and 25 (1.9%) holdings from the Musandam governorate 
(15 cattle, 35 sheep, 95 goats and 6 camels). 
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Figure 3.2 Distribution of the total livestock population (%) in various wilayats 
(districts) of Oman (MAF, 2005). 
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Figure 3.3 Distribution of the cattle population (%) in various wilayats (districts) of 
Oman (MAF, 2005). 
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 Figure 3.4 Distribution of the sheep population (%) in various wilayats of Oman 
(MAF, 2005).Figure 3.5 Distribution of the goat population (%) in various wilayats of 
Oman (MAF, 2005). 
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Figure 3.5 Distribution of the goat population (%) in various wilayats of Oman 
(MAF, 2005). 
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Figure 3.6 Distribution of the camel population (%) in various wilayats of Oman 
(MAF, 2005). 
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Figure 3.7 Location of the livestock holdings sampled for mapping of brucellosis in 
the Sultanate 
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Table 3.5 Distribution of samples collected for the study on the seroprevalence of brucellosis in Oman 
Governorate 
Cattle Sheep Goats Camels Total 
Holdings 
(% of 
total) 
Individual 
No. 
(% of total) 
Holdings 
(% of total) 
Individual 
No. 
(% of total) 
Holdings 
(% of 
total) 
Individual 
No. 
(% of total) 
Holdings 
(% of 
total) 
Individual 
No. 
(% of total) 
Holdings 
(% of 
total) 
Individual 
No. 
(% of total) 
Batinah 209 (1.45) 
753 
(1.13) 
170 
(2.08) 
659 
(0.59) 
165 
(0.69) 
676 
(0.99) 
40 
(3.14) 
118 
(2.09) 
274 
(0.57) 
2206 
(0.36) 
Al Buraimi 
21 
(2.56) 81 (1.36) 
56  
(4.7) 
267  
(0.49) 
30 
(1.85) 
146 
(0.15) 
43 
(11.05) 
140 
(2.01) 
90 
(2.24) 
634 
(0.39) 
Al Dakhiliyah 
79 
(1.42) 
260 
(1.35) 71 (1.74) 
278  
(0.64) 
85 
(0.97) 
367 
(0.18) 
41 
(3.85) 
138 
(2.05) 
164 
(0.84) 
1043 
(0.38) 
Al Dhahirah 
52 
(6.33) 
152 
(0.92) 50 (1.50) 
212  
(0.52) 
53 
(0.80) 
232 
(0.16) 
40 
(4.24) 
135 
(1.55) 
101 
(0.67) 
731 
(0.34) 
Dhofar 
41 
(0.48) 
198 
(0.11) 35 (10.2) 
312  
(4.10) 
74 
(1.59) 
1208 
(0.71) 
162 
(2.66) 
904 
(1.69) 
232 
(1.19) 
2622 
(0.65) 
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Governorate 
Cattle Sheep Goats Camels Total 
Holdings 
(% of 
total) 
Individual 
No. 
(% of total) 
Holdings 
(% of total) 
Individual 
No. 
(% of total) 
Holdings 
(% of 
total) 
Individual 
No. 
(% of total) 
Holdings 
(% of 
total) 
Individual 
No. 
(% of total) 
Holdings 
(% of 
total) 
Individual 
No. 
(% of total) 
Musandam 5 (6.58) 
15  
(4.62) 8 (1.70) 
35  
(0.62) 
21 
(1.02) 
95  
(0.14) 
2 
(16.67) 
6  
(15.79) 
25 
(0.96) 
151 
(0.20) 
Muscat 
18 
(1.68) 
69  
(1.55) 19 (1.12) 
82  
(0.59) 
16 
(0.47) 
73  
(0.15) 
4 
(19.05) 
15 
(28.85) 
30 
(0.48) 
239 
(0.36) 
Sharqiyah 
55 
(0.87) 
172 
(1.17) 75 (0.93) 
272  
(0.45) 
93 
(0.55) 
406  
(0.13) 
75 
(2.09) 
247 
(1.08) 
179 
(0.51) 
1097 
(0.27) 
Al Wusta 
2 
(10.00) 4 (9.31) 24 (2.31) 
98  
(0.66) 
25 
(1.22) 
105  
(0.15) 
145 
(9.22) 
547 
(2.39) 
172 
(3.68) 
754 
(0.69) 
Total 
482 
(1.18) 
1704 
(0.57) 
508 
(1.79) 
2215 
(0.63) 
562 
(0.80) 
3308 
(0.21) 
552 
(3.69) 
2250 
(1.92) 
1267 
(0.82) 
9477 
(0.41) 
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3.2.1.4. Distribution of samples 
3.2.1.4.1 Age related distribution of samples 
The sampled livestock were categorized into 4 age groups. For cattle and camels the 
groups were ≤ 2 years; > 2 to ≤ 5 years; >5 to ≤ 10 years; and > 10 years. For sheep and 
goats the animals were categorized as ≤ 1 year; > 1 to ≤ 3 years; > 3 to ≤ 5 years; and > 5 
years. Data regarding this distribution are presented in Table 3.6 for cattle and camels, and 
in Table 3.7 for small ruminants (sheep and goats).  
Of the 1704 samples from cattle, 28.9% (492) were ≤ 2 years, 41.5% (708) were > 2 to ≤ 5 
years, 24.6% (419) were >5 to ≤ 10 years and 4.9% (85) were > 10 years. The age 
distribution of 2250 camels sampled was: 17.9% (402) ≤ 2 years of age, 22.5% (507) 
between the age of > 2 to ≤ 5 years, 40.5% (912) between > 5 to ≤ 10 years of age and 
19.1% (429) above the age of 10 years. 
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Table 3.6 Age related distribution of cattle and camels sampled to determine the 
seroprevalence of brucellosis 
Species 
Age Groups (years) 
Total ≤ 2  > 2 to ≤ 5  >5 to ≤ 10  > 10  
Cattle 492
2 
708
1 
419
2 
85
3 
1,704 
Camel 402
b 
507
b 
912
a 
429
b 
2,250 
Values with different numerical superscripts are significantly different, χ2=70.9, 
3df, p<0.001 
Values with different alphabetic superscripts are significantly different, χ2=114.5, 
3df, p<0.001 
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Table 3.7 Age related distribution of sheep and goats sampled to determine the 
seroprevalence of brucellosis 
Species 
Age Groups (years) 
Total ≤ 1  >1 to ≤ 3 >3 to ≤ 5 > 5  
Sheep 221
3 
1320
1 
469
2 
205
3 
2,215 
Goat 199
d 
1315
a 
1127
b 
667
c 
3,308 
Values with different numerical superscripts are significantly different, χ2=435.01, 
3df, p<0.001 
Values with different alphabet superscripts are significantly different, χ2=142.97, 
3df, p<0.001 
3.2.1.4.2 Sex related distribution of sampled animals 
The number of males and females sampled for each of the different species is presented in 
Table 3.8. As the study was directed towards breeding herds, significantly more (p<0.05) 
females were sampled than males. When data for all species were combined, 83.8% of the 
samples were collected from females. 
 
3.2.1.4.3 Breed related distribution in the sampled populations 
Data regarding the distribution of breed in the different species is presented in 
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Table 3.9. Samples from local breeds of livestock constituted 79.5% (n=7538) of all 
samples, with 12.9% (1219) of samples coming from cross-bred animals and 7.6% (720) 
from imported animals. Most animals sampled were of a local breed with 63.4% (n=1081), 
50.2% (n=1112), 94.3% (n=3119) and 98.9% (n=2226) of cattle, sheep, goats and camels, 
respectively, being local breeds.  
A greater proportion of imported animals were sampled in sheep (16.2%) compared with 
12.9, 3.7 and 0.8% for cattle, goats and camels, respectively. The highest proportion of 
crossbred animals (33.6%) was also in sheep followed by cattle (23.7%), goats (2.0%) and 
camels (0.3%). These differences were statistically significant (P<0.001). 
 
Table 3.8 Sex related distribution of samples collected to determine the 
seroprevalence of brucellosis in Oman 
Animal 
Species 
Male Female Total P Value 
No. 
Tested 
% of total 
species 
sampled 
No. Tested % of total 
species 
sampled 
Camel 252 11.2 1998 88.8 2250 <0.001 
Cattle 422 24.8 1282 75.2 1704 <0.001 
Goat 429 13.0 2879 87.0 3308 <0.001 
Sheep 431 19.5 1784 80.5 2215 <0.001 
Total 1534 16.2 7943 83.8 9477 <0.001 
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Table 3.9 The distribution of samples collected from different breeds 
Animal 
Species 
Breed Total P Value 
Local (%) Imported (%) Cross (%) 
Camel 2226 (98.9) 18 (0.8) 6 (0.3) 2250 p<0.001 
Cattle 1081 (63.4) 220 (12.9) 403 (23.7) 1704 p<0.001 
Goat 3119 (94.3) 124 (3.7) 65 (2.0) 3308 p<0.001 
Sheep 1112 (50.2) 358 (16.2) 745 (33.6) 2215 p<0.001 
Total 7538 (79.5) 720 (7.6) 1219 (12.9) 9477 p<0.001 
 
3.3 Results  
3.3.1 General Seroprevalence of Brucellosis in Oman 
3.3.1.1 Herd based seroprevalence of brucellosis 
For the purpose of calculating herd based prevalence of brucellosis, only unvaccinated 
holdings were considered. This resulted in samples from only 1267 holdings being 
included in this aspect of the seroprevalence study. Samples were first screened with the 
RBPT test and then the cELISA was used to confirm seropositive animals. In total 30 
(2.4%, 95% CI 1.6, 3.4) holdings contained one or more seropositive animals. The 
geographical distribution of the positive holdings is presented in Table 3.10. The highest 
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herd prevalence was in the Dhofar governorate (8.6%, 95% CI 5.3, 13). No seropositive 
animals were found in Al Buraimi, Al Wusta and Musandam governorates. The difference 
between the herd prevalence between localities was significant (χ2 (8df) =50.26, p<0.001) 
(Table 3.10). The overall herd seroprevalence in the northern governorate was 0.97% (95% 
CI 0.5, 1.8). 
When the seroprevalence was calculated for individual species, 2.3% of goat holdings 
(95% CI 1.2, 3.9), 1.4% of camel holdings (95% CI 0.6, 2.8), 1.2% of cattle holdings (95% 
CI 0.5, 2.7), and 0.6% of sheep holdings (95% CI 0.1, 1.7) contained some seropositive 
animals. These differences between species were not significantly different (χ2 (3df) 
=5.78, p=0.122). 
There was no significant difference in the herd prevalence for cattle between localities 
(p=0.319). The highest herd prevalence for cattle was observed in Muscat (5.6%) followed 
by Dhofar (4.9%). 
Only three holdings (0.59%, 95% CI 0.1, 1.7) contained seropositive sheep, with one each 
in Batinah (0.6%, 95% CI 0.0, 3.2), Al Dakhiliyah (1.4%, 95% CI 0.0, 7.6) and Al 
Dhahirah Governorates (2.0%, 95% CI 0.1, 10.6). There was no significant difference in 
the herd prevalence for sheep between the sampled localities (χ2 (8df) =3.97, p=0.876). 
There was a significant difference in the herd prevalence for goats between governorates 
(χ2 (1df) =24.19, p<0.001). Of 562 goat holdings, 13 (2.3%, 95% CI 1.2, 3.9) contained 
positive animals and these holdings were found only in Batinah (0.6%, 95% CI 0.0, 3.3) 
and Dhofar governorates (16.2%, 95% CI 8.7, 26.6). 
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The highest percentage of camel holdings containing some seropositive animals was in 
Dhofar governorate (3.7%, 95% CI 1.4, 7.9) followed by one herd in each of Al Sharqiyah 
(1.3%, 95% CI 0.0, 7.2) and Batinah governorates (2.5%, 95% CI 0.1, 13.2). These 
differences were, however, not significant (χ2 (2df) =1.05, p=0.59). 
 
 
3.3.1.2 Individual animal seroprevalence 
In total 33 (0.4%; 95% CI 0.2, 0.5) animals were seropositive to brucellosis (Table 3.11). 
When data for all species were combined the highest animal level prevalence was in the 
Dhofar governorate (0.9%, 95% CI 0.6, 1.3). In this governorate 23 animals belonging to 
20 unvaccinated herds were seropositive. Other positive animals were detected in Muscat 
(0.4%, n=1), Al Dakhiliyah (0.19%, n=2), Batinah (0.18%, n=1), Al Sharqiyah (0.18%, 
n=2), and Al Dhahirah (0.14%, n=1). The animal level seroprevalence was significantly 
different between governorates (χ2 (5df) =20.69, p<0.001). 
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Table 3.10 Herd level seroprevalence of brucellosis in the sampled holdings 
Governorate Cattle Sheep Goat Camel Total 
Pos./Tested 
(Prev. %) 
95% CI Pos./Tested 
(Prev. %) 
95% CI Pos./Tested 
(Prev. %) 
95% CI Pos./Tested 
(Prev. %) 
95% CI Pos./Tested 
(Prev. %) 
95% CI 
Batinah 1/209 (0.48) 0.0-2.6 1/170 (0.59) 0-3.2 1/165 (0.61) 0.0-3.3 1/40 (2.5) 0.1-13.2 4/274 (1.46)c 0.4-3.7 
Al Buraimi  0/21 (0.0) 0.0-16.1 0/56 (0.0) 0-6.4 0/30 (0) 0.0-11.6 0/43 (0) 0.0-8.2 0/90 (0) 0.0-4.0 
Al Dakhiliyah 1/79 (1.27) 0.0-6.9 1/71 (1.41) 0-7.6 0/85 (0) 0.0-4.2 0/41 (0) 0.0-8.6 2/164 (1.22)c 0.1-4.3 
Al Dhahirah 0/52 (0.0) 0.0-6.8 1/50 (2.0) 0.1-10.6 0/53 (0) 0.0-6.7 0/40 (0) 0.0-8.8 1/101 (0.99)c 0.0-5.4 
Dhofar  2/41 (4.88) 0.6-16.5 0/35(0) 0-10 12/74 (16.2)* 8.7-26.6 6/162 (3.7) 1.4-7.9 20/232 (8.62)a 5.3-13.0 
Musandam  0/5 (0.0) 0.0-52.2 0/8(0) 0-36.9 0/21 (0) 0.0-16.1 0/2 (0) 0.0-84.2 0/25 (0) 0.0-13.7 
Muscat  1/18 (5.56) 0.1-27.3 0/19(0) 0-17.6 0/16 (0) 0.0-20.6 0/4 (0) 0.0-60.2 1/30 (3.3)a,c 0.1-17.2 
Sharqiyah  1/55 (1.82) 0-9.7 0/75(0) 0-4.8 0/93 (0) 0.0-3.9 1/75(1.33) 0.0-7.2 2/179 (1.12)c 0.1-4.0 
Al Wusta  0/2 (0.0) 0-84.2 0/24(0) 0-14.2 0/25 (0) 0.0-13.7 0/145(0) 0.0-2.5 0/172 (0) 0.0-2.1 
Total  6/482 (1.24) 0.5-2.7 3/508(0.59) 0.1-1.7 13/562(2.31) 1.2-3.9 8/552(1.45) 0.6-2.8 30/1267 (2.37) 1.6-3.4 
*Values with different superscripts are significantly different, χ2=73.05, 8df, p<0.001 
Values with different alphabetic superscripts in the total column are significantly different, χ2=50.26 8df, p<0.001 
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In cattle, 0.4% (n=7, 95% CI 0.2, 0.8) were seropositive. Three of these originated from the 
Dhofar governorate (1.5%) and there was one seropositive cattle from Muscat (1.4%), Al 
Sharqiyah (0.6%), Al Dakhiliyah (0.4%) and Batinah (0.1%) governorates. These 
differences were not significantly different (χ2 (4df) =7.86, p=0.096) (Table ). 
Only 3 sheep were seropositive (0.1%, 95% CI 0.0, 0.4) and one each came from Batinah, 
Al Dakhiliyah and Al Dhahirah governorates. These geographical differences in the 
seroprevalence for sheep were not significant (χ2 (2) =0.78, p=0.678). 
In contrast the seroprevalence for goats varied significantly between governorates (χ2 (1df) 
=5.06, p=0.02). More goats were positive than any other species with 13 from the Dhofar 
governorate (1.08%, 95% CI 0.6, 1.8) and 1 from Batinah (0.1%, 95% CI 0.0, 0.8) being 
positive. 
There were 9 seropositive camels (0.4%, 95% CI 0.2, 0.8). There was no significant 
difference in the seroprevalence in camels between Governorates (χ2 (2df) =0.42, p=0.811). 
The highest seroprevalence was observed in camels from Dhofar and Batinah governorates 
(0.8% each) followed by Al Sharqiyah (0.4%). 
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Table 3.11 Individual animal seroprevalence to brucellosis in sampled livestock species 
Governorate 
Cattle Sheep Goat Camel Total 
Pos./Tested 
(Prev%) 
95% 
CI 
Pos./Tested 
(Prev%) 
95% 
CI 
Pos./Tested * 
(Prev%) 
95% 
CI 
Pos./Tested 
(Prev%) 
95% 
CI 
Pos./Tested 
(Prev%) 
95% 
CI 
Batinah  1/753 (0.13) 0.0-0.7 1/659 (0.15) 0.0-0.8 1/676 (0.15) 
0.0-
0.8 1/118 (0.85) 0.0-4.6 4/2206 (0.18)
b
 
0.0-
0.5 
Al Buraimi  0/81 (0) 0.0-4.5 0/267 (0) 0.0-1.4 0/146 (0) 
0.0-
2.5 0/140 (0) 0.0-2.6 0/634 (0) 
0.0-
0.6 
Al Dakhiliyah 1/260 (0.38) 0.0-2.1 1/278 (0.36) 0.0-2.0 0/367 (0) 
0.0-
1.0 0/138 (0) 0.0-2.6 2/1043 (0.19)
b
 
0.0-
0.7 
Al Dhahirah 0/152 (0) 0.0-2.4 1/212 (0.47) 0.0-2.6 0/232 (0) 
0.0-
1.6 0/135 (0) 0.0-2.7 1/731 (0.14)
b
 
0.0-
0.8 
Dhofar  3/198 (1.52) 0.3-4.4 0/312 (0) 0.3-1.2 13/1208 (1.08) 
0.6-
1.8 7/904 (0.77) 0.3-1.6 23/2622 (0.88)
a
 
0.6-
1.3 
Musandam  0/15 (0) 
0.0-
21.8 0/35 (0) 
0.0-
10.0 0/95 (0) 
0.0-
3.8 0/6 (0) 
0.0-
45.9 0/151 (0) 
0.0-
2.4 
Muscat  1/69 (1.45) 0.0-7.8 0/82 (0) 0.0-4.4 0/73 (0) 
0.0-
4.9 0/15 (0) 
0.0-
21.8 1/239 (0.42)
b
 
0.0-
2.3 
Sharqiyah  1/172 (0.58) 0.0-3.2 0/272 (0) 0.0-1.3 0/406 (0) 
0.0-
0.9 1/247 (0.4) 0.0-2.2 2/1097 (0.18)
b
 
0.0-
0.7 
Al Wusta  0/2 (0) 
0.0-
60.2 0/98 (0) 0.0-3.7 0/105 (0) 
0.0-
3.5 0/547 (0) 0.0-0.7 0/754 (0) 
0.0-
0.5 
Total  7/1704 (0.41) 0.2-0.8 3/2215 (0.14) 0.0-0.4 14/3308 (0.42) 
0.2-
0.7 9/2250 (0.4) 0.2-0.8 33/9477 (0.35) 
0.2-
0.5 
 
*Values in the column are significantly different, χ2=19.53, 8df, p=0.01 
Values with different alphabetic superscripts in a column are significantly different, χ2=31.11 8df, p<0.001 
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3.3.2 Specific seroprevalence for brucellosis 
3.3.2.1 Sex specific seroprevalence for brucellosis 
Data regarding the seroprevalence in the different sex categories are summarised in 
Table 3.12. There was no significant difference in the seroprevalence between the 
genders when all species data were combined (χ2 (1df) =1.19, p=0.275).  
A comparison between the sexes was only possible for cattle where 3 of 7 positive 
animals were males (0.7%; 95% CI 0.1, 2.1) and 4 (0.03%; 95% CI 0.1, 0.8) were 
females. These differences were not significant (χ2 (1df) =1.09, p=0.297) (Table 3.12). 
All of the seropositive sheep, goats and camels were female. 
3.3.2.2 Age related prevalence of brucellosis 
There was no difference in the seroprevalence of brucellosis in different age groups of 
cattle (χ2 (3df) = 2.282, p=0.516) and camels (χ2=0.18, 2df, p=0.915) (Table 3.13).The 
highest seroprevalence in cattle was observed in the >10 year old animals (1.18%, 95% 
CI 0.0, 6.4) followed by 0.61% (95% CI 0.1, 1.8) in cattle up to the age of 2 years, 
0.28% (95% CI 0.0, 1.0) in cattle from 2 to 5 years of age and 0.24% (95% CI 0.0, 1.3) 
in animals 5 to 10 years of age. 
The highest seroprevalence observed in different age groups of camels was as follows: 
0.5% in the > 10 years old camels (95% CI 0.2, 1.3), 0.5% in the 5.1 to 10 years old 
camels (95% CI 0.1, 1.7) and 0.4% in the 2.1 to 5 years old camels (95% CI 0.0, 1.4). 
No camels belonging to the ≤ 2 years age group (95% CI 0.0, 0.9) were seropositive for 
brucellosis. The differences observed for the prevalence among various age groups were 
not significant (χ2 (2df) =0.18, p=0.915). 
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No valid comparison was possible regarding the observed prevalence of brucellosis in 
different age groups for sheep as all positive animals (n=3, 0.2%) belonged to the sheep 
between > 1 to ≤ 3 years of age (Table 3.14). In goats the highest seroprevalence was 
observed in the <5 years of age (0.6%, 95% CI 0.2, 1.5), however there were no 
significant differences between age groups for goats (χ2 (2df) =0.48, p=0.785). 
 
3.3.2.3 Influence of breed on prevalence of brucellosis 
When data for all species were combined the highest seroprevalence was observed in 
imported breeds, where 6 (0.83%, 95% CI 0.3, 1.8) animals were found to be 
seropositive. This seroprevalence was higher than that for local (0.33%, 95% CI 0.2, 
0.5) and cross bred animals (0.16%, 95% CI 0.0, 0.6) (χ2 (2df) =6.17, p=0.045). 
Similarly for cattle, the seroprevalence in imported breeds (1.82%, 95% CI 0.5, 4.6) was 
significantly higher than that of crossbreds (0.5%, 95% CI 0.1, 1.8) and local cattle 
(0.09%, 95% CI 0.0, 0.5) (χ2 (2df) =13.49, p=0.001). Although the seroprevalence in 
imported breeds (0.56%, 95% CI 0.1, 2.0) of sheep was higher than for local breeds 
(0.09%, 0.0, 1.5), this difference was not significant (χ2 (1df) =2.93, p=0.086). All 
seropositive goats (0.45%, 95% CI 0.2, 0.8) and camels (0.4%, 95% CI 0.2, 0.8) were of 
local breeds (Table 3.15). 
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Table 3.12 Sex related seroprevalence of brucellosis in the sampled animals 
Animal 
Species 
Male Female 
Tested Positive Prevalence Tested Positive Prevalence 
(95% CI) (95% CI) 
Camel 252 0 0 (0.0, 1.5) 1998 9 0.45 (0.2, 0.9) 
Cattle 422 3 0.68 (0.1, 
0.1) 
1282 4 0.31 (0.1, 0.8) 
Goat 429 0 0 (0.0, 0.9) 2879 14 0.49 (0.3, 0.8) 
Sheep 431 0 0 (0.0, 0.9) 1784 3 0.17 (0.0, 0.5) 
Total 1534 3 0.2
1 
(0.0, 0.6) 7943 30 0.38
1
(0.3, 0.5) 
Values with similar superscripts are not significantly different, χ2 (1df) =1.19, 
p=0.275  
 
Table 3.13 Age related seroprevalence of brucellosis in sampled cattle and 
camels 
Age 
Groups 
(years) 
Camel Cattle 
Positive / 
Tested 
Prevalence 
95%CI 
Positive / 
Tested 
Prevalence 
95%CI 
≤2  0/402 0 (0.0, 0.9) 3/492 0.61a (0.1, 1.8) 
2.1 to ≤5 2/507 0.391 (0.0, 1.4) 2/708 0.28a (0.0, 1.0) 
5.1 to ≤10 5/912 0.551 (0.2, 1.3) 1/419 0.24a (0.0, 1.3) 
>10 2/429 0.47
1
 (0.1, 1.7) 1/85 1.18
a
 (0.0,
 
6.4)
 
Values with the same alphabetic superscripts are not significantly different, χ2 (3df) 
=2.282, p=0.516  
Values with the same numerical superscripts are not significantly different, χ2 (2df) 
=0.18, p=0.915  
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Table 3.14 Age related seroprevalence of brucellosis in sampled sheep and goats 
Age 
Groups 
(years) 
Goat Sheep 
Positive / 
Tested 
Prevalence 
95%CI* 
Positive / 
Tested 
Prevalence 
95%CI 
≤ 1 year 0/199 0 (0.0, 1.8) 0/221 0 (0.0, 1.7) 
>1 to ≤ 3 5/1315 0.38 (0.1, 0.9) 3/1320 0.23 (0.0, 0.7) 
>3 to ≤ 5 5/1127 0.44 (0.1, 1.0) 0/469 0 (0.0, 0.8) 
> 5 4/667 0.6 (0.2, 1.5) 0/205 0 (0.0, 1.8) 
*Not significantly different, χ2 (2df) =0.48, p=0.78 
 
Table 3.15 Breed related seroprevalence of brucellosis in sampled animal species 
Species Local Imported Crossbred animals 
Positive 
/ Tested 
Prev. (%) Positive 
/ 
Tested 
Prev. (%) Positive 
/ 
Tested 
Prev. (%) 
95 % CI 95 % CI 95 % CI 
Camel 9/2226 0.4 (0.2, 0.8) 0/18 0 (0.0, 18.5) 0/6 0 (0.0, 45.9) 
Cattle 1/1081 0.09
 
(0.0, 0.5) 4/220 1.82
1 
(0.5, 4.6 ) 2/403 0.5
2 
(0.1, 1.8) 
Goat 14/3119 0.45 (0.2, 0.8) 0/124 0 (0.0, 2.9) 0/65 0 (0.0, 5.5) 
Sheep 1/1112 0.09 (0.0, 0.5) 2/358 0.56 (0.1, 2.0 ) 0/745 0 (0.0, 0.5) 
Total 25/7538 0.33
 
(0.2, 0.5) 6/720 0.83
a 
(0.3, 1.8 ) 2/1219 0.16
b 
(0.0, 0.6) 
Values with different alphabetic superscripts are significantly different, χ2 (2df) 
=6.17, p=0.045  
Values with different numerical superscripts are significantly different, χ2 (2df) 
=13.49, p=0.001 
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3.3.3 Within-herd seroprevalence of brucellosis in affected herds 
Within-herd seroprevalence of all positive cattle, sheep, goat and camel holdings, along 
with their geographical locations, are presented in  
Table 3.15 to 3.19 and Figures 3.8 to 3.11. 
 In 6 herds where at least one head of cattle was found seropositive for brucellosis, the 
within-herd prevalence varied from 1.4 to 100% ( 
Table 3.16). The herds containing a seropositive animal in Al Dakhiliyah (50%), Al 
Sharqiyah (100%) and Muscat (25%) governorates were all small (comprising only 1 to 
4 cattle) and all seropositive animals were imported and consequently the vaccination 
status of the animals could not be confirmed. These animals were purchased from local 
markets for sacrificial purposes, although the duration they had been on the farms was 
not ascertained. The seropositive herds in Batinah and Dhofar governorates contained a 
sufficient number of cattle and the within-herd seroprevalence varied from 1.4 to 4.4%. 
The differences in the within-herd prevalence were not significant between localities (χ2 
=1.24, 2df, p=0.536). 
In sheep herds containing seropositive animals the prevalence varied from 5 to 20% ( 
Table 3.17), however these differences were not significant (χ2=1.61 2df, p=0.447). The 
seroprevalence varied from 0.7 to 16.7% in positive goat herds. These positive herds 
were found only in 7 wilayats of Batinah and Dhofar governorates (Table 3.18). There 
was also no significant difference in the seroprevalence between infected goat herds 
(χ2=17.42, 12df, p=0.134). The within-herd seroprevalence in the 8 infected camel herds 
varied from 1.7 to 20%. The within herd seroprevalence for camels was also not 
significantly different between infected herds (χ2 =7.42, 7df, p=0.386) (Table 3.19). 
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3.3.4 Prevalence of brucellosis in different wilayats 
The seroprevalence of brucellosis in cattle, sheep, goat and camel herds located in 
different wilayats in Oman is presented in Table 3.20 to 3.23. Maps based upon this 
distribution were built to identify the wilayats of higher risk in Oman (Figures 3.8 to 
3.12). In total herds from 15 wilayats (24.6%) were found to be seropositive for 
brucellosis. 
Positive cattle herds were located in the wilayats of Barka (Batinah), Sumail (Al 
Dakhiliyah), Dima wa Taaiyin (Al Sharqiyah) and A’seeb (Muscat) of northern Oman 
(Table 3.20 & Figure 3.8). From the southern Dhofar governorate an infected herd was 
found in both Salalah and Taqah. The herd prevalence varied from 3.7 to 16.7%, 
however these differences were not significant (χ2=2.45, 5df, p=0.783). The within-herd 
prevalence in these wilayats varied from 0.99 to 4.35% and these were also not 
significantly different (χ2 =3.37, 5df, p=0.642). 
Positive sheep holdings were found only in wilayats located in the northern 
governorates i.e. Saham (Batinah), Sumail (Al Dakhiliyah) and Yunqul (Al Dhahirah). 
The herd level prevalence varied from 4.76 to 10% (χ2=0.33, 2df, p=0.846). There was 
no significant difference in the within herd seroprevalence between the wilayats (range 
1.1 to 2.4%) (χ2=0.37, 2df, p=0.832) (Table 3.21 and Figure 3.9). 
Only one goat farm was found positive in Batinah governorate (wilayat Saham) from 
the north of Oman while 12 herds from 7 wilayats (Al Mizyounah, Muqshin, Sadah, 
Salalah, Shaleem, Taqah and Thumrayt) in the southern Dhofar governorate were 
positive (Table 3.22 and Figure 3.10). The herd prevalence varied from 4.76 to 44.4% in 
positive goat herds, although these were not significantly different (χ2=10.48, 7df, 
p=0.162). The within herd prevalence varied from 0.4 to 16.7% and these differences 
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were also not significant (χ2=5.48, 7df, p=0.601). 
From the north of Oman, two camel herds were positive in the wilayats of Shinas 
(Batinah) and Ja’alan Bani Bu Hassan (Al Sharqiyah). In Dhofar, 6 camel herds were 
positive for brucellosis in three wilayats (Al Mizyounah, Salalah and Taqah). The herd 
level prevalence was similar between wilayats (χ2=11.51, 4df, p=0.021) and ranged 
from 6.4 to 100%. The individual animal prevalence was significantly different between 
wilayats (χ2=16.59, 4df, p=0.002) varying from 1.4 to 33.3% (Table 3.23 and Figure 
3.11). 
Overall the herd level prevalence varied from 2.6 to 14.3% in the 15 wilayats of Oman 
where seropositive animals were detected (χ2=7.49, 14df, p=0.914) (Table 3.24 and 
Figure 3.12). The highest herd level prevalence was observed in the wilayat of 
Mazyounah where three (14.3%) herds contained at least one seropositive animal. Other 
wilayats with seropositive animals included Salalah (n=9, 12.9%), Sumail (n=2, 11.8%), 
Seeb (n=1, 10%), Taqah (n=3, 10%), Sadah (n=1, 9.1%), Shinas (n=1, 8.3%), Dima wa 
Altaaiyin (n=1, 7.7%), Shaleem (n=2, 7.4%), Saham (n=2, 6.3%), Yunqal (n=1, 6.3%), 
Muqshin (n=1, 4.2%), Thumrayt (n=1, 3.8%), Ja’alan bani bu Hasan (n=1, 3.7%) and 
Barka (n=1, 2.6%). 
The individual level prevalence in seropositive herds (n=30) ranged from 0.23% in 
Thumrayt (n=1) to 2.39% in Salalah (n=12). The individual prevalence observed in 
decreasing order in other wilayats was 1.96% in Sumail, 1.45% in Seeb and Dima wa 
Taaiyin, 1.40% in Mazyounah, 1.22% in Taqah, 0.82% in Shinas, 0.76% in Yunqal, 
0.74% in Ja’alan bani bu Hasan, 0.68% in Saham, 0.56% in Sadah, 0.49% in Muqshin, 
and 0.38% in Barka and Shaleem. However, these differences were not significant 
(χ2=19.43, 14df, p=0.1491). 
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Table 3.16 The within-herd seroprevalence of brucellosis in infected cattle 
holdings 
Governorate Wilayat Town / 
Village 
No. positive 
animals (No. 
tested) 
Prevalence % 
(95% CI) 
Batinah Barka Al Naa'man 1 (70) 1.4 (0.0-7.7) 
Al Dakhiliyah Sumail Al Hayl 1 (2)* 50.0 (1.3-98.7) 
Al Sharqiyah Dima wa 
Taaiyin 
Miss 1 (2)* 50.0 (1.3-98.7) 
Muscat A'Seeb Mabellah 
North 
1 (4)* 25.0 (0.6-80.6) 
Dhofar Salalah Zaik 2 (45) 4.4 (0.5-15.1) 
Dhofar Taqah Damr 1 (60) 1.7 (0.0-8.9) 
Total 6 Wilayats 6 Towns / 
Villages 
7 (183) 3.8 (1.6-7.7) 
*Positive cattle were males of imported breeds and were bought from local markets for 
sacrificial purposes. The vaccination status against brucellosis in these animals could 
not be ascertained. 
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Table 3.17 Within-herd seroprevalence of brucellosis in positive sheep holdings 
Governorate Wilayat Town/Village 
No. positive 
animals 
(No. tested) 
Prevalence %
 
(95% CI)* 
Al Batinah  Saham Al Mantaifa 1 (20) 5.0 (0.1-24.9)
 
Al Dakhiliyah Al Somrah Sumrah 1 (5) 20.0 (0.5-71.6)
 
Al Dhahirah Yunqal Alwuqba 1 (20) 5.0 (0.1-24.9)
 
Total 3 Wilayats 
3 Towns / 
Villages 
3 (45) 6.7 (1.4-18.3) 
* Not significantly different, χ2 (2df) =1.61, p=0.4477 
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Table 3.18 Within-herd seroprevalence of brucellosis in positive goat holdings 
Governo
rate 
Wilayat 
Town / 
Village 
No. 
positive 
animals 
(No. 
tested) 
Prevalence % 
(95% CI)* 
Batinah Saham Mjez Sughra 1 (33) 3.0
 
(0.1-15.8) 
Dhofar Muqshin City Center 1 (25) 4.0
 
(0.1-20.4) 
Dhofar Mazyounah Mitan 1 (40) 2.5
 
(0.1-13.2) 
Dhofar Mazyounah Mitan 1 (30) 3.3
 
(0.1-17.2) 
Dhofar Sadah Soob 1 (150) 0.7
 
(0.0-3.7) 
Dhofar Shaleem Shaleem 1 (70) 1.4
 
(0.0-7.7) 
Dhofar Shaleem Showmiyah 1 (100) 1.0
 
(0.0-5.4) 
Dhofar Thumrayt Rawiyah 1 (50) 2.0
 
(0.1-10.6) 
Dhofar Salalah Alsan 1 (30) 3.3
 
(0.1-17.2) 
Dhofar Salalah Alsan 1 (12) 8.3
 
(0.2-38.5) 
Dhofar Salalah Salalah 1 (50) 2.0
 
(0.1-10.6) 
Dhofar Salalah Salalah 2 (12) 16.7
 
(2.1-48.4) 
Dhofar Taqah Jibjat 1 (20) 5.0
 
(0.1-24.9) 
Total 8 Wilayats 
10 Town / 
Villages 
14 (622) 2.3 (1.2-3.7) 
* Not significantly different, χ2 (12df) =17.42, p=0.1343 
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Table 3.19 Within-herd seroprevalence of brucellosis in positive camel holdings 
Governorate Wilayat 
Town / 
Village 
No. 
Positive 
animals 
(No. 
Tested) 
Prevalence % 
(95% CI)* 
Batinah Shinas Alfarfarah 1 (6) 16.7
 
(0.4-64.1) 
Al Sharqiyah 
Ja'alan Bani Bu 
Hassan 
Falaj Al 
Mashaikh 
1 (5) 20.0
 
(0.5-71.4) 
Dhofar Mazyounah Mizyounah 1 (20) 5.0
 
(0.1-24.9) 
Dhofar Salalah Ghado 2 (40) 5.0
 
(0.6-16.9) 
Dhofar Salalah Hajeef 1 (60) 1.7
 
(0.0-8.9) 
Dhofar Salalah Hajeef 1 (50) 2.0
 
(0.1-10.6) 
Dhofar Salalah Salalah 1 (25) 4.0
 
(0.1-20.4) 
Dhofar Taqah Jibjat 1 (20) 5.0
 
(0.1-24.9) 
Total 5 Wilayats 
7 Town / 
Village 
9 (226) 3.9 (1.8-7.4) 
* Not significantly different, χ2 (7df) =7.42, p=0. 3861 
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Table 3.20 Herd based and individual seroprevalence of brucellosis in cattle 
originating from different wilayats of Oman 
Governorate Wilayat 
Cattle Herds Individual Cattle 
Positive 
(Tested) 
Prevalence %
 
(95% CI)# 
Positive 
(Tested) 
Prevalence % 
(95% CI)* 
Batinah Barka 1 (27) 3.7 (0.1-19.0)
 
1 (101) 0.99 (0.0-5.4)
 
Al Dakhiliyah Sumail 1 (6) 16.7 (0.4-64.1)
 
1 (15) 6.67 (0.2-31.9)
 
Al Sharqiyah 
Dima wa 
Taaiyin 
1 (6) 16.7 (0.4-64.1)
 
1 (23) 4.35 (0.1-21.9)
 
Muscat A'Seeb 1 (8) 12.5 (0.3-52.7)
 
1 (33) 3.03 (0.1-15.8)
 
Dhofar Salalah 1 (12) 8.3 (0.2-38.5)
 
2 (72) 2.78 (0.3-9.7)
 
Dhofar Taqah 1 (20) 5.0 (0.1-24.9)
 
1 (88) 1.14 (0.0-6.2)
 
* Not significantly different, χ2 (5df) =2.45, p=0.7833 
# Not significantly different, χ2 (5df) =3.37, p=0.0.6424 
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Table 3.21 Herd based and individual seroprevalence of brucellosis in sheep 
originating from different wilayats of Oman 
Governorate Wilayat 
Sheep Herds Individual Sheep 
Positive 
(Tested) 
Prevalence %
 
(95% CI)* 
Positive 
(Tested) 
Prevalence % 
(95% CI)# 
Batinah Saham 1 (21) 
4.76 
(0.1-23.8)
 
1 (88) 
1.14 
(0.0-6.2)
 
Al Dakhiliyah Sumail 1 (12) 
8.33 
(0.2-38.5)
 
1 (41) 
2.44 
(0.1-12.9)
 
Al Dhahirah Yunqul 1 (10) 
10.0 
(0.3-44.5)
 
1 (45) 
2.22 
(0.1-11.8)
 
# Not significantly different, χ2 (2df) =0.33, p=0.8463 
* Not significantly different, χ2 (2df) =0.37, p=0.8326 
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Table 3.22 Herd based and individual seroprevalence of brucellosis in goats 
originating from different wilayats of Oman 
Govt. Wilayat 
Goat Herds Individual Goats 
Positive 
(Tested) 
Prevalence %
 a 
(95% CI) 
Positive 
(Tested) 
Prevalence %
 b
 
(95% CI) 
Batinah Saham 1 (21) 4.76 (0.1-23.8) 1 (88) 1.14 (0.0-6.2) 
Dhofar Muqshin 1 (3) 33.3 (0.8-90.6) 1 (161) 0.62 (0.0-3.4) 
Dhofar Mazyounah 2 (9) 22.2 (2.8-60.0) 2 (124) 1.61 (0.2-5.7) 
Dhofar Sadah 1 (10) 10.0 (0.3-44.5) 1 (242) 0.41 (0.0-2.3) 
Dhofar 
Shaleem & 
The 
Hallanitat Isl. 
2 (19) 10.5 (1.3-33.10 2 (359) 0.56 (0.1-2.0) 
Dhofar Thumrayt 1 (13) 7.6 (0.2-36.0) 1 (267) 0.37 (0.0-2.1) 
Dhofar Salalah 4 (9) 44.4 (13.7-78.8) 5 (283) 1.77 (0.6-4.1) 
Dhofar Taqah 1 (4) 25.0 (0.6-80.6) 1 (91) 1.1 (0.0-6.0) 
a
 not significantly different, χ2 (7df) =10.48, p=0.163 
bnot significantly different, χ2 (7df) =5.48, p=0.602 
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Table 3.23 Herd based and individual seroprevalence of brucellosis in camels 
originating from different wilayats of Oman 
Govt. Wilayat 
Camel Herds Individual Camels 
Positive 
(Tested) 
Prevalence %
 
(95% CI)* 
Positive 
(Tested) 
Prevalence % 
(95% CI)# 
Batinah Shinas 1 (1) 
100 
(2.5-100.0) 
1 (3) 
33.3 
(0.8-90.6) 
Al Sharqiyah 
Ja'alan 
Bani Bu 
Hassan 
1 (8) 
12.5 
(0.3-52.70 
1 (18) 
5.6 
(0.1-27.3) 
Dhofar 
Al 
Mizyounah 
1 (11) 
9.1 
(0.2-41.3) 
1 (52) 
1.9 
(0.0-10.3) 
Dhofar Salalah 4 (62) 
6.4 
(1.8-15.7) 
5 (308) 
1.6 
(0.5-3.7) 
Dhofar Taqah 1 (14) 
7.1 
(0.2-33.9) 
1 (70) 
1.4 
(0.0-7.7) 
#Significantly different, χ2 (4df) =11.51, p=0.0214 
* Not Significantly different, χ2 (3df) =0.45, p=0.930 
F Value=3.097, P=0.019 for all 5 wilayats  
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Table 3.24 Herd based and individual seroprevalence of brucellosis in different 
wilayats of Oman 
Govt. Wilayat 
Herd Individual 
Pos. 
(Tested) 
Prev.
 a
 
(95% CI) 
Pos. 
(Tested) 
Prev.
 b
 
(95% CI) 
Batinah 
Barka 1 (39) 
2.6% 
(0.1-13.5) 
1 (266) 
0.38% 
(0.0-2.1) 
Saham 2 (32) 
6.3% 
(0.8-20.8) 
2 (293) 
0.68% 
(0.1-2.4) 
Shinas 1 (12) 
8.3% 
(0.2-38.5) 
1 (122) 
0.82% 
(0.0-4.5) 
Al 
Dakhiliyah 
Samail 2 (17) 
11.8% 
(1.5-36.4) 
2 (102) 
1.96% 
(0.2-6.9) 
Al Sharqiyah 
Dima wa 
Taaiyin 
1 (13) 
7.7% 
(0.2-36.0) 
1 (69) 
1.45% 
(0.0-7.8) 
Ja'alan Bani 
Bu Hassan 
1 (27) 
3.7% 
(0.1-19.0) 
1 (135) 
0.74% 
(0.0-4.1) 
Al Dhahirah Yunqal 1 (16) 
6.3% 
(0.2-30.2) 
1 (131) 
0.76% 
(0.0-4.2) 
Muscat Seeb 1 (10) 
10.0% 
(0.3-44.5) 
1 (69) 
1.45% 
(0.0-7.8) 
Dhofar 
Salalah 9 (70) 
12.9% 
(6.1-23.0) 
12 (503) 
2.39% 
(1.2-4.1) 
Taqah 3 (30) 
10.0% 
(2.1-26.5) 
3 (245) 
1.22% 
(0.3-3.5) 
Muqshin 1 (24) 
4.2% 
(0.1-21.1) 
1 (205) 
0.49% 
(0-2.7) 
Mazyounah 3 (21) 
14.3% 
(3-36.3) 
3 (214) 
1.40% 
(0.3-4) 
Sadah 1 (11) 
9.1% 
(0.2-41.3) 
1 (180) 
0.56% 
(0-3.1) 
Shaleem & 
The 
Hallanitat 
Island 
2 (27) 
7.4% 
(0.9-24.3) 
2 (528) 
0.38% 
(0-1.4) 
Thumrayt 1 (26) 
3.8% 
(0.1-19.6) 
1 (430) 
0.23% 
(0-1.3) 
a - not significantly different, χ2 (14df) =7.49, p=0.9141 
b - not significantly different, χ2 (14df) =19.43, p=0.1491) 
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Figure 3.8 Herd based prevalence of brucellosis in cattle from different wilayats of 
Oman 
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Figure 3.9 Herd based prevalence of brucellosis in sheep from different wilayats of 
Oman 
126 
 
  Figure 3.10 Herd based prevalence of brucellosis in goats from different wilayats 
of Oman 
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Figure 3.11 Herd based prevalence of brucellosis in camels from different wilayats 
of Oman 
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Figure 3.12 Herd based prevalence of brucellosis in all species from different 
wilayats of Oman 
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3.4 Discussion  
One of the main objectives of the current study was to determine the seroprevalence of 
brucellosis in farm animals (cattle, sheep, goats and camels) of Oman and map its 
distribution by using Geographic Information System (GIS) tools. The study was also 
important from a public health perspective as current knowledge on disease distribution 
can help in the development of efficient control methods for this zoonotic disease in the 
Sultanate. 
There has been an emergence or re-emergence of many zoonoses worldwide (Beran and 
Steel, 1994; Godfroid et al, 2005). One step towards their eradication is the 
identification and elimination of infected reservoir animals (Aldomy et al, 1992). The 
infection of animals or contamination of their products may result in the direct or 
indirect exposure of humans to these zoonotic agents and subsequent infection. It has 
been recommended that the control of human and animal brucellosis should be a major 
international priority for the medical and veterinary professions (Beran and Steel, 1994). 
Brucellosis, caused by Brucella melitensis, remains a widespread public health problem. 
In Oman, B. melitensis is considered a public health problem, especially in the Dhofar 
Governorate where people of all ages are likely to consume raw milk and milk products. 
A comprehensive study of brucellosis in Oman has not previously been undertaken, and 
the real prevalence of brucellosis in all governorates and wilayats of the country has 
previously not been determined. This study is the first comprehensive seroprevalence 
study of brucellosis in farm animals (camel, cattle, goat and sheep) in Oman and 
provides valuable information in developing suitable control programs for the disease in 
this country. 
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3.4.1 Prevalence of brucellosis in Oman 
3.4.1.1 Seroprevalence of brucellosis in Oman on a herd basis  
Although many countries have developed strategic plans and control programs to 
eradicate B. melitensis from farm animals, and many others have significantly reduced 
the prevalence of infection among their animal populations, B. melitensis is still widely 
distributed in the world (Corbel, 1989). In many less developed and developing 
countries, B. melitensis continues to cause major losses in livestock and poses a serious 
threat to people (Crawford et al, 1990).  
According to the results of this study, 30 (2.8%) of 1267 holdings contained 
seropositive animals for brucellosis. The distribution of positive holdings was 
significantly different between southern and northern governorates. In the southern 
governorate (Dhofar) significantly more holdings (n = 20, 8.6%) contained seropositive 
animals compared to the northern governorates (n = 10, 0.97%) (p < 0.001). The high 
herd prevalence in Dhofar can be credited to: the active importation of live animals 
from countries in the Horn of Africa without prior monitoring of their brucellosis status; 
communal grazing of livestock; and the tropical weather, including monsoon rains and 
suitable temperatures, which favor the spread of the disease. The restriction of the 
exportation and movement of female animals from Dhofar to other regions in Oman and 
the approved importation of only castrated males to other regions may explain the 
containment of the disease to Dhofar and the low prevalence in the northern region. 
In 2003, at the beginning of the control program, the prevalence of disease among cattle 
herds in Dhofar was determined by the Brucella Diagnostic Unit (BDU) at 6.5%. In the 
current study the herd prevalence in cattle in Dhofar was slightly lower at 4.9%. In 
contrast a study undertaken in 2010 by the same scientist who conducted the initial 
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serological study in 2003 in Dhofar reported an increase in the prevalence to 24% in 
cattle herds. Although the decrease in seroprevalence in the current study compared to 
2003 could be a result of the ongoing control program and better education of the 
owners, the drastic increase in 2010 study was unexpected. This may have been due to a 
real increase in the prevalence due to the improper adoption of the control program over 
the years or it may have reflected misclassification of vaccinated and non-vaccinated 
animals as a consequence of a failure to use animal identification. 
Although, there was no significant differences in the seroprevalence between infected 
cattle herds, the highest percentage was observed in Muscat (5.6%) followed by Dhofar 
(4.9%). The result of Dhofar can be explained due to the endemic nature of the disease 
and the size of the cattle herds in this region. However in Muscat, the capital of Oman, 
there are only small numbers of animals, and quarantine facilities and slaughter houses 
are present, consequently the significantly higher prevalence (P<0.001) as compared to 
other northern districts was surprising. This higher seroprevalence could be due to the 
limited number of samples (95%CI 0.1-27.3) collected in this governorate, and also the 
seropositive case was an imported bull and consequently a history of vaccination could 
not be excluded. Furthermore the majority of the positive reactors found in cattle in the 
northern area were males of imported breeds kept for sacrificial purposes, consequently 
a prior history of vaccination could not be excluded and this may have resulted in 
seropositive reactions.  
Seropositive sheep were detected in only three flocks (0.6%) and there was no 
significant difference between districts. In contrast 2.3% of goat herds were seropositive 
and infection was significantly higher in Dhofar (16.2%) than in the other districts. In 
Oman, small ruminants (sheep and goats) are usually treated as one group and the 
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results of most previous studies did not separate out the prevalence for the two species. 
The prevalence of disease among small ruminants in Dhofar was determined by the 
BDU at 16.9 and 7.9% in 2003 and 2010, respectively. However, in the current study 
the prevalence was 16.2% in the goat herds, while no sheep herd was found positive in 
Dhofar. This consistent prevalence observed in goats could be related to the fact that 
during the current study herds from all wilayats of the northern region of Oman were 
sampled compared with previous studies where samples were only collected from 
wilayats where a vaccination program was being undertaken. Thus the differences 
observed could be due to the low prevalence of infection in the BDU studies as a result 
of vaccination or could be due to differences in the study design, animal selection or 
diagnostic tests used.  
Only 8 herds contained seropositive camels (1.4%) with most seropositive cases and 
herds located in Dhofar (6 cases). However, there was no significant difference between 
the herd prevalence in camels belonging to the northern and southern regions of Oman. 
Dhofar, the endemic area, contains approximately 50% of the total camel and cattle 
population in Oman and as a consequence most of the human cases of brucellosis have 
also been recorded here. In 2009, the BDU conducted a study to determine the herd 
prevalence among camel holdings (4.3%); however the study was limited to one area of 
Dhofar (Salalah). 
In conclusion, this study documented the overall seroprevalence of brucellosis in animal 
holdings to be 2.8% with 30 infected holdings. A significantly higher prevalence was 
observed in the Dhofar governorate than in any other governorates/regions. A possible 
reason for this might be the already endemic nature of disease in Dhofar, more inter-
species contact, sharing of common pasture, large herd size and unhygienic husbandry 
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conditions in this governorate as supported by findings reported by other researchers 
(Alton et al, 1988; Grilló et al, 1997; European Commission, 2001; Corbel et al, 2006). 
Overall the seroprevalence in the Northern governorates was lower than in Dhofar 
governorate where the disease would appear to be endemic. A comparatively higher 
number of goat holdings were positive for brucellosis when compared to the other 
animal species tested. This could be due to the reported higher susceptibility of all goat 
breeds to brucellosis, as compared to sheep, and the apparent higher susceptibility of 
milking breeds compared to those kept for meat purposes (Corbel & Brinley-Morgan, 
1984). Furthermore the vaginal excretions of goats are more copious and last for at least 
2-3 months post-partum and usually two thirds of the naturally acquired infections result 
in an infection of the udder with excretion of Brucella in the milk during subsequent 
lactations (Alton, 1990a). This study found serological evidence of infection in camels 
with these animals having had contact with infected small ruminants. Similar 
observations have been reported in various other studies (European Commission, 2001; 
Musa and Shigidi, 2001; Abbas and Aqab, 2002). However, clinical disease/signs 
(including abortions) were rarely reported by the owners of positive camel holdings. 
Others have reported that the exhibition of clinical disease is very rare in camels 
infected with B. melitensis, and the current findings concur with their research (Abbas 
and Aqab, 2002; Corbel et al, 2006). Although clinical disease is seldom seen in camels, 
possible shedding of the organism in milk may lead to transmission of infection to 
humans and subsequent disease.  
3.4.1.2 Individual level seroprevalence of brucellosis in Oman  
The individual animal seroprevalence to brucellosis was generally low (< 1%) in the 
sampled cattle holdings. Even in the brucellosis endemic Dhofar governorate, the 
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individual animal prevalence was manageable (< 2%). These findings may be a result of 
the ongoing control programs through mass vaccination. However, a lack of cooperation 
from some local farmers did not allow the collection of samples from the desired 
number of unvaccinated herds, thus the real prevalence could be different to that 
reported in this study which may have introduced selection bias by not being a true 
cross-section of susceptible herds. Moreover, the seroprevalence in the northern regions 
could also differ from that reported here as most of the positive animals (3 of 4) were 
imported and consequently may have been vaccinated which have a greater probability 
of inducing false positive serological reactions. Since the scientific community is still 
looking for a reliable test to distinguish between naturally infected and vaccinated 
animals (European Commission, 2001; Corbel et al, 2006), the true prevalence of 
brucellosis might differ from past and future studies.  
In 2003, the individual seroprevalence of cattle in Dhofar was reported to be 3.7% and 
this increased to 8% in 2010 (BDU), however in the current study the individual 
seroprevalence of cattle in Dhofar was only 1.5%. Cases in sheep and goats were also 
reported in Dhofar with the individual seroprevalence reported by the BDU dropping 
from 4.5% in 2003 to 1.3% in 2010. However in the current study the individual 
seroprevalence in small ruminants from Dhofar was only 1% and was significantly 
different from that found in other governorates. In contrast the individual 
seroprevalence of brucellosis in camels in this study was only 0.8% and there was no 
significant difference between the seroprevalence in camels from the Southern and 
Northern regions. In Dhofar, the individual seroprevalence in camels was 0.77% which 
was slightly lower than the 1% reported in 2009 (MAF, 2009).  
A higher seroprevalence was found in imported animals in this study and this may be 
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due to their susceptibility to infection if they were imported from disease-free-areas or 
the result of false positive reactions if they had previously been vaccinated against 
brucellosis in their country of origin (Thrusfield, 2005). A higher prevalence of 
brucellosis was also reported by Seboxa (1982) and Tschopp et al. (2013) in Ethiopia, 
and Ali et al. (2014) in Pakistan in crossbred cattle. This could be linked to the open 
herd management structure where bulls were purchased from markets without 
knowledge on their disease or vaccine status, malnutrition, poor husbandry or tropical 
environmental stress. 
The seroprevalence of brucellosis was not affected by the gender of the sampled 
animals. This is not unexpected due to the similar management of males and females. 
However, males are usually kept for a shorter period of time than females which may 
reduce the chance of interaction with infected females or other herds and hence the 
probability of infection (Teklue et al, 2008; Tolosa et al, 2008; Dinka and Chala, 2009).  
Generally the prevalence of brucellosis increased with the age of the animals, possibly 
because of the higher risk of contracting the disease after puberty due to increased 
contacts with potentially infected animals as described by others (Tolosa et al, 2008; 
Dinka and Chala, 2009; Teklue et al, 2013). 
The individual animal seroprevalence was compared with studies from other countries 
in the region. However, other countries in the Middle East are not isolated as trade in 
animals and animal products are significant. The southern governorate of Dhofar shares 
a border with the Republic of Yemen while the northern region shares borders with the 
United Arab Emirates (UAE) and Saudi Arabia. The individual animal prevalence in 
cattle (0.4%) was higher than that found in Yemen (0.06%), whilst lower than that 
reported in UAE (1.3%), Saudi Arabia (18.7%), Iraq (3%) and Iran (0.8%) (Gul and 
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Khan, 2007). This finding is probably associated with the lower number of goats and 
cattle imported from the Horn of Africa into Oman for consumption and breeding 
purposes when compared with Saudi Arabia and the UAE. However the numbers 
imported into Oman is higher than that into Yemen which may account for the higher 
prevalence in Oman than Yemen. 
The seroprevalence in sheep sampled in this study (0.1%) was also slightly lower than 
that reported in Yemen (0.6%) (AlShamahy et al, 2000) and significantly lower than 
that reported in the UAE, Saudi Arabia and Iran (3.4%, 9.7% and 10.8%, respectively) 
(Gul and Khan, 2007). This may partly be explained by the overall lower number of 
sheep in Oman, compared to these other countries. Unlike goats, the limited numbers of 
imported sheep mainly go to slaughter houses and very few are kept for breeding. 
Generally Omanis prefer the meat of goat and cattle to that of sheep.  
Although goats comprise approximately 70% of the total livestock in Oman (MAF, 
2005), the seroprevalence of brucellosis in goats was lower than in neighbouring Middle 
Eastern countries. For instance, the prevalence of disease among goats in Jordon was 
reported at 27% (AlMajali, 2005) and 9.7% in Saudi Arabia. These values are markedly 
higher than that of Oman (0.4%) and Yemen (1.3%) (Gul and Khan, 2007). Good 
quarantine measures with the limited importation of goats into Oman, when compared 
with Saudi Arabia, may have played an important role in these differences. 
In camels, the individual prevalence found in this study (0.4 %) was much less than that 
reported in Iraq, Saudi Arabia, and UAE (17.2, 8 and 2% respectively) (Gul and Khan, 
2007). In Oman, the importation of camels has been banned for a long time. The main 
purpose for which camels are reared in the southern region is for meat production and 
there is limited transfer of live camels to the northern region where camels are mostly 
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kept for racing. 
However, most of the other studies mentioned did not calculate herd level prevalence, 
and this may also account for differences between the current study and the previously 
conducted studies. 
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CHAPTER FOUR 
RISK FACTORS ANALYSIS 
4.1 Introduction  
The environmental conditions and type of husbandry, including lambing in enclosures 
and overcrowding, greatly influence the spread of brucellosis (Al-Majali et al, 2009). 
The greatest risk for the entry of the disease is through the introduction of infected 
animals (Kellar et al, 1976; Reviriego et al, 2000; Crawford et al, 1990). The practice of 
transhumance has been reported to have a strong correlation with the presence of 
brucellosis (Alton, 1990a; Kabagambe et al, 2001; Refai, 2002). The disease is also 
enhanced in village flocks where animals graze communal pastures (Nicoletti et al, 
1987; Crawford et al, 1990). Several authors have highlighted the correlation of disease 
with several factors including age, breed and a history of abortion in the herd (Silva et 
al, 2000; Luna-Martínez and Mejía-Terán, 2002; Amin et al, 2005). 
This study was designed to investigate the role of several potential risk factors that can 
affect the prevalence of brucellosis in Oman. The variables at the individual animal 
level included age, sex, breed, and animal’s history of abortion and at the herd level 
variables were herd size, cohorts, sharing of pasture, history of abortion in a herd and 
the location of the herd. 
4.2 Materials and Methods  
Information regarding different individual and herd level variables was collected on 
predesigned and pretested proformas as described in Chapter 3. All the data was 
inserted in the Excel sheets and variables were categorized and later coded to facilitate 
final analysis. 
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The Chi-square test for independence was used to determine if the prevalence varied 
between different genders, age groups and locations. The Fisher’s exact test was used if 
any of the cells were less than 5 in a 2 x 2 Table. Confidence intervals for 
seroprevalence were calculated using the Exact Binomial Method. Odds ratios (OR) and 
their 95% confidence intervals were calculated to determine the association between 
factors and the presence of antibodies to brucellosis. The associations between the 
outcome response variables (seropositivity) and explanatory variables (information 
recorded through the proforma) were determined using binary logistic regression (IBM 
SPSS Statistics 17.0 for Windows®, IBM Corporation, Route 100 Somers, New York, 
USA). The outcome variable was dichotomized (0=negative and 1=positive) and the 
response variables were dichotomized or categorized wherever applicable. Bivariable 
screening was conducted and variables yielding significant associations at P ≤ 0.20 
(based on the Wald statistic) were offered to a binary logistic regression model. A 
backward stepwise model was constructed. All variables found significant (P ≤ 0.20) 
were offered to the initial screening model and then removed based on the likelihood 
ratio tests. The Hosmer-Lemeshow test, the Nagelkerke R square test and the observed 
versus predicted values (Residual statistics) to identify outliers at 0.5 cut off point were 
used to assess the fit of the final models (Urdaz-Rodriguez et al, 2009). 
4.3 Results 
4.3.1 Univariable analyses for the seropositivity of brucellosis in cattle 
Univariable analysis of the risk factors for individual animals revealed that older cattle 
(> 10 years of age) were more likely to test positive for brucellosis than cattle aged >5 
to ≤10 years (OR: 4.98, 95%CI = 0.31 - 79.56), >2 to ≤5 (OR: 4.20, 95%CI = 0.38 - 
46.37) and ≤ 2 (OR: 1.94, 95%CI = 0.20 - 18.68). Age was further categorized to 
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construct two groups (≤ 5 years and > 5 years of age) and analysis revealed that odds for 
testing positive were almost identical in cattle ≤ 5 years (OR: 1.05, 95%CI = 0.20, 5.43) 
and those > 5 years (P=0.953). 
Males were more likely to be seropositive than females (OR: 2.29, 95%CI 0.51, 10.26), 
however this difference was not significant (p=0.266). Imported cattle were more likely 
to be seropositive than crossbred cattle (OR: 3.71, 95%CI 0.68, 20.43) although this 
was also not significant. However imported cattle were significantly more likely to be 
seropositive than local cattle (OR: 20.0, 95%CI 2.22, 179.82). Individual cattle with a 
previous history of abortion were more likely to be seropositive than cattle without a 
history of abortion (OR: 22.19, 95%CI 2.43, 202.35). 
Analysis of data at the herd level indicated that cattle belonging to larger herds (more 
than 30 animals) were more likely to test positive than those kept in smaller herds (up to 
5 head), although this difference was not significant (OR: 4.56, 95%CI 0.88, 23.50). 
Cattle reared separately without having interaction with other ruminants on the farm 
were significantly more likely to be seropositive than those managed with small 
ruminants (OR: 19.70, 95%CI 3.13, 123.86), or both small ruminants and camels (OR: 
18.26, 95% CI 1.82, 183.19). The sharing of pasture between cattle and other species of 
livestock was found not to influence the likelihood of seropositivity in cattle (OR: 1.03, 
95%CI 0.19, 5.66). Cattle belonging to herds with a history of abortions were more 
likely to test positive (OR: 9.02, 95%CI 1.58, 51.62) than those from herds with no 
history of abortions. Cattle belonging to herds located in the south of Oman (Dhofar 
governorate) were slightly more likely to test seropositive to brucellosis compared with 
cattle from the north of Oman (OR: 5.45, 95%CI 0.97, 30.68). 
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4.3.2 Multivariable analysis to identify factors influencing the seroprevalence of 
brucellosis in cattle  
Of the 9 variables analyzed in the initial univariable analyses (Table 4.1) sex, breed 
(P=0.001), abortion history (P<0.001), herd size (P=0.001), cohort animals (P<0.001), 
history of abortions in herd (P=0.003) and governorate (P=0.031)] were significantly 
associated with the presence of antibodies to brucellosis (Wald P < 0.2). All other 
variables [age (P=0.516), sex (P=0.266) and sharing of pasture (P=0.977)] were not 
associated with seropositivity (Wald P > 0.2). 
For infection in individual animals variables with a P < 0.2 (breed and history of 
abortion) were entered into a multivariable logistic regression model. Breed was 
removed at the first step ( 
 
 
Table 4.2) and only a prior history of abortion was found to be significantly associated 
with brucellosis (P=0.006). Consequently no multivariable model could be presented for 
the seroprevalence of brucellosis at the individual level in cattle. 
All herd level variables yielding a P < 0.2 were entered into a second multivariable 
regression model. Governorate, herd size and abortion history of the herd were removed 
on subsequent steps and only the variable cohort animals (0.007) was found 
significantly associated with prevalence (Table 4.3). Consequently again no suitable 
multivariable model could be developed to determine risk factors for herd infectivity. 
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Table 4.1 Univariable risk factors for seropositivity to brucellosis in Cattle 
Variable 
Name 
Variable 
Percent 
seropositive 
Odds ratio 
(95% CI) 
P 
Age (years) 
<= 2 3/492 (0.61) 0.52 (0.05, 5.0) 
0.516 
2.1 to 5 2/708 (0.28) 0.24 (0.02, 2.7) 
5.1 to 10 1/419 (0.24) 0.2 (0.01, 3.3) 
>10 1/85 (1.18) 1.0 
Combined 
Age  
< 5 years  5/1200 (0.42) 1.05 (0.20, 5.43) 
0.953 
> 5 years 2/504 (0.39) 1 
Breed 
Local 1/1081 (0.09) 0.19 (0.02, 2.05) 
0.001 Imported 4/220 (1.82) 3.71 (0.68, 20.43) 
Crossbred 2/403 (0.5) 1.0 
Sex 
Male 3/422 (0.68) 2.29 (0.51, 10.26) 
0.266 
Female 4/1282 (0.31) 1.0 
Abortion 
History 
Yes 1/15 (6.67) 
22.19 (2.43, 
202.35) 
< 0.001 
No 6/1689 (0.35) 1.0 
Herd Size ≤ 5 3/167 (1.79) 0.22 (0.04, 1.13) 0.001 
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Variable 
Name 
Variable 
Percent 
seropositive 
Odds ratio 
(95% CI) 
P 
6 to 15 0/207 (0.00) - 
16 to 30 0/69 (0.00) - 
> 30 3/39 (7.69) 1.0 
Cohorts 
Small ruminants 2/304 (0.66) 0.51 (0.01, 0.32) 
< 0.001 
Camels 0/11 (0.00) - 
Small ruminants 
& Camels 
1/141 (0.71) 0.06 (0.01, 0.55) 
Cattle 3/26 (11.54) 1.0 
Pasture 
sharing 
Yes 2/158 (1.27) 1.03 (0.19, 5.66) 
0.977 
No 4/324 (1.23) 1.0 
Abortion 
history in 
herd 
Yes 2/27 (7.41) 9.02 (1.58, 51.62) 
0.003 
No 4/455 (0.88) 1.0 
Governorate 
South (Dhofar) 2/42 (4.76) 5.60 (0.99, 33.56) 
0.085 
North (Rest of 
Oman) 
4/440 (0.91) 1.0 
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Table 4.2 Final binary logistic regression model for predicting brucellosis at individual level in cattle surveyed for the 
prevalence of brucellosis in Oman 
Variable Name Variables B S.E. Wald Sig. Odds Ratio 95% C.I. 
Lower Upper 
Abortion         
History of Abortion 3.099 1.128 7.552 0.006 22.186 2.432 202.354 
Constant -5.739 0.448 164.124 0 0.003   
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Table 4.3 Final logistic regression model for predicting brucellosis at herd level in cattle surveyed for the prevalence of 
brucellosis in Oman 
Variable Name Variables B S.E. Wald Sig. Odds 
Ratio 
95% C.I.  
Lower Upper 
Cohorts    12.262 0.007    
Cattle only 2.905 1.176 6.097 0.014 18.261 1.82 183.18 
Cattle with small 
ruminants 
-0.076 1.229 0.004 0.951 0.927 0.083 10.311 
Cattle with Camels -16.261 12118.636 0 0.999 0 0 . 
Constant -4.942 1.004 24.247 0 0.007   
Variable(s) entered on final step: Cohort animals 
146 
 
4.3.3 Univariable analysis to identify factors influencing the seropositivity to 
brucellosis in sheep  
The influence of age, sex, breed, and individual animal history of abortion on 
seropositivity to the brucellosis were analysed at the individual sheep level. At the flock 
level, the variables flock size, cohorts, sharing of pasture, history of abortion in a flock 
and location of flock were also tested for association with the presence of infection 
(Table 4.4).  
Imported sheep were more likely, although not significantly, to be seropositive than 
local breeds (OR: 6.24, 95% CI 0.56, 69.04). No other comparison was possible with 
respect to age, sex and history of abortion as all seropositive sheep belonged to only one 
age group (>3 to ≤5), were females and had no prior history of abortion. 
Flock level analysis was only possible for flock size and sheep belonging to flocks 
containing 10 to 25 individuals were more likely, although not significantly, to test 
positive than those from flocks containing less than 10 sheep (OR: 1.87, 95% CI 0.17, 
20.78). No other comparison was possible as all sheep found positive were kept with 
goats on mixed managed farms, did not have access to common pasture, originated from 
flocks with no recent history of abortions and all were located in governorates in the 
north of Oman. 
4.3.4 Multivariable analysis to identify factors influencing the seroprevalence of 
brucellosis in sheep  
The results for the 9 variables analysed are displayed in Table 4.4. Of these variables, 
only breed (P = 0.052) was found to be associated with brucellosis (Wald P < 0.2). Thus 
no multivariable analysis was possible regarding the seroprevalence of brucellosis in 
sheep. 
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Table 4.4 Univariable risk factors for seropositivity to brucellosis in sheep 
Variable 
Name 
Variable Percent 
seropositive 
Odds Ratio 
(95% CI) 
P 
Value 
Age (years) Age <= 1years 0/221 (0.0) - 
NA 
Age 1.1 to 3 years 3/1320 (0.23) - 
Age 3.1 to 5 years 0/469 (0.0) - 
Age > 5 years 0/205 (0.0) 1 
Combined 
Age  
> 5 years 0/205 (0.0) - 
NA 
 
< 5 years 3/2010 (0.15) 1 
Breed 
Cross 0/745 (0.0) - 
NA Imported 2/358 (0.56) 6.24 (0.56, 69.04) 
Local 1/1112 (0.09) 1 
Sex 
Male 0/431 (0.0) - 
NA 
Female 3/1784 (0.17) NA 
Abortion 
History 
Yes 0/16 (0.0)  
NA 
No 3/2199 (0.14)  
Flock Size Up to 10 Sheep 1/169 (0.59) 1 0.629 
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Variable 
Name 
Variable Percent 
seropositive 
Odds Ratio 
(95% CI) 
P 
Value 
10 to 25 Sheep 2/182 (1.09) 1.87 (0.17, 20.78) 
26 to 50 Sheep 0/110 (0.0) - 
> 50 Sheep 0/47 (0.0) - 
Cohorts Sheep Only 0/5 (0.0) - 
NA 
Cattle 0/6 (0.0) - 
Goats 0/95 (0.0) - 
Camels 0/3 (0.0) - 
With other 
ruminants 
3/399 (0.75) - 
Pasture Sharing Yes 0/252 (0.0) - 
NA 
No 3/252 (1.19)  
Abortion history 
in herd 
Yes 0/22 (0.0) - 
NA 
No 3/486 (0.62) - 
Governorate South (Dhofar) 0/35 (0.0) - 
NA 
North (Rest of 
Oman) 
3/473 (0.63) - 
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4.3.5 Univariable analysis to identify factors influencing the seropositivity to 
brucellosis in goats 
The influence of individual level variables (age, sex, breed, individual animal history of 
abortion) and herd level variables (herd size, cohorts, sharing of pasture, history of 
abortion in a herd and location of herd) on the seroprevalence of brucellosis in goats are 
summarized in Table 4.5. 
Analysis of individual level variables indicated that goats older than 5 were slightly 
more likely to be seropositive than those >1 to ≤3 years (OR: 1.67, 95% CI 0.45 6.22) 
and >3 to ≤5 (OR: 1.37, 95% CI 0.37, 5.12), although this difference was not significant 
(P=0.704). Age categories were further combined to construct two groups (≤ 5 years 
and > 5 years of age) and analysis revealed that goats > 5 years were more likely to test 
positive (OR: 1.59, 95% CI 0.49, 5.08) as compared to those ≤ 5 years. However, the 
difference was still statistically not significant (P=0.432). No analyses by odds ratios 
were possible for sex, breed and individual animal abortion history as all positive goats 
were female, of local breeds and had no previous history of abortions.  
When data were analysed at the herd level the following outcomes were observed. 
Although goats kept in herds with 26-50 head and 10-25 head were more likely to test 
positive than those in herds of more than 50 animals (OR: 1.03, 95% CI=0.23, 4.69 and 
OR: 1.36, 95% CI=0.33, 5.55, respectively), this difference was not significant 
(P=0.501). Goats in mixed herds with camels (OR: 1.95, 95% CI=0.41, 9.41), with 
sheep (OR: 10.86, 95% CI 1.16, 101.35) and in mixed herds with all ruminant species 
(OR: 10.23, 95% CI 2.60, 40.25) were more likely to test seropositive than those kept 
alone. Goats sharing pasture with other ruminants were found more likely, but not 
significantly, to test positive for brucellosis (OR: 2.51, 95% CI 0.68, 9.23). Goats 
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belonging to herds having a history of abortion were significantly more likely to contain 
seropositive animals (OR: 10.81, 95%CI 3.33, 35.06) than those from flocks with no 
history of abortions. Similarly goats originating from flocks located in the south of 
Oman (Dhofar) were more likely to be infected than flocks from the north of Oman 
(OR: 94.26, 95% CI 12.05, 737.39). 
4.3.6 Multivariable analysis to identify factors influencing the seroprevalence of 
brucellosis in goats  
Of the 9 variables analysed in the univariable analyses (Table 4.5), sex (P=0.148), 
cohort animals (P<0.001), pasture sharing (P=0.151), history of abortions in herd 
(P<0.001) and governorate (P<0.001) were significantly associated with brucellosis 
(Wald P < 0.2). All other variables [age (P=0.704), breed (P=0.653), individual animal’s 
history of abortion (P=0.59) and herd size (P=0.501)] were not associated with disease 
(Wald P > 0.2). 
Only one variable was found to be significantly associated with brucellosis at the 
individual level, so no multivariate analysis was possible. All herd level variables found 
significantly associated with brucellosis in goats were used for the multivariate model 
building. Cohorts and sharing of pasture were removed from the model (P > 0.05) and 
only the variables governorate and history of abortions in a herd were found 
significantly associated with the presence of brucellosis. The results showed that goats 
belonging to herds located in the Dhofar governorate (OR: 74.88, 95% CI = 9.41, 
596.04) and having a previous history of abortion in the herd (OR: 4.43, 95% CI = 1.18, 
16.65) were more likely to test positive for brucellosis (Table 4.6). However, the model 
did not have a good fit (Chi-Square = 0.00 and 0.416 - Hosmer-Lemeshow test and 
Nagelkerke R Square values respectively). 
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Table 4.5 Univariable risk factors for seropositivity to brucellosis in Goats 
Variable 
Name 
Variable % seropositive OR (95% CI) P Value 
Age (years) <= 1 0/199 (0.0) - 
0.704 
Age 1.1 to 3 
years 
5/1315 (0.38) 0.63 (0.17, 2.36) 
Age 3.1 to 5 
years 
5/1127 (0.44) 0.74 (0.19, 2.76) 
Age > 5 years 4/667 (0.6) 1 
Combined 
Age  
> 5 years 4/667 (0.44) 1.59 (0.49, 5.08) 
0.432 
< 5 years 10/2641 (0.38) 1 
Breed 
Local 14/3119 (0.45) - 
NA Imported 0/124 (0.0) - 
Cross 0/65 (0.0) - 
Sex 
Male 0/429 (0.0) - 
NA 
Female 14/2879 (0.49) - 
Abortion 
History 
Yes 0/67 (0.0) - 
NA 
No 14/3241 (0.43) - 
Herd Size Up to 10 Goats 0/75 (0.0) - 
0.501 10 to 25 Goats 4/167 (2.39) 1.03 (0.23, 4.69) 
26 to 50 Goats 6/191 (3.14) 1.36 (0.33, 5.55) 
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Variable 
Name 
Variable % seropositive OR (95% CI) P Value 
> 50 Goats 3/129 (2.33) 1 
Cohorts Cattle 0/46 (0.0) - 
< 0.001 
Sheep 1/77 (1.29) 0.18 
(0.02, 1.78) 
Camels 4/32 (12.5) 1.95 
(0.41, 9.41) 
with ruminants 5/363 (1.38) 0.19 
(0.04, 0.83) 
Only Goats 3/44 (6.82) 1 
Pasture 
Sharing 
Yes 10/323 (3.09) 2.51 
(0.68, 9.23) 
0.151 
 
No 3/239 (1.26) 1 
Abortion 
History in 
Herd 
Yes 5/35 (14.29) 10.81 
(3.33, 35.06) <0.001 
No 8/527 (1.52) 1 
Governorate South 
(Dhofar) 
12/74 (16.21) 94.26 
(12.05, 737.36) 
< 0.001 
North 
(Rest of Oman) 
1/488 (0.2) 1 
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Table 4.6 Final binary logistic regression model for predicting brucellosis at the herd level in goats in Oman 
Variable Name Variables B S.E. Wald Sig. 
Odds 
Ratio 
95% C.I 
Lower Upper 
Region Southern Region 4.316 1.058 16.627 < 0.001 74.876 9.406 596.041 
Abortion 
History in Herd 
Presence of 
Abortion 
1.489 0.675 4.863 0.027 4.434 1.18 16.656 
 Constant -10.647 2.029 27.527     
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4.3.7 Univariable analysis to identify factors influencing the seropositivity to 
brucellosis in camels  
The influence of individual level variables (age, sex, breed, individual animal history 
of abortion) and herd level variables (herd size, cohorts, sharing of pasture, history of 
abortion in a herd and governorate) on the seroprevalence of brucellosis in camels was 
analyzed (Table 4.7). 
Analysis of individual level variables indicated that the camels which were in the age 
group of >5 to ≤10 years were more likely, although not significantly, to test positive 
than camels >2 to ≤5 years of age (OR: 1.39, 95% CI 0.27, 7.20) and >10 years old 
(OR: 1.18, 95% CI 0.23, 6.09). Furthermore, age categories were combined to 
construct two groups (≤ 5 years and > 5 years of age) and analysis was performed 
again. It was revealed that camels > 5 years were more likely to test positive (OR: 
2.38, 95% CI 0.49, 11.48) as compared to those ≤ 5 years. However, no odds ratio 
analyses were possible for sex, breed and individual animal abortion history as all 
positive camels were female, local breeds and had no prior history of abortion.  
When variables at the herd level were analyzed, camels kept in large sized herds (>30 
head) were found more likely to contain seropositive animals than in herds with ≤ 5 
head (OR: 5.01, 95% CI 0.52, 48.55), 6-15 heads (OR: 7.54, 95%CI 0.78, 73.02) or 
16-30 camels (OR: 1.99, 95% CI 0.39, 10.00). Camels kept with cattle in mixed herds 
were more likely to test positive for brucellosis than those kept alone (OR: 4.60, 95% 
CI 0.73, 29.18). However, camels kept with only small ruminants were less likely to 
test positive than those kept with only camels (OR: 0.22, 95% CI 0.02, 2.15), and with 
cattle and small ruminants (OR: 0.60, 95% CI 0.10, 3.67). Camels belonging to herds 
having a history of abortions were significantly more likely to contain seropositive 
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animals than those from herds with no history of abortion (OR: 8.71, 95% CI 2.12, 
35.81). Camels originating from herds located in the south of Oman (Dhofar) were 
more likely to be seropositive for brucellosis than those from the north of Oman (OR: 
7.46, 95% CI 1.49, 37.37). As all seropositive camels shared pasture with other 
ruminants no comparison by odds ratios was possible for this variable. 
4.3.8 Multivariable analysis to identify factors influencing the seroprevalence of 
brucellosis in camels 
Of the 9 variables analysed with univariable analyses (Table 4.7), abortion history in 
herd (P<0.001), pasture sharing (P=0.032), herd size (0.182), cohorts (0.016) and 
governorate (P=0.004) were found to be significantly associated with brucellosis 
(Wald P < 0.2). The variables age (P=0.539) and individual animal’s history of 
abortion (P=0.671) were not associated with disease (Wald P > 0.2). No valid 
comparison was possible regarding the breed and sex of camels as all positive animals 
were of female sex and local breeds.  
No variable was found significantly associated with seroprevalence of brucellosis at 
the individual level, and consequently no multivariate analysis could be conducted. 
Herd level variables found significant on the initial univariable analyses were used to 
construct the initial multivariate model. However, the variables sharing of pasture, 
cohorts, herd size and governorate were removed at subsequent steps and only 
previous history of abortion in a herd was found to be significantly associated with the 
presence of brucellosis. Thus no multivariable model could be produced to explain the 
presence of brucellosis in camels (Table 4.8). 
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Table 4.7 Univariable risk factors for seropositivity to brucellosis in camels 
Variable Name Variable 
% 
seropositive 
OR 
(95% CI) 
P 
Value 
Age 
≤ 2 years 0/403 (0.0) - 
0.539 
> 2 to ≤ 5 years 2/506 (0.39) 0.85 (0.12, 6.03) 
> 5 to ≤ 10 
years 
5/912 (0.55) 1.18 (0.23, 6.09) 
>10 years 2/429 (0.47) 1 
Combined Age 
Group 
> 5 years 7/1341 (0.52) 2.38 (0.49, 11.48) 
0.28 
< 5 years 2/909 (0.22) 1 
Breed 
Local 9/226 (0.4) - 
NA Imported 0/18 (0.0) - 
Cross 0/6 (0.0) - 
Sex 
Male 0/252 (0.0) - 
NA 
Female 9/1998 (0.45) - 
Abortion History 
Yes 0/44 (0.0) - 
NA 
No 9/2206 (0.41) - 
Herd Size 
≤ 5 Camels 1/128 (0.78) 0.19 (0.02, 1.95) 
0.182 
6 to 15 Camels 1/191 (0.53) 0.13 (0.01, 1.30) 
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Variable Name Variable 
% 
seropositive 
OR 
(95% CI) 
P 
Value 
16 to 30 
Camels 
3/154 (1.95) 0.50 (0.09, 2.55) 
> 30 Camels 3/79 (3.8) 1 
Cohorts 
Small 
ruminants 
1/219 (0.46) 0.22 (0.02, 2.15) 
0.016 
Cattle 2/23 (8.69) 4.60 (0.73, 29.18) 
Cattle & small 
ruminants 
2/162 (1.23) 0.60 (0.10, 3.67) 
Only Camels 3/148 (2.03) 1 
Pasture Sharing 
Yes 8/353 (2.27) - 
NA 
No 0/199 (0.0) - 
Abortion History in 
Herd 
Yes 4/60 (6.67) 8.71 (2.12, 35.81) 
<0.001 
No 4/492 (0.81) 1 
Governorate 
South (Dhofar) 6/162 (3.7) 7.46 (1.49, 37.37) 
0.004 
North (Rest of 
Oman) 
2/390 (0.51) 1 
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Table 4.8 Final binary logistic regression model for predicting brucellosis at herd level in camels in Oman 
 
Variable Name  Variable B S.E. Wald Sig. Odds Ratio 
95% C.I. 
Lower Upper 
Abortion History 
History of abortion 2.165 0.721 9.015 0.003 8.714 2.121 35.809 
Constant -4.804 0.502 91.564 0 0.008     
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4.4 Discussion 
Many factors, including host, agent and environmental factors, directly or indirectly 
influence the prevalence, distribution and transmission of a disease (Burridge, 1981). 
A large herd size, a high stocking density, older animals, frequent introduction of 
untested livestock, unrestricted grazing and grazing of communal pastures can all be 
associated with a high seroprevalence of brucellosis (Nicoletti, 1976; Breitmeyer et 
al, 1992; Kadohira et al, 1997). 
In order to estimate the effects of risk factors on the seroprevalence of disease in the 
sultanate, several parameters were structured in form of a questionnaire (Appendix 1) 
and the results presented in Tables (4.1 to 4.8). Information on disease is often 
collected from three sources: the owner; direct observation of herds/flocks; and from 
neighbours of the owner's livestock holdings. However in Oman, the quality of 
information collected from these sources may be questionable. In the current study, 
most private livestock owners had no systematic herd records or an animal 
identification system. Consequently no reliable data were available regarding the 
number of births, early mortalities, the birth of weak young or stillbirths or the 
number of abortions occurring each year in the flocks/herds. Most of the sampled 
herds were managed by illiterate expatriate workers who were not familiar with the 
origin of the animals if they had been purchased. Owners were usually reluctant to 
provide exact financial details regarding the annual purchase and selling of animals.  
Several factors were analyzed as potential risk factors at both the individual and 
herd/flock level. In this study the individual animal factors analyzed included age, 
sex, breed and individual animal history of abortion and the herd/flock level factors 
included herd size, cohorts, sharing of pasture, history of abortion in a herd and 
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location of the herd. 
Questionnaire based information (Appendix 1) collected during this study indicated 
that several factors could be considered as potential risk factors for the disease 
increasing the risk of an animal or herd/flock being infected with brucellosis. 
However, the risk factors associated with seropositivity varied between species at 
both the individual and herd/flock levels in the univariable and multivariable 
analyses. 
Individual animal level analysis revealed that breed (P = 0.01) and history of abortion 
(P < 0.001) were significantly associated with brucellosis in cattle (Table 4.1). 
Similarly, in sheep, breed (P = 0.05) and a history of abortion (P = 0.02) were also 
significantly associated with seropositivity. However these variables were not 
associated with seropositivity in goats and camels.  
The finding of a significantly higher seroprevalence in imported cattle (1.8%) and 
sheep (0.6%) was in agreement with other studies. Chantal and Thomas (1976) and 
Akakpo (1987) indicated that crossbred cattle (B. taurus and B. indicus) were more 
susceptible to Brucella than were purebred B. indicus cattle. This may have been 
explained by the emergence of resistance in local breeds to the endemic diseases as 
compared to imported and cross-bred animals. However it is likely that management 
of imported and cross-bred animals is different to that of local bred animals. These 
animals may be housed more intensively resulting in a greater opportunity in 
transmission of bacteria between the species. Others have highlighted the importance 
of management and husbandry practices adopted on the transmission of Brucella 
(Crawford et al, 1990; Reviriego et al, 2000). 
The seroprevalence of disease in cattle with a history of abortion (6.7%) was 
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significantly higher than those without an abortion history (OR=22). This was 
expected, as the disease usually manifests itself as abortions (Jones, 1982; Mahajan 
and Kulshreshtha, 1986; Arda et al, 1987; Kenar et al, 1990). Fensterbank (1977) 
reported that one infected cow at parturition could shed enough bacteria to infect up 
to 600,000 animals and the antibodies induced by infection are likely to last for the 
duration of the animal’s life (Alton, 1990a; Durán-Ferrer, 1998). However, a history 
of abortion was not associated with brucellosis in sheep where no sheep with a 
history of abortion were seropositive compared to 0.14% in those without a history of 
abortion. In Oman, it is well accepted that abortion in sheep from brucellosis is rare 
compared to cattle and goats (MAF, 2013). This may be due to either more tolerance 
by the local sheep to disease or it may reflect the findings of other researchers where 
sheep have been shown to be very resistant to re-infection compared to other 
ruminants (Alton, 1990a; Durán-Ferrer, 1998).The higher susceptibility of goats 
compared to sheep has also been recorded by Crespo (1994) and Reviriego et al, 
(2000). It also could be related to the latent carrier status of goats which have been 
identified as an important source of infection in other regions of the world (Plommet 
et al, 1973; Lapraik et al, 1975; Fensterbank, 1978; Dolan, 1980). 
Age is known as one of the intrinsic factors influencing brucellosis seropositivity 
(Megersa et al, 2011). The influence of age on seroprevalence has already been 
mentioned in previous brucellosis studies (Kadohira et al, 1997; Kubuafor et al, 
2000; Faye et al, 2005; Muma et al, 2006; Chimana et al, 2010). In the current study, 
although the prevalence of disease was not significantly affected by age, it is obvious 
that the older cattle, goats and camels had higher seroprevalences than did the 
younger animals. Similar findings were reported by Akakpo (1987) and Kadohira et 
al. (1997). Clinical disease mainly affects the actively producing animals that are 
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allowed to graze freely on contaminated pasture as compared to young animals which 
have not reached reproductive productive age. Furthermore older animals have more 
opportunities to have contact with infected animals than do other animals. Similar 
observations have been reported by Botha and Williamson, (1989), Silva et al, (2000) 
and Amin et al, (2005). It is also possible that the high prevalence of brucellosis 
among the older animals might be related to maturity and therefore, the organism 
propagates and produces either a latent infection or overt clinical manifestations. 
As observed by Ocholi et al. (1996), this study also failed to find a significant 
difference between the prevalence in male and female (P =0.266) cattle, although a 
higher seropositivity was observed in female small ruminants and camels compared 
with males. The equal susceptibility of male and female has been reported previously 
(European Commission, 2001). It was expected that females may have a higher 
prevalence as the disease is mainly manifested in adult reproductive animals. The 
similar prevalence in adult males and females may be explained by the similar 
likelihood of contacting animals when grazing communal pasture. 
In the univariable analysis of infection in cattle herds, herd size, cohorts (animals that 
were grazed with cattle), a history of abortions in the herd and location were 
associated with seroprevalence. Similarly in sheep, cohorts, history of abortions in the 
flock and location were significant. Again in camels similar findings were reported 
with pasture sharing, cohorts, history of abortion in the herd and location significantly 
associated with evidence of infection. 
Crawford (1990) and Enright and Boca (1990) reported that the risk factors 
associated with the spread of the disease within a herd included herd size, population 
density and the method of housing. The effect of herd size and mixed farming of 
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multiple species on the risk of infections with contagious diseases has been well 
documented (Salman and Meyer 1987). The larger herds may provide more chances 
for contact between animals and in particular contact with an infected animal. Mixed 
farming, and especially raising sheep and/or goats along with cattle, has been 
reported by many researchers to be a risk factor for transmission of Brucella between 
different animal species ( Omer et al, 2000; Abbas and Agab, 2002; Al-Majali et al, 
2007). In this study, animals raised in smaller herds (5 animals or less) were less 
likely to be seropositive than those from larger herds/flocks (30 or more animals). 
Abbas and Agab (2002) and Al-Majali (2005) and Al-Majali et al, (2008) reported 
similar findings in camels and goats, respectively. In larger herds/flocks there is a 
greater opportunity of contact between animals and a greater probability that some 
animals will be calving/lambing/kidding at any one point in time which would 
facilitate the spread of infection (Camus, 1980; Akakpo, 1987). 
Mixed farming of multiple species of animals was significantly associated with 
seropositivity (P < 0.001) for goats and camels. This may be due to increased 
opportunity of contact between species and the sharing of potentially contaminated 
pastures. This is particularly important in Dhofar governorate where sharing of 
pasture is a common feature of livestock rearing. In contrast higher chances for being 
seropositive were observed in cattle which were kept separate from other species 
(11.5%) than those kept with small ruminants (0.66%) or with both camels and small 
ruminants (0.71%). A possible explanation might be the sharing of communal 
pastures, confined contaminated farm space and communal water sources that 
provided more chances of contracting the disease. The role of small ruminants in the 
epidemiology of B. melitensis is well documented, with these animals acting as the 
main host for this organism. Omer et al. (2000) and Abbas and Agab (2002) have 
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reported the impact of mixing small ruminants with cattle on the seroprevalence of 
brucellosis, and consequently the finding of the lower prevalence in cattle mixed with 
small ruminants in this study is surprising. It is possible that other managerial factors 
may be affecting the spread of Brucella within cattle herds. For example farmers 
removed small ruminant manure more frequently than cattle manure. Brucella can 
survive for up to 60 days in damp soil and 30 days in urine (Bercovich, 1998). 
Farming cattle alone may also give more opportunities for these animals to be in 
close contact than with other species as they are usually kept together for a longer 
period before culling or slaughtering.  
The use of communal pastures allows the frequent contact between animals providing 
increased opportunity of exposure of susceptible animals to infectious materials 
arising from parturition. Similar observations have been reported by Reviriego et al, 
(2000) who highlighted that contacts between goats and sheep at the flock level was 
one of most important risk factors for infection. However, the report of European 
Commission (2001) has reported a low risk for sheep in Latin America, even when 
raised in contact with infected goats. Furthermore contamination of pasture may also 
occur through other animals which may remove and distribute placental material such 
as dogs, cats and other carnivores such as foxes (European Commission, 2001). 
A history of abortions in herds/flocks was significantly (P= 0.003) associated with 
infection in camels (7.1%, OR=8.7), cattle (7.4%, OR=9.02) and goats (14.3%, 
OR=10.8). This is expected as the major sign of brucellosis is abortion. Abortion 
facilitates the release of an enormous number of microorganisms which can 
contaminate the environment and subsequently be ingested by at-risk healthy animals 
in the infected herd/flock (Alton, 1982). 
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More camel (3.7%, OR=7.5), cattle (4.9%, OR=5.5) and goat (16.2%, OR=94.3) 
herds located in the southern Dhofar governorate were seropositive than those located 
in the northern governorates (0.5%, 0.9%, 0.2%, respectively). This finding was 
expected as the disease has primarily been localized in Dhofar during the past two 
decades (Ismaily et al, 1988). The high humidity, moderate temperature and shorter 
periods of direct sunlight for several months in Dhofar may have allowed the bacteria 
to survive in the environment for a longer period in this southern region compared to 
the northern regions where high temperatures and strong sunlight are predominant. 
This finding is in agreement with those reported by Nicoletti (1980), Alton (1985) 
and Al-Talafha et al. (2003). Moreover, introduction of infected animals shipped 
from the endemic areas in the Horn of Africa directly to the Salalah Port may have 
introduced brucellosis to this governorate and contributed towards the maintenance of 
brucellosis in the governorate. Crawford et al. (1990) described the introduction of 
new animals from endemic regions as an important risk factor for the spread of the 
disease. Therefore, in a country where importation of animals takes place, it is 
necessary to monitor the population and confirm the biotype present so that an 
effective control programme can be implemented. In the following chapter a study to 
identify the biotypes of Brucella present in Oman is summarised. 
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CHAPTER FIVE 
BIOTYPING, ANTIBIOGRAM AND GENETIC ANALYSIS 
5.1 Introduction  
Brucellae are Gram negative, cocco-bacilli, facultative intracellular pathogens which 
can be transmitted to a susceptible host mostly by direct contact, ingestion or via 
aerosol. On the basis of pathogenicity, host preference and phenotypic characteristics 
six species of Brucella have been commonly listed (Osterman, 2006) with four new 
species being recently recognised (Ewalt et al, 1994; Foster et al, 1996; Clavareau et 
al, 1998; Scholz et al, 2010; Tiller et al, 2010; Banai and Corbel, 2010; Nymo et al, 
2011). The phylogenetic tree of the Brucella spp. is presented in Figure 5.1. Based on 
their cultural morphology, serotyping and biochemical characteristics, these species 
may be further sub-divided into sub-types; also known as biovars, or biotypes (Alton 
et al, 1988; OIE, 2009). 
The importance of biotyping of Brucella species is to provide epidemiological 
information, establish the characteristics of the agent(s), to handle outbreaks and to 
facilitate control/eradication strategies (Unver et al, 2006; Ica et al, 2012). Brucella 
abortus contains 7 biovars (1 to 6 and 9) and B. melitensis contains 3 biovars (OIE, 
2008). Each biovar may have many strain types. Biovar 1 of B. abortus is considered 
the most prevalent among cattle, however it is also found worldwide in many animal 
species including sheep and goats, buffalo, horses, camels, and humans. Besides 
biovar 1, biovar 2 has also been isolated from infected cattle in New South Wales, 
Australia (Hornitzky and Searson, 1986).  
Several authors have described the two common ways for biotyping isolates: firstly the 
phage typing method which involves lysis by phages; and secondly by examining 
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oxidative metabolic profiles on selected amino acid and carbohydrate substrates. 
However, the latter method has disadvantages in that it is hazardous, time consuming 
and needs adequate laboratory facilities. Biovars of B. abortus can also be 
differentiated by their utilization of CO2, production of H2S, growth on media with 
dyes (thionin and basic fuchsin), and utilization of monospecific antiserum (OIE, 
2009).  
Corbel and Brinley-Morgan (1984) identified significant DNA homology of the 
species within the genus and similar polynucleotide sequences were detected. As a 
result, the usual biotyping tests may not always reveal the full extent of differences 
between biovars, especially where the differences may rely upon a single 
characteristic. Aldrick (1968) stressed the importance of performing biotyping tests as 
soon as possible after culturing as the colonies are unstable and may not be visible 
after repeated subculturing. 
Isolation and identification of Brucella species are based on culture and phenotypic 
analysis (biotyping). Although undoubtedly providing valuable information, biotyping 
was, and remains, a highly specialized and time-consuming approach requiring 
experienced staff and well-optimized non-commercial reagents ideally used under 
secure biological containment. 
As outlined in Chapter 2 a range of molecular typing techniques are available to 
differentiate between strains. In Oman, B. melitensis biovar-1 is the only type that has 
been isolated from cattle, camels, sheep and goats in the southern region (Adam and 
El-Rashied, 2013). However a comprehensive epidemiological study on the strains and 
types of Brucella infecting animal and humans in the Sultanate has not yet been 
undertaken. In this chapter the findings from the examination of isolates from Oman to 
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determine their genetic relatedness are reported. 
Figure 5.1 Phylogenetic tree of the Brucella spp. (Garritty et al, 2005). 
 
5.2 Materials and Methods 
5.2.1. Collection of samples for bacterial isolation and identification 
A total of 14 blood samples were collected (July 2012) from serologically positive 
(RBPT and cELISA) brucellosis goats originating from a flock (n = 67) in Sohar, 
which had experienced a series of abortions. The blood samples were collected in 
sterile test tubes (25mL) containing sterile acid-citrate-dextrose as anticoagulant. The 
samples were transported to the laboratory in ice packs for bacterial isolation and 
identification. All microbiological work was conducted in the class II, type A2 
biosafety cabinet. The whole facility was restricted to other laboratory staff except for 
the investigators and all precautions were taken to avoid the spill over infection. The 
facility was disinfected routinely. 
The samples (10mL) were inoculated in duplicate into culture broth vials (Oxoid 
SIGNAL
TM
 Blood Culture System). The growth indicator device was fixed on each 
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culture vial aseptically by inserting the needle through the center of the rubber stopper 
and the cap on the body of the indicator device tightened by turning it clockwise. 
Following inoculation, the culture systems were incubated at 36 ± 1 °C on a shaker 
(150 orbits/minute) for the first 24 hours. Thereafter, the system was removed from 
the shaking apparatus and placed on a shelf of the incubator for the next 6 days. 
Similarly each of the inoculated vials was incubated in a microaerophilic (5-8% CO2) 
environment using a CO2 generation system (Oxoid) in a 2.5L gas jar. During 
incubation, the system was examined twice daily for positive signals of microbial 
growth (when a small portion of the blood-broth mixture from the culture vials was 
displaced into the sleeve of indicator system as a result positive pressure developed by 
microbial growth). Vials with positive signals were sub-cultured as follows. Indicator 
devices with growth signals were gently mixed, unscrewed and the chamber’s contents 
were cultured on sheep blood agar plates (BAP). The growth signals (blood broth 
mixture) were also examined by microscopy after applying a Gram stain. The growth 
on the BAP were examined for colony morphology, hemolytic pattern and processed 
for catalase and oxidase tests and for urease activity. The catalase test was carried out 
on a slide by emulsifying a suspected colony in a drop of 3% hydrogen peroxide. The 
oxidase test was performed using an oxidase test strip (Oxoid, U.K.) and the urease 
activity of isolates was determined in Christensen’s medium (Quinn et al, 1984). 
5.2.2. Procurement of Brucella Strains  
Previously identified, 21 Brucellae were also obtained from the Brucellosis Diagnostic 
Unit, for bio-typing, molecular identification/typing and antimicrobial susceptibility. 
These isolates were recovered on microbiological investigation of milk samples 
(n=186), aborted fetuses (n = 3), placental tissues (n = 2) and uterine swabs (n = 9) of 
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different animal species (including cattle, sheep, goats and camels) from the Southern 
region of Oman (Dhofar) from 1997-2007. The sample identification (VRC lab ID), 
animal species, sample type and year of isolation identification are shown in Table 5.6.  
5.2.3. Biotyping 
For conventional bio-typing at the biovar level, presumptively identified Brucella spp. 
were investigated for their CO2 requirements, H2S production, sensitivity to dyes 
(thionin and basic fuchsin) and agglutination with A and M mono-specific sera (Quinn 
et al, 1984; OIE, 2009). For testing sensitivity to thionin and fuchsin, the test was 
carried out by incorporating the dyes separately in trypticase soy agar at a 
concentration of 20 µg/ml (1:50,000) or 40 µg/ml (1:25,000). The medium was 
prepared by heating a 0.1 per cent solution of either dye in a boiling water bath for 20 
minutes and then adding it to the required amount of autoclaved agar. The dye was 
mixed with the agar and poured into Petri dishes. A sterile swab was used to inoculate 
the dye media with a suspension of the test strain. The inoculated plates were 
incubated at 37ºC for 3-4 days and then examined for growth. The differential 
characteristics of biovars of B. melitensis and B. abortus species Table 5.1) were 
followed to reach the results. 
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Table 5.1 Differential characteristics of the biovars of Brucella species 
Species Biovar CO2 
Requirement 
H2
 
Production Growth on Dyes 
(20microgram/mL) 
Agglutination with mono-
specific sera 
Thionin Basic 
fuchsin 
A B 
 
B. melitensis 
1 - - + + - + 
2 - - + + + - 
3 - - + + + + 
 
 
B. abortus  
1 +
a
 + - + + - 
2 +a + - - + - 
3 +a + + + + - 
4 +a + - +b - + 
5 - - + + - + 
6 - - + + + - 
9  +or _ + + + - + 
a  strains positive on primary isolation 
b Some basic fuchsin-sensitive strains were isolated 
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5.2.4. Determination of antimicrobial susceptibility profiles (antibiogram) of 
Brucella melitensis 
In vitro antibiotic susceptibility profiles of B. melitensis (n = 15) collected over a 
decade (1998-2008) were assessed to 18 antibiotics/antimicrobials [amoxicillin (AC), 
ampicillin (AM), ampicillin-sulbactam (AB), amoxicillin clavulanic acid (XL), 
trimethoprim-sulphamethoxazole (TS), cefotaxime (CT), cefuroxime (XM), 
ceftriaxone (TX), ceftazidime (TZ), chloramphenicol (CL), enrofloxacin (EF), 
norfloxacin (NX), gatifloxacin (GA), levofloxacin (LE), gemifloxacin (GEM), 
ciprofloxacin (CI), moxifloxacin (MX) and ofloxacin (OF)] using the E test following 
the guidelines of the Clinical Laboratory Standard Institute (CLSI, 2008). 
Staphylococcus aureus ATCC 25923 and E. coli ATCC 25922 (American Type 
Culture Collection, Rockville, Maryland, USA) were used as the quality control 
organisms. The details of the procedures used were as follows. 
 
5.2.4.1 Preparation of susceptibility testing medium 
The susceptibility testing was performed on Mueller-Hinton agar plates supplemented 
with 5% sheep blood. The medium was prepared by dissolving 38 grams of 
dehydrated Mueller-Hinton agar (Oxoid, U.K) in 1 litre of distilled water and this was 
sterilized by autoclaving at 121˚C for 15 minutes. Immediately after autoclaving, the 
medium was allowed to cool in a thermostatically controlled water bath set at 50˚C 
and 5% sheep blood was added to the media and gently mixed to avoid bubbling. The 
media were then poured into flat-bottomed Petri dishes (150mm) to give a uniform 
depth of approximately 4 mm. The agar medium was then allowed to cool at room 
temperature and then was stored at 4˚C in a refrigerator until used. 
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5.2.4.2 Preparation of McFarland turbidity standard and inoculation of plates.  
An inoculum equal to 0.5 McFarland turbidity standard (BioMerieux, France) was 
prepared for each Brucella strain by placing bacterial colonies into sterile water. The 
colonies were diluted to give a final inoculum of 10
5
 to 10
6
 CFU/mL. 
After adjusting the turbidity of the inoculum suspension, a sterile cotton swab was 
dipped into the adjusted suspension. The swab was rotated several times and pressed 
firmly on the inside wall of the tube above the fluid level to remove excess inoculum 
from the swab. The dried surface of Mueller-Hinton-Blood agar plates was inoculated 
by streaking the swab over the entire sterile agar surface. This procedure was repeated 
by streaking two more times, rotating the plates approximately 60˚ each time to ensure 
an even distribution of inoculum. As a final step the rim of the agar was swabbed. For 
the determination of antibiotic susceptibility of the B. melitensis isolates, antibiotic 
strips (AB Biodisk, BioMerieux, France) were placed on the surface of the inoculated 
agar plate using sterile forceps. The plates were inverted and placed in an incubator set 
at 37˚C. After incubation for 48 hours, the zone of inhibition around each antibiotic 
strip was read and recorded (Figure 5.2). 
5.2.5 Molecular identification and typing 
This part of the study undertook investigations on 15 isolates of Brucella collected 
between 1998 and 2008 from foetal and milk samples taken from camels originating 
from the northern region of Oman (Dhofar) and on 14 blood samples isolated from a 
recently suspected outbreak (2010) of caprine brucellosis in the southern region of 
Oman (Sohar). All isolates and suspected samples were examined by species specific 
novel PCR assays (Hinić et al, 2008, 2009). All isolates had previously been phage 
typed and their identities confirmed with standard biochemical procedures (Alton et al, 
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1988; Behroozikhah et al, 2005). In vitro antimicrobial susceptibility (minimum 
inhibitory concentrations) (n=15) was determined by the E test as described by CLSI 
(2008). 
5.2.5.1 Genomic DNA preparation of Brucella isolates and blood samples 
The genomic DNA was purified by using a genomic DNA purification kit (Fermentas, 
Germany) following the manufacturer’s instructions. 
 1μl of culture were placed into 1.5ml micro-centrifuge tubes. 
 The tubes were centrifuged at 5000 rpm for 10 minutes. 
 The supernatant was discarded and the pellet retained. 
 The pellet was then suspended in 150µl enzyme buffer (25 mM Tris HCL, 5 
mM glucose and 10 mM EDTA) and 500µl Lysostaphin (Sigma) enzyme that had 
been prepared by dissolving 5mg of the lyophilised content in 100 ml of 0.1 M 
NaCl. 
 The mixture was then incubated at 37°C for 1 hour. 
 400 µl lysis buffer was mixed with 200 μl sample of enzymatic treated mixture. 
 The mixture was incubated at 65°C for 30 minutes. This was longer than the 5 
minutes recommended by the manufacturer, as this period was not effective. 
 Following incubation, 600µl of chloroform was added and the contents gently 
emulsified by inversion. 
 The mixture was then centrifuged at 10,000 rpm for 2 minutes. 
 175 
 
 The upper aqueous phase containing DNA was transferred to a fresh 1.5ml 
eppendorf tube. 
 The precipitation solution was prepared by mixing 720µl of nuclease free water 
with 80µl of 10X concentrated solution supplied in the kit. 
 800µl of the prepared precipitation solution was then added to the mixture. 
 The mixture was mixed at room temperature for 1-2 min, and then centrifuged at 
10,000 rpm for 2 minutes. 
 The supernatant was removed and the DNA pellet dissolved in 100µl of 1.2M 
NaCl solution. 
 300µl of ethanol was added to the mixture and the DNA precipitated at 20°C for 
10 minutes. 
 The mixture was then centrifuged at 10,000 rpm for 15 minutes. 
 The ethanol was decanted and the pellet washed with 70% pre-chilled ethanol. 
 The DNA was resuspended in 100µl of nuclease free water 
For the blood samples, individual genomic DNA preparations were made by adding 
1.0µl of blood to 20µl of BR-A (Lysis buffer available with BloodReady Multiplex 
PCR Kit, Genescript, USA). The mixture was mixed well and used directly in the 
PCR. 
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5.2.5.2 DNA Amplification 
The reaction was performed using BactReady
TM
 multiplex PCR system (Genescript, 
USA). The reaction mixture (20 μl; Table 5.2) was prepared in thin walled, flat cape, 
DNase-RNase free 0.2 mL tubes (Thermo-Tubes, Thermo-scientific, UK) with 1 µL of 
template DNA. The genomic target, primer sequence and product size is outlined in  
Table 5.3. Amplifications were performed using a micro-processed controlled Swift
TM
 
Maxi Thermal Cyler Block (ESCO Technologies Inc. France) under the following 
conditions: activation of Script
TM
 DNA polymerase at 94 for 15 minutes followed by 
35 cycles of denaturation (95ºC for 1 minute), annealing (55ºC for 1 minute), 
extension (72ºC for 1 minute) and a final extension step of 72ºC for 3 minutes. The 
PCR thermal profile is summarised in Table 5.4. The amplicons were analyzed by 
agarose gel electrophoresis using a horizontal mini agarose gel electrophoresis system 
(ENDURO
TM
 Labnet International Inc., Woodbrige, NJ, USA) cell. A mixture of 
undiluted PCR products (5 µL) and 5X loading dye (1 µL; Fermentas Thermo Fischer 
Scientific Inc., UK) was loaded onto 1.2% Agarose gel (multipurpose agarose, low 
EEO, multipurpose, Fischer Scientific Ltd, Loughborough, UK) containing ethidium 
bromide (0.5 µg/mL; Fischer Scientific Ltd, Loughborough, UK) for DNA staining. 
The PCR products were loaded using a dye (5x loading dye, Qiagen) to 1.2% agarose 
gel (TopVision
TM
 Agarose, Fermentas, Germany) containing ethidium bromide (0.5 
µG/mL; Fischer Scientific Ltd, Loughborough, UK) in 0.5X TAE buffer. The gels 
were run in 1X TAE buffer (50X TAE Buffer, Fischer Scientific Ltd, Loughborough, 
UK) at 80 volts (80mA) for 1 hour. The amplicons were visualised on a 
transilluminator (Vilbert Lourmart, Cedex France) and saved using a gel 
documentation systems (DP-CF-011, France). The size of the products was measured 
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using a ready to use 100 bp molecular marker (O gene-Ruler 100bp DNA ladder, 
Fermentas, Thermo-scientific, UK). 
Table 5.2 Composition of PCR reaction mixture used for amplification of 
Brucellae specific genes 
Reagents Volume (μl) Final concentration 
PCR grade (DNAse free) water 7  
Forward primer 1 50nM 
Reverse primer 1 50nM 
DNA solution 1  
PCR Premix 10  
Total volume 20  
 
Table 5.3 DNA target sequence of primers used to detect Brucella and PCR 
product size 
Target Sequence Product 
Size 
Reference 
IS711 
 
5’ GCTTGAAGCTTGCGGACAGT 3’ 
5’ GGCCTACCGCTGCGAAT 3’ 
63 Hinić et al, 
2008 
BMEII0466 
 
5’ GCTTGAAGCTTGCGGACAGT 3’ 
5’GGCCTACCGCTGCGAAT 3’ 
67 Hinić et al, 
2008 
BruAb2_0168 
  
5’ TCGCATCGGCAGTTTCAA3’ 
5’ CCAGCTTTTGGCCTTTTCC3’ 
81 Hinić et al, 
2008 
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Table 5.4 Thermal profiles for PCR of Brucellae amplicons with the set of 
primers at concentration of 50 nM. 
Steps Temperature Time 
Activation of ScriptTM DNA 
Polymerase 
94˚C 15 minutes 
Denaturation 94˚C 40 seconds 
Annealing  55˚C 2 minutes 
Extension 65˚C 5 minutes 
Final Extension 72˚C 3 minutes 
Total CYCLES = 35 
 
5.2.5.3 Optimization of randomly amplified polymorphic DNA (RAPD) 
conditions  
Since the reproducibility of the RAPD technique is influenced by the reaction 
components and the machine (Williams et al, 1990), the PCR conditions were 
initially optimised for the concentration of genomic DNA, 10 X PCR buffer, MgCl2, 
dNTPs, primer and Taq DNA polymerase to obtain reproducible results. The 
following quantities were used in this reaction. 
Thermal Cycler  : Eppendorf, Germany 
DNA Template   : 1.5 µl 
Taq DNA polymerase : 0.2 U (MBI, Fermentas, Vilnius, Lithuania) 
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d3H2O   : 9.3 µl 
10XPCR Buffer  : 2.5 µl 
Gelatin    : 2.5 µl 
MgCl2    : 3.0 µl  
dNTPS    : 4.0 µl 
10 mer Primers   : 2.0 µl 
The total reaction volume was 25 µl. 
The PCR temperature profile was: hot start at 95˚C for 5 minutes; denaturation at 95˚C 
for 1minute; primer annealing at 34˚C for 1 minute; extension at 72˚C for 2 minutes 
followed by a final extension at 72˚C for 10 minutes. 
 
5.2.5.4 RAPD primers 
The oligo decamer primers were synthesized by Gene Link Company (UK). Out of 50 
random decamer primers, four were selected on the basis of their pre-tested 
polymorphic nature. The list of the primers, along with their sequences, is displayed in 
Table 5.5. 
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Table 5.5 List of oligonucleotide RAPD primers along with their sequences 
used for RAPD-PCR analysis of B. melitensis 
S. No. Primer Name Sequence (5 ׳--3׳ ) 
1 GL DecamerA-09 GGGTAACGCC 
2 GL Decamer J-05 CTCCATGGGG 
3 GL Decamer K-01 CATTCGAGCC 
4 GL Decamer K-19 CACAGGCGGA 
 
Fifteen isolates were explored for RAPD analysis by means of 4 oligonucleotide 
polymorphic RAPD primers. Each primer-template yielded distinct, easily detectable 
bands of variable intensities. Two of the 15 isolates failed to yield any band and were 
excluded from the analysis (RAPD data of 13 isolates is shown in figure 5.5). 
Considering all the primers and isolates, a total of 111 bands were obtained. The 
genetic similarity matrix of RAPD data for 13 isolates was constructed based on Nei 
and Li’s (1979) coefficient of similarity.  
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5.3 Results 
5.3.1 Isolation and identification 
Of the 14 serologically positive (RBPT and cELISA) caprine blood samples, 7 yielded 
positive signals for growth between 48-60 hours of incubation in an aerobic 
environment. On sub-culturing, all samples yielded translucent, smooth, convex, non-
hemolytic colonies of approximately 1mm diameter on blood agar plates after 36 
hours of incubation. Upon prolonged incubation (56 hours), colonies became 
yellowish grey, however remained smooth and convex. All cultures did not require 
supplementary CO2 for growth. Gram-negative cocco-bacilli were observed by 
microscopy (100×) after Gram staining of the colonies. All isolates (n = 7) were 
catalase, oxidase and urease positive and inhibited by thionin (1:50000) dye on serum 
dextrose agar. All isolates also showed agglutination reaction with monospecific 
antiserum M and were negative for antiserum A on the slide agglutination test. 
Similarly, Brucella isolates obtained from the repository of Oman and originating 
from the Dhofar region had the same biochemical reactions and had agglutination with 
mono-specific antiserum M. These results confirmed the isolates as B. melitensis 
belonging to biovar 1 (Table 5.7). 
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Table 5.6 Details of previous and recent isolates of Brucella melitensis strains (n = 
28). 
Strain ID Animal Location 
Year of 
Isolation 
Source of 
isolation 
B_mel 
VRC1 
Cow Dhofar 1997 Milk 
B_mel 
VRC2 
Cow Dhofar 1999 Milk 
B_mel 
VRC3 
Cow Dhofar 1999 Milk 
B_mel 
VRC4 
Cow Dhofar 1999 Milk 
B_mel 
VRC5 
Cow Dhofar 2003 Milk 
B_mel 
VRC6 
Cow Dhofar 2004 Milk 
B_mel 
VRC7 
Cow Dhofar 2004 Milk 
B_mel 
VRC8 
Goat Dhofar 2004 Milk 
B_mel 
VRC9 
Goat Dhofar 2004 Fetus 
B_mel 
VRC10 
Goat Dhofar 2004 Milk 
B_mel 
VRC11 
Camel Dhofar 2004 Milk 
B_mel 
VRC12 
Camel Dhofar 2004 Milk 
B_mel 
VRC13 
Camel Dhofar 2005 Milk 
B_mel 
VRC14 
Camel Dhofar 2005 Milk 
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Strain ID Animal Location 
Year of 
Isolation 
Source of 
isolation 
B_mel 
VRC15 
Cow Dhofar 2007 Milk 
B_mel 
VRC16 
cow Dhofar 1997 Placenta 
B_mel 
VRC17 
Goat Dhofar 1997 Placenta 
B_mel 
VRC18 
Goat Dhofar 1997 Fetus 
B_mel 
VRC19 
Goat Dhofar 1997 Milk 
B_mel 
VRC20 
Goat Dhofar 1997 Milk 
B_mel 
VRC21 
Goat Dhofar 1997 Milk 
B_mel 
VRC22 
Goat Dhofar 1998 Fetus 
B_mel 
VRC23 
Goat Saham 2010 Blood 
B_mel 
VRC24 
Goat Saham 2010 Blood 
B_mel 
VRC25 
Goat Saham 2010 Blood 
B_mel 
VRC26 
Goat Saham 2010 Blood 
B_mel 
VRC27 
Goat Saham 2010 Blood 
B_mel 
VRC28 
Goat Saham 2010 Blood 
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Table 5.7 Biochemical characteristics and typing results of Brucella species from livestock in Oman 
Strain ID Catalase Oxidase Urease H2S 
production 
CO2 
requirement 
Growth on dyes Agglutination 
with 
monospecific 
antisera 
Brucella 
Species 
Biovar 
Basic 
Fuchsin 
Thionin A M 
B_mel VRC1 + + + - - + - - + B. melitensis 1 
B_mel VRC2 + + + - - + - - + B. melitensis 1 
B_mel VRC3 + + + - - + - - + B. melitensis 1 
B_mel VRC4 + + + - - + - - + B. melitensis 1 
B_mel VRC5 + + + - - + - - + B. melitensis 1 
B_mel VRC6 + + + - - + - - + B. melitensis 1 
B_mel VRC7 + + + - - + - - + B. melitensis 1 
B_mel VRC8 + + + - - + - - + B. melitensis 1 
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Strain ID Catalase Oxidase Urease H2S 
production 
CO2 
requirement 
Growth on dyes Agglutination 
with 
monospecific 
antisera 
Brucella 
Species 
Biovar 
Basic 
Fuchsin 
Thionin A M 
B_mel VRC9 + + + - - + - - + B. melitensis 1 
B_mel VRC10 + + + - - + - - + B. melitensis 1 
B_mel VRC11 + + + - - + - - + B. melitensis 1 
B_mel VRC12 + + + - - + - - + B. melitensis 1 
B_mel VRC13 + + + - - + - - + B. melitensis 1 
B_mel VRC14 + + + - - + - - + B. melitensis 1 
B_mel VRC15 + + + - - + - - + B. melitensis 1 
B_mel VRC16 + + + - - + - - + B. melitensis 1 
B_mel VRC17 + + + - - + - - + B. melitensis 1 
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Strain ID Catalase Oxidase Urease H2S 
production 
CO2 
requirement 
Growth on dyes Agglutination 
with 
monospecific 
antisera 
Brucella 
Species 
Biovar 
Basic 
Fuchsin 
Thionin A M 
B_mel VRC18 + + + - - + - - + B. melitensis 1 
B_mel VRC19 + + + - - + - - + B. melitensis 1 
B_mel VRC20 + + + - - + - - + B. melitensis 1 
B_mel VRC21 + + + - - + - - + B. melitensis 1 
B_mel VRC22 + + + - - + - - + B. melitensis 1 
B_mel VRC23 + + + - - + - - + B. melitensis 1 
B_mel VRC24 + + + - - + - - + B. melitensis 1 
B_mel VRC25 + + + - - + - - + B. melitensis 1 
B_mel VRC26 + + + - - + - - + B. melitensis 1 
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Strain ID Catalase Oxidase Urease H2S 
production 
CO2 
requirement 
Growth on dyes Agglutination 
with 
monospecific 
antisera 
Brucella 
Species 
Biovar 
Basic 
Fuchsin 
Thionin A M 
B_mel VRC27 + + + - - + - - + B. melitensis 1 
B_mel VRC28 + + + - - + - - + B. melitensis 1 
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5.3.2 Antimicrobial susceptibility of Brucella melitensis isolates  
According to antibiotic susceptibility using the E-test, all isolates (n=28) were 
susceptible to antibiotics/antimicrobials of the beta-lactam group (including amoxicillin, 
ampicillin, ampicillin-sulbactam, amoxicillin clavulanic acid, cefotaxime, ceftriaxone) 
except for cefuroxime and ceftazidime. These latter antibiotics showed higher MIC90 
values (16 and 24 µg/mL MIC90 respectively) (Table 5.8 and 5.9). Trimethoprim-
sulphamethoxazole showed good activity since it had 0.125µg/mL MIC90. Similarly all 
strains were inhibited by chloramphenicol at 2 µg/mL. Of the quinolones, ciprofloxacin 
(0.125 µg/mL MIC90) showed good anti-Brucella activity compared to the other 
antimicrobials of the same group. 
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Table 5.8 Inhibitory concentration of different antimicrobials against B. melitensis isolates (n = 28) recovered from livestock in Oman 
Strain ID Antimicrobials 
AC AM AB XL TS CT XM TX TZ CL EF NX GA LE GEM CI MX OF 
B_mel VRC1 0.38 2 4 1 0.05 0.8 12 1 24 2 0.5 0.5 0.38 0.19 1 0.13 0.38 0.5 
B_mel VRC2 0.38 1.5 3 0.8 0.05 1 6 0.5 16 1.5 0.3 0.8 0.38 0.19 1 0.13 0.25 0.5 
B_mel VRC3 0.19 2 1.5 0.5 0.03 0.5 8 1 12 2 0.2 0.5 0.38 0.13 1.5 0.13 0.38 0.5 
B_mel VRC4 0.75 8 6 1 0.05 1 6 0.8 24 1.5 0.5 0.5 0.38 0.13 1 0.13 0.38 0.5 
B_mel VRC5 0.38 1.5 4 0.8 0.13 1.5 12 4 16 1.5 0.3 0.8 0.38 0.09 1 0.09 0.25 0.3 
B_mel VRC6 0.25 1.5 6 0.5 0.13 1 16 1.5 16 2 0.5 0.5 0.5 0.19 1.5 0.13 0.38 0.5 
B_mel VRC7 0.75 8 6 1 0.06 6 12 6 16 2 0.5 1 0.5 0.19 0.75 0.13 0.25 0.5 
B_mel VRC8 0.38 2 3 0.8 0.06 1 6 1 12 1.5 0.5 0.8 0.38 0.13 0.75 0.13 0.19 0.4 
B_mel VRC9 0.38 1.5 4 0.8 0.05 1 6 0.8 12 2 0.5 0.8 0.5 0.09 0.75 0.09 0.38 0.4 
B_mel VRC10 0.25 1.5 6 0.8 0.02 0.5 4 0.8 12 1 0.4 0.8 0.09 0.09 1 0.09 0.25 0.4 
B_mel VRC11 0.5 2 3 1 0.05 1.5 12 16 8 1.5 0.5 1 0.38 0.13 1 0.13 0.13 0.5 
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Strain ID Antimicrobials 
AC AM AB XL TS CT XM TX TZ CL EF NX GA LE GEM CI MX OF 
B_mel VRC12 0.38 0.8 6 0.8 0.09 1.5 6 1 24 1.5 0.3 0.8 0.38 0.13 1 0.09 0.25 0.4 
B_mel VRC13 0.13 2 2 0.5 0.05 0.5 4 0.5 12 1 0.5 0.5 0.19 0.13 0.75 0.06 0.19 0.2 
B_mel VRC14 0.19 1.5 1 0.4 0.06 0.5 4 0.5 8 1.5 0.2 0.4 0.13 0.06 0.75 0.06 0.19 0.3 
B_mel VRC15 0.25 2 1.5 0.4 0.09 0.5 6 1 12 1.5 0.3 0.4 0.13 0.06 0.75 0.06 0.19 0.3 
B_mel VRC16 0.19 1.5 2 0.8 0.02 1 8 1.5 16 1 0.3 0.4 0.38 0.09 0.5 0.09 0.25 0.2 
B_mel VRC17 0.75 8 4 1 0.13 1 12 1 24 1.5 0.5 0.5 0.5 0.19 1 0.13 0.13 0.3 
B_mel VRC18 0.25 2 3 0.4 0.06 0.5 6 2 16 1.5 0.3 0.5 0.19 0.13 1 0.09 0.38 0.3 
B_mel VRC19 0.25 2 8 1 0.13 1.5 6 4 12 1 0.5 1 0.5 0.19 0.5 0.06 0.13 0.4 
B_mel VRC20 0.38 1.5 6 1 0.13 1.5 12 1.5 16 1 0.3 0.5 0.13 0.06 1 0.13 0.38 0.5 
B_mel VRC21 0.5 8 6 1 0.09 3 12 0.8 24 2 0.4 0.8 0.13 0.13 1 0.09 0.19 0.5 
B_mel VRC22 0.5 4 2 75 0.13 0.5 16 4 24 2 0.2 1 0.19 0.13 0.75 0.06 0.13 0.2 
B_mel VRC23 0.75 8 8 1 0.05 1.5 8 8 24 1.5 0.2 0.5 0.13 0.19 1 0.09 0.38 0.4 
B_mel VRC24 0.38 8 8 0.8 0.09 1 4 1.5 12 1.5 0.5 0.5 0.38 0.13 1 0.13 0.19 0.4 
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Strain ID Antimicrobials 
AC AM AB XL TS CT XM TX TZ CL EF NX GA LE GEM CI MX OF 
B_mel VRC25 0.75 8 12 1 0.13 3 12 2 12 1 0.3 0.5 0.09 0.09 1 0.13 0.13 0.5 
B_mel VRC26 0.5 8 8 1 0.02 6 16 4 16 1.5 0.2 0.4 0.13 0.13 1.5 0.13 0.13 0.3 
B_mel VRC27 0.75 8 8 1 0.13 0.5 8 4 12 1.5 0.2 0.4 0.19 0.19 1 0.09 0.19 0.2 
B_mel VRC28 0.75 4 6 1 0.13 1.5 12 6 16 1 0.4 0.5 0.38 0.06 1.5 0.06 0.38 0.3 
B_mel VRC1 thru B_mel VRC21 = Isolates from Dhofar (South) of Oman  
B_mel VRC22 thru B_mel VRC28 = Isolates from Sohar (North) of Oman 
AC: amoxicillin; AM: ampicillin; AB: ampicillin-sulbactam; XL: amoxicillin clavulanic acid; TS: trimethoprim-sulphamethoxazole; CT: 
cefotaxime; XM: cefuroxime; TX: ceftriaxone; TZ: ceftazidime; CL: chloramphenicol; EF: enrofloxacin; NX: norfloxacin; GA: gatifloxacin; 
LE: levofloxacin; GE: gemifloxacin; CI: ciprofloxacin; MX: moxifloxacin; OF: ofloxacin 
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Figure 5.2 Antimicrobial susceptibility testing of Brucella melitensis. Inoculated 
Mueller Hinton Blood agar plates. 
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Table 5.9 Minimum inhibitory Concentration (MICs) of selected Beta-lactam antibiotics against B. melitensis (previously and recently 
isolated)  
Antimicrobials 
Minimum Inhibitory Concentrations (µg/mL) and Number of Isolates 
0.023 0.032 0.047 0.064 0.094 0.125 0.19 0.25 0.38 0.5 0.75 1 1.5 2 3 4 6 8 12 16 24 
Amoxicillin (AC) - - - - - 1 3 5 8* 4 7** - - - - 
- - - - 
- - 
Ampicillin (AM) -- - - - - - - - - - 1 - 8 8* 
 
2  9** - 
- - 
Ampicillin-Sulbactam (AB) - - - - - - - - - - - 1 2 3 4 
4 8* 5** 1 
- - 
Amoxicillin Clavulanic acid (XL) 
        
3 3 9* 13** - - - 
- - - - 
- - 
Trimethoprim-sulphamethoxazole (TS) 3 1 7 4* 4 9** - - - - - - - - - 
- - - - 
- - 
Cefotaxime (CT)  - - - - - - - - - 8 1 8* 8 - 2** 
 2 - - 
- - 
Cefuroxime (XM) - - - - - - - - - - - - - - - 
4 8 4* 9 
3** 
 Ceftriaxone (TX) 
         
3 4 6 4* 2 - 
5 2* 1 1 
  Ceftazidime (TZ) - - - - - - - - - - - - - - - 
- - 2 10 
9* 7** 
Chloramphenicol (CL) - - - - - - - - - - - 7 14* 7** - 
- - - - 
- - 
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Antimicrobials 
Minimum Inhibitory Concentrations (µg/mL) and Number of Isolates 
0.023 0.032 0.047 0.064 0.094 0.125 0.19 0.25 0.38 0.5 0.75 1 1.5 2 3 4 6 8 12 16 24 
Enrofloxacin (EF) - - - - - - 6 8* 3 11** -- - - - - 
- - - - 
- - 
Norfloxacin (NX) - - - - - - 
  
5 12* 7 4** - - - 
- - - - 
- - 
Gatifloxacin (GA) - - - - 2 6 4 
 
11* 5** - - - - - 
- - - - 
- - 
Levofloxacin (LE) - - - 4 5 11* 8** - - - - - - - - 
- - - - 
- - 
Gemifloxacin (GEM) - - - - - - - - 
 
2 7 15* 4** - - 
- - - - 
- - 
Ciprofloxacin (CI) - - - 6 9* 13** - - - - - - - - - 
- - - - 
- - 
Moxifloxacin (MX) - - - - - 6 7 6* 9** - - - - - - 
- - - - 
- - 
Ofloxacin (OF) - - - - - - 4 7 7* 10** - - - - - 
- - - - 
- - 
Asterisks (* & **) indicate MIC50 and MIC 90 values, respectively 
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5.3.3 Molecular identification of Brucellae in blood samples by conventional PCR 
All presumptively identified Brucella isolates (n = 21) and 7 of the 14 brucellosis 
suspect blood samples were correctly identified as Brucella by PCR amplification of 
IS711 target (Figure 5.3). All of these samples were further identified as B. melitensis as 
they produced 67 bp amplicons (Figure 5.5). Based on the analysis of the PCR results, 
biochemical reactions and agglutination with mono-specific antiserum indicated the 
existence of B. melitensis biovar 1 in the Sultanate of Oman (Table 5.7). 
 
Figure 5.3 Conventional PCR amplification of B. melitensis gDNA prepared from 
presumptively identified Brucella isolates from the southern region of Oman 
(Dhofar) (# 7-12) and from blood samples from suspected outbreak of brucellosis 
in the northern region of Oman (Sohar) (#1-6).  
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Figure 5.4 Conventional PCR amplification from blood using the primer set 
(BMEII0466). Samples of aborted goats from northern region (Sohar) of Oman 
Lane (1 through 7); M: GelPilot low range (Fermentas) 
 
 
Fifteen isolates were explored by RAPD analysis using 4 oligonucleotide polymorphic 
RAPD primers. Each primer-template yielded distinct, easily detectable bands of 
variable intensities (Figure 5.5). Considering all of the primers and isolates, a total of 
111 bands were obtained. The genetic similarity matrix of RAPD data for 13 isolates 
was constructed based on Nei and Li’s (1979) coefficient of similarity. The similarity 
matrix (13.3% to 93.7%) indicated a significant difference between isolates (Table 5.10. 
The UPGMA cluster of the 13 isolates further revealed associations based on the RAPD 
analysis. The 13 isolates were classified into 4 clusters/clades (Figure 5.6). These results 
showed that the genetic distances among the isolates might be attributed to time 
differences between the culture of strains and perpetuation of the organism within the 
host. 
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Figure 5.5 RAPD-PCR amplification profile of B. melitensis (biovar 1) with a 
single set of primers.  
 
 
 
 
 
 
 
Figure 5.6 Dendrogram of B. melitensis isolates (1 to 13) obtained from similarity 
matrix based on Nie’s UPGMA  
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Table 5.10 Similarity matrix of B. melitensis (n = 13) recovered from aborted camel foetus and camel milk. (Nei's genetic 
identity above the diagonal and genetic distance below the diagonal) 
Pop 
ID 
1 2 3 4 5 6 7 8 9 10 11 12 13 
1 **** 0.7500 0.7500 0.6875 0.6875 0.8125 0.7500 0.7500 0.7500 0.8125 0.6875 0.8750 0.6875 
2 0.2877 **** 0.8750 0.9375 0.6875 0.9375 0.6250 0.8750 0.7500 0.6875 0.6875 0.7500 0.8125 
3 0.2877 0.1335 **** 0.9375 0.6875 0.9375 0.7500 .08750 0.7500 0.6875 .6875 0.7500 0.6875 
4 0.3747 0.0645 0.0645 **** 0.6250 0.8750 0.6875 0.8125 0.6875 0.6250 0.6250 0.6875 0.7500 
5 0.3747 0.3747 0.3747 0.4700 **** 0.7500 0.8125 0.6875 0.5625 0.6250 0.6250 0.6875 0.5000 
6 0.2076 0.0645 0.0645 0.1335 0.2877 **** 0.6875 0.9375 0.8125 0.7500 0.7500 0.8125 0.7500 
7 0.2877 0.4700 0.2877 0.3747 0.2076 0.3747 **** 0.6250 0.6250 0.5625 0.6875 0.7500 0.5625 
8 0.2877 0.1335 0.1335 0.2076 0.3747 0.0645 0.4700 **** 0.8750 0.8125 0.8125 0.8750 0.8125 
9 0.2877 0.2877 0.2877 0.3747 0.5754 0.2076 0.4700 0.1335 **** 0.8125 0.8125 0.8750 0.9375 
10 0.2076 0.3747 0.3747 0.4700 0.4700 0.2877 0.5754 0.2076 0.2076 **** 0.7500 0.8125 0.7500 
11 0.3747 0.3747 0.3747 0.4700 0.4700 0.2877 0.3747 0.2076 0.2076 0.2877 **** 0.8125 0.7500 
12 0.1335 0.2877 0.2877 0.3747 0.3747 0.2076 0.2877 0.1335 0.1335 0.2076 0.2076 **** 0.8125 
13 0.3747 0.2076 0.3747 0.2877 0.6931 0.2877 0.2076 0.5754 0.2076 0.2076 0.0645 0.2877 **** 
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5.4 Discussion 
Understanding the epidemiological aspects of brucellosis is pivotal before devising a 
disease control program. Included in these aspects, is the need to have knowledge of the 
causation of the disease (type of etiological agent) and the host species involved. 
Consequently the isolation, typing and subtyping of the organism(s) causing brucellosis 
in the Sultanate are crucial for planning an effective program to control the disease. 
For phenotypic identification of Brucella at the biovar level, bacteriological methods in 
combination with morphological, cultural and biochemical characteristics are followed. 
Classification of strains into species is based on their natural host preference, sensitivity 
to Brucella phages [Tbilisi (Tb), Weybridge (Wb), Berkeley (Bk2) and Izatnagar (Iz)] 
and oxidative metabolic profiles (OIE, 2009). Speciation is carried out by determining 
aerobic requirement for primary isolation, H2S production, growth in the presence of 
dyes (thionin and basic fuchsin), and agglutination response to mono-specific antisera 
(A and M) (Corbel and Brinley-Morgan, 1975; Alton et al, 1988; OIE 2009; Godfroid et 
al, 2010). The foregoing protocols are used for typing and enable differentiation of the 
species and biotypes of Brucella. 
In the present study, all isolates were identified as B. melitensis. These isolates were 
recovered from various samples (milk, uterine discharges, placenta and fetus) from 
cows, sheep, goats and camels from the endemic (southern) and “disease free” 
(northern) regions of Oman. All isolates of B. melitensis (n = 28) were classified as 
biovar 1 and it is likely that this isolate is responsible for most, if not all, outbreaks of 
brucellosis in Oman.  
There are 3 biotypes of B. melitensis, which have been isolated in different frequencies 
from different countries. Brucella melitensis biotype 3 is the most prevalent biotype in 
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countries of the Middle East. Biotypes 1 and 2 are found to a lower extent in these 
regions, but are more common in south-eastern Europe (OIE, 2009). The results of the 
present study are in line with those obtained by Nicoletti (1986) who isolated and 
identified B. melitensis from milk samples of goats in Dhofar. Similarly, B. melitensis 
has been isolated from human specimens submitted for diagnosis of brucellosis from 
patients presented to the major hospitals of the country (Scrimgeour et al, 1999). 
The route of entry of brucellosis into Dhofar is not known; however, it has been alleged, 
and is likely, that the disease entered through the importation of animals from other 
infected countries (including Yemen). Recent genomic analyses (single nucleotide 
polymorphism; SNP) of 32 isolates of B. melitensis from Oman at Northern Arizona 
University have shown lineages of the local strains with African strains (Nigeria, Chad, 
Tanzania) (Jeffery Foster, personal communication). This information is also supported 
by the animal importation policy of Oman, with most small ruminants imported 
originating from African nations. 
The endemicity of the disease in Dhofar is of concern as livestock from this region are a 
potential source of infection for livestock in the disease free regions (North of Oman). 
Since inter-strain genomic variability was not observed in the SNP analysis described, 
the occurrence of the outbreak in Sohar in 2010 would appear to be a result of the 
transportation of diseased animals from the south to the north of Oman. 
Investigations on the role of B. melitensis Rev 1 associated abortions in Dhofar have not 
been investigated, and in this region livestock are widely vaccinated with Rev 1 as part 
of the control program. Isolation of B. melitensis Rev 1 from aborted fetuses and milk of 
small ruminants has been reported elsewhere (Blasco, 1997, Pishva and Salehi, 2008; 
Bardenstein et al, 2002; European Commission, 2001). In this study, none of the B. 
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melitensis isolates showed phenotypic characters similar to those of B. melitensis Rev 1 
and in this situation it would appear that the abortions were not associated with the 
vaccinal strain. In conclusion, B. melitensis biotype 1 was the only strain isolated from 
cases of brucellosis in Oman and it is likely that this strain is of importance in the 
country.  
Brucellosis is one of the most common zoonotic infections in the world (Ariza et al, 
2007; Dean et al, 2012) and is considered a reemerging disease in many parts of the 
world (WHO, 2006a; Russo et al, 2009). Nearly half a million new human cases of 
brucellosis are registered annually (Pappas et al, 2006). The disease is transmitted to 
humans through the consumption of raw milk, unpasteurized dairy products or through 
direct contact with infected animals, their tissues (primarily placentas) and aborted 
fetuses. In humans brucellosis causes debility, fever, sweating, fatigue, weight loss, 
headaches, and joint pain persisting for weeks to months. Neurological complications, 
endocarditis and multiple abscessation (testicular or bone) can also develop (Corbel, 
2006). In addition, brucellosis causes major economic losses through time lost by 
patients from normal daily activities (Corbel, 2006) and losses through reduced animal 
production (Roth et al, 2003). 
Oman has a high incidence of human brucellosis (Idris et al, 1993) along with other 
middle eastern countries including Saudi Arabia, Yemen, United Arab Emirates, 
Palestine, Syria, Jordan, Iran, Iraq, and Turkey (Refai, 2002). In the Middle East, 
Bahrain is the only country which has not reported the disease (Refai, 2002). The 
disease has had a significant impact on the Indian subcontinent where the disease is 
widespread with a range of prevalences reported (Vaishnavi and Kumar, 2007). Also 
significant proportions of humans seropositive for brucellosis were reported from India 
 202 
 
in samples of high risk individuals (veterinarians and para-veterinarians, shepherds, 
butchers and animal owners) (Agasthya et al, 2007; El Tahir et al, 2011). 
Brucellosis is an important and ongoing public health problem in the Sultanate, and 
nearly 95% of cases are seen in the southern region (Dhofar) where semi-nomadic 
Bedouins live in the mountainous region along with their animal flocks (cows, camels, 
goats). Early human serological investigations (Idris et al, 1993) indicated that nearly 
1% of healthy residents (especially children) of this region had been exposed to 
infection and samples for bacteriological culture invariably yielded B. melitensis 
(Scrimgeour et al, 1999). Subsequent investigations of human brucellosis have shown 
that the ingestion of raw milk, milk products (in 63% of cases) and direct contact with 
animals (in 87% of cases) were the major routes of infection in children (El-Amin et al, 
2001). 
Brucella spp., are intracellular pathogens, that survive within the scavenger cells 
(macrophages). Therefore, the treatment of brucellosis requires not only combined 
regimens of antibiotics but also use of antimicrobials that have the ability to attain 
optimum MICs within the macrophages and retain efficacy even in acidic environments 
(Pappas et al, 2005). The World Health Organization Expert Committee recommends 
oral combination of doxycycline and rifampicin for 6 weeks for brucellosis (WHO, 
2006). Alternatively, doxycycline-streptomycin and doxycycline-sulphamethoxazone-
trimethoprim (SXT) combinations are advised (Solera et al, 1997b; Pappas et al, 
2005b). However controlled clinical treatment trials using SXT, newer macrolides and 
beta-lactams have shown poor results (Falagas and Bliziotis, 2006). Treatment failures 
and relapses are major problems in the management of brucellosis (WHO, 2006) and 
are mostly related to pharmacokinetics and pharmacodynamics of antimicrobials rather 
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than resistance development. The high incidence of relapse, resistance to rifampin 
(especially in regions with endemic tuberculosis), toxic effects (oto-nephrotoxicity) of 
streptomycin, and the risk of emergence of resistant Brucella strains (Marianelli et al, 
2004; Pappas et al, 2005; Ariza et al, 2007) have led to the investigation of new 
therapeutic options for brucellosis (Mehmet et al, 2013). Only a few reports on in vitro 
antimicrobial susceptibilities of Brucella spp. using different methods, including broth 
microdilution (Rubinstein et al, 1991; Gur et al, 1999), agar dilution (Garcia-Rodriguez, 
et al, 1995; Yamazhan et al, 2005), and E-test (Gur et al, 1999; Bodur et al, 2003; 
Baykam et al, 2004) are available. The uses of Brucella agar (Rubinstein et al, 1991) 
and Mueller-Hinton agar supplemented with 5% sheep blood (Gur et al, 1999; Baykam 
et al, 2004) have been described for susceptibility testing. E-test is a simple, reliable, 
reproducible, and less laborious and time consuming method for antimicrobial 
susceptibility testing and has been reported for the testing of Brucella strains (Gur et al, 
1999; Baykam et al, 2004; Yamazhan et al, 2005). Non-significant differences in MICs 
of E-, broth and agar microdilution techniques have been reported (Gur et al, 1999) and 
these differences are believed to be due to different strains and methodologies used 
(Akova et al, 1999; Yamazhan et al, 2005). In view of the highly infectious nature of 
the pathogen, the E-test method was used to investigate in vitro susceptibilities of B. 
melitensis strains to 18 antimicrobials. 
In the present study a high level of resistance (MIC90≤ 8) was noted in ampicillin and its 
potentiated form (ampicillin-sulbactam), whereas MICs were markedly low for 
amoxicillin and amoxicillin-clavulanic acid (MIC90≤ 0.75 to 1). Among cephalosporins, 
a high level of resistance was observed against cefuroxime (MIC90≤ 16) and ceftazidime 
(MIC90≤ 24). Only 11 strains (39%) were sensitive to ceftriaxone and others were 
resistant at 6 μg/ml. These results are in agreement with those reported from Turkey, 
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where variable MICs (0.25 to 8 μg/ml) were found against 50 human isolates (Tanyel et 
al, 2007). In contrast Egyptian workers (Abdel-Maksoud et al, 2012) found probable 
resistance to ceftriaxone among 2% (7/355) of B. melitensis isolates. In the results of the 
current study there is evidence of development of resistance to penicillin antibiotics. 
These results preclude the use of ceftriaxone as a second line of therapy for brucellosis 
(Plenque et al, 1986). A variety of antimicrobials possess activity in vitro against B. 
melitensis, however results of routine susceptibility tests do not always correlate with 
clinical efficacy. Treatment of humans with brucellosis with beta-lactams (penicillins 
and cephalosporins) has been associated with a high rate of relapses (WHO, 2006).  
Except for norfloxacin and gamifloxacin, all quinolones tested in this study showed low 
MICs (0.064 to 0.75 μg/ml). Based on available MICs data against Brucella spp. 
(Garcia-Rodriguez et al, 1995; Trujillano-Martin et al, 1999; Tanyel et al, 2004; 
Turkmani et al, 2006; Abdul-Maksoud et al, 2012), optimum bioavailability, high tissue 
and intracellular concentrations (within the macrophages), quinolones are attractive 
therapeutic alternatives for the treatment of brucellosis in humans. Nevertheless, poor 
activity of quinolones in an acidic environment (Garcia-Rodriguez et al, 1991; Akova et 
al, 1999), would question the effectiveness of these antibiotics (Turkmani et al, 2006). 
Treatment trials with ciprofloxacin in humans (Lang et al, 1990, Doganay and Aygen, 
1992; López-Merino et al, 2004) and levofloxacin alone and in combination with 
rifampicin in mice (Arda et al, 2004) demonstrated the ineffectiveness of these 
antimicrobials. Moreover, the results of randomized clinical trials of brucellosis have 
discouraged the use of quinolone based combinations as a first line of therapy (Kalo et 
al, 1996). In contrast 45 days of an oral combination of doxycycline and ofloxacin has 
been shown to be as effective as a doxycycline-rifampicin combination (Saltoglu et al, 
2002). However, present data suggests that quinolones might play a role in combination 
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therapy, particularly where intolerance and resistance preclude the use of recommended 
combinations for brucellosis (Tanyel et al, 2007). 
Oral treatment regimens containing sulfas and trimethoprim are considered suitable 
lower cost combinations than traditional combinations. The SXT combination has 
mostly been prescribed for children and pregnant women with brucellosis (Young, 
1995). The present study revealed low MIC50 (0.064 μg/ml) and MIC90 (0.125 μg/ml) 
values for TS and this corresponds with the results of susceptibility reports of Brucella 
spp. from Turkey (Kilic et al, 2008 and Bayram et al, 2011). Since in vitro SXT 
resistance of Brucella spp. has been reported (Kinsara et al, 1999; Baykam et al, 2004), 
the selection of this combination for treatment of brucellosis should be based on 
susceptibility results.  
Isolation of Brucella is the gold standard diagnostic method for the diagnosis of 
brucellosis. However, this procedure is laborious and entails a considerable turnover 
time (~ 1 week). This also requires a biosafety level 3 laboratory and skilled technical 
personnel. Handling of live Brucella cultures involves high risk of laboratory-acquired 
infections, therefore, very strict biosafety rules must be observed. Molecular diagnostic 
methods (eg PCR) have considerably reduced this risk and are the most reliable tools in 
terms of sensitivity and specificity (Leyla et al, 2003). More than 400 scientific reports 
are available in the literature on the PCR-based diagnosis of brucellosis (Yu and 
Nielsen, 2010). 
Both blood and serum samples are often used in PCR-based diagnosis of brucellosis 
(Leal-Klevezas, 1995, Zarva 2001). However, inhibitors in body fluids frequently affect 
PCR results (Espy et al, 2006). Disappearance of hemoglobin substantially increases 
PCR sensitivity (Miller et al, 1988). Several commercial kits are capable of extracting 
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low amounts of relatively pure Brucella DNA from animal serum (Queipo-Ortuno et al, 
2008). The use of FTA cards for DNA extraction has been found to be accurate and 
reproducible (Pizzoli et al, 2007). These cards have been used for DNA extraction from 
body fluids (Yu and Nielsen, 2010). In the present study, gDNA was extracted using a 
commercially available kit and this yielded a good DNA concentration in the samples 
tested. 
Several types of primer pairs have been used to identify the genus Brucella. The primer 
sequences have been derived from different polymorphic regions of genomes of 
Brucella species and include sequences encoding BCSP 31(B4/B5) (Baily et al, 1992), 
16SrRNA(F4/R2) (Romero et al, 1995), 16s-23S 16S–23S intergenic transcribed 
spacers (ITS) (Bru ITS-S/Bru ITS-A) (Rijpens et al, 1996; Bricker et al, 2000), 16S-
23S rDNA interspace (ITS66/ITS279) (Keid et al, 2007), IS711 (IS313/IS639) (Hénault 
et al, 2000), per (bruc1/bruc5) (Bogdanovich et al, 2004), omp2 (JPF/JPR) (Leal-
Kleveza, 1995), outer membrane proteins (omp 2b,omp2a and omp31) (Imaoka et al, 
2007), proteins of the omp25/omp31 family of Brucella spp. (Vizcaino et al, 2004), and 
arbitrary primed PCR (AP-PCR) or randomly amplified polymorphic DNA (RAPD) 
PCR (Fekete et al, 1992). The diagnostic sensitivity and specificity of these sets of 
primers have been found to be inconsistent. Genus-specific PCR assays targeted at the 
Brucella BCSP31gene and 16S-23S rRNA operon are highly conserved in Brucella and 
are often used for screening of brucellosis in humans, animals and food samples (e.g., 
milk) (Bricker, 2002). Comparative analyses of three genus-specific PCR assays 
(bcsp31, omp2 and 16S rRNA gene sequences), revealed a poor diagnostic efficiency of 
16S rRNA on bovine blood samples, while bcsp31 was most sensitive and had similar 
sensitivity to omp2 PCR (Mukherjee et al, 2007). A combined use of these two primers 
(bcsp31 and omp2) significantly augmented the diagnostic sensitivity and specificity of 
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the assay. 
Recently a novel PCR assay for the rapid detection and differentiation of members of 
the Brucella genus and species has been developed (Hinić et al, 2009). For the rapid, 
sensitive and accurate detection of Brucella spp., the multiple insertion element IS711, 
which is stable in both number and position in the Brucella chromosomes, was a target. 
For species differentiation, unique genetic loci of B. melitensis have been identified and 
the BMEII0466 region has been chosen from the open reading frame for the 
construction of a primer set. This PCR assay is reported to be highly specific and 
suitable for both conventional and real time PCR formats (Yu and Nielsen, 2010). In the 
present study, a novel PCR was employed to identify Brucellae at the genus and species 
levels. These tests correctly identified the organisms both in blood and broth medium. 
These results verify the sensitivity and specificity of PCR primers. 
Although PCR tests have high sensitivity and specificity, serological assays are easier to 
use and more widely adopted in the field. In the following chapter a range of serological 
assays are compared. 
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CHAPTER SIX 
COMPARISON OF SEROLOGICAL TESTS 
6.1 Introduction  
Control programmes for brucellosis depend mainly on diagnosis of infection by 
serological tests (Nielsen et al, 2002). However serological tests may have issues with 
low specificity and sensitivity. A number of serological tests have been developed to 
detect brucellosis since the original agglutination test was described (Wright & Smith, 
1897). The Rose Bengal test (RBPT), buffered plate agglutination test, the complement 
fixation test (CFT), and enzyme linked immunosorbent assays (ELISA) have been used 
for screening both herds and individual animals for brucellosis (OIE, 2009). As none of 
these tests are suitable for all epidemiological situations (European Commission, 2001), 
a combination of bacteriological isolation, growth characteristics, serological methods 
and molecular techniques are critical to identify the bacterium (Nielson et al, 2002). 
Serological tests have been used widely to screen the humoral response in cattle with B. 
abortus infection however false positive and false negative reactions are of concern 
because the sensitivity and specificity of the tests are not 100%. Modifications have 
been made to the agglutination test in an attempt to increase its specificity (MacMillan, 
1990). The complement fixation test (CFT) was developed to supplement the 
agglutination tests in cattle (Hill, 1963). However, as the CFT is complex and 
expensive, it has been used mostly as a confirmatory test (OIE, 2009). Although it is 
widely assumed that the available serological tests for B. abortus infection in cattle are 
also adequate for diagnosing B. melitensis infection in small ruminants (European 
Commission, 2001), the tests have not been validated as opposed to B. abortus (Nielson 
et al, 2002). No serological tests have been developed specifically for B. melitensis and 
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accordingly the RBPT and the CFT are the most widely used tests for the serological 
diagnosis of brucellosis in sheep and goats (MacMillan, 1990). 
Subsequently indirect enzyme-linked immunosorbent assays (iELISA) were developed 
to enhance the diagnostic sensitivity and specificity. However the specificity can be 
affected by vaccinal antibodies, as well as antibodies induced by other microorganisms. 
In these conditions, only the Native Hapten (NH) gel precipitation test appears capable 
of differentiating immunity induced by natural infection from that arising from 
vaccination (Díaz et al, 1979; OIE, 2008).  
The competitive enzyme-linked immunosorbent assay (cELISA) was developed to 
overcome some of these disadvantages, however the test lacks specificity in vaccinated 
animals and those infected with Yersinia enterocolitica O:9 (Marín et al, 1999; Muñoz 
et al, 2005) and is costly to administer (Nielsen et al,1989; MacMillan et al, 1990; 
Nielsen et al, 1996). This led to the development of the fluorescence polarisation assay 
(FPA) for detection of antibody to B. abortus and B. suis (Nielsen et al, 1996; Nielsen et 
al, 1999). However, the test was reported to have lower accuracy compared to the 
ELISAs (Burriel et al, 2004). Recently the brucellosis immunochromatography assay 
(ICA), a simplified version of ELISA, has been developed and this is a convenient, 
rapid and suitable field test for animal brucellosis (Montasser et al, 2012). 
This study compared the results of a number of tests in diagnosing brucellosis (B. 
melitensis infection) in different animal species. 
6.2 Materials and Methods 
All samples which tested positive on the RBPT were further tested with a solid phase 
immunochromatography assay (ICA; Anigen B. abortus rapid test, Animal Genetics 
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Inc., Korea), an indirect ELISA (SVANOVIR
®
 Brucella-AB I-ELISA, Sweden) and a 
competitive ELISA (COMPLISA, Veterinary Laboratory Agency, UK). An interrater 
reliability analysis using the Kappa statistic was performed to determine the level of 
agreement between these tests.  
6.3 Results 
6.3.1 Comparison of different tests used for the diagnosis of brucellosis in cattle 
In total 78 cattle were found to be positive to the RBPT. These samples were further 
tested through a rapid test, indirect ELISA (iELISA), and a competitive ELISA 
(cELISA) (Table 6.1). Of these RBPT positive samples, 30.05% (n=25) and 80.77% 
(n=63) were positive on the ICA and iELISA, respectively. All 78 animals positive on 
the RBPT were also positive on the cELISA. Comparison of the Kappa statistic for the 
ICA and iELISA indicated a “poor” agreement (k = 0.034). No comparison was 
possible regarding the results of cELISA with all other tests as all RBPT positive 
animals tested positive to the cELISA (Table 6.2). 
Table 6.1 Results of different tests used for testing against brucellosis in cattle 
Sample 
No. 
Governorate  Vaccination 
status for 
brucellosis 
RBPT ICA iELIS
A 
cELISA 
1 Batinah Not vaccinated 2+ -ve +ve +ve 
2 Al Dakhiliyah Not vaccinated 1+ -ve +ve +ve 
3 Sharqiyah Not vaccinated 4+ +ve +ve +ve 
4 Muscat Not vaccinated 4+ +ve +ve +ve 
5 Dhofar Vaccinated 2+ +ve +ve +ve 
6 Dhofar Vaccinated 4+ +ve +ve +ve 
7 Dhofar Vaccinated 4+ +ve +ve +ve 
8 Dhofar Vaccinated 4+ +ve +ve +ve 
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Sample 
No. 
Governorate  Vaccination 
status for 
brucellosis 
RBPT ICA iELIS
A 
cELISA 
9 Dhofar Vaccinated 4+ +ve +ve +ve 
10 Dhofar Vaccinated 4+ +ve -ve +ve 
11 Dhofar Vaccinated 4+ +ve +ve +ve 
12 Dhofar Vaccinated 4+ +ve +ve +ve 
13 Dhofar Vaccinated 4+ +ve +ve +ve 
14 Dhofar Vaccinated 4+ +ve -ve +ve 
15 Dhofar Vaccinated 4+ -ve +ve +ve 
16 Dhofar Vaccinated 4+ -ve -ve +ve 
17 Dhofar Vaccinated 4+ -ve +ve +ve 
18 Dhofar Vaccinated 4+ -ve +ve +ve 
19 Dhofar Vaccinated 4+ -ve +ve +ve 
20 Dhofar Vaccinated 3+ -ve +ve +ve 
21 Dhofar Vaccinated 4+ -ve +ve +ve 
22 Dhofar Vaccinated 4+ -ve -ve +ve 
23 Dhofar Vaccinated 2+ -ve +ve +ve 
24 Dhofar Vaccinated 3+ -ve +ve +ve 
25 Dhofar Vaccinated 3+ -ve +ve +ve 
26 Dhofar Vaccinated 3+ -ve +ve +ve 
27 Dhofar Vaccinated 4+ -ve +ve +ve 
28 Dhofar Vaccinated 4+ -ve +ve +ve 
29 Dhofar Vaccinated 4+ -ve +ve +ve 
30 Dhofar Vaccinated 4+ -ve +ve +ve 
31 Dhofar Not vaccinated 4+ -ve +ve +ve 
32 Dhofar Vaccinated 4+ -ve +ve +ve 
33 Dhofar Vaccinated 4+ -ve +ve +ve 
34 Dhofar Vaccinated 4+ -ve +ve +ve 
35 Dhofar Vaccinated 2+ -ve -ve +ve 
36 Dhofar Vaccinated 4+ -ve +ve +ve 
37 Dhofar Vaccinated 4+ -ve +ve +ve 
38 Dhofar Vaccinated 4+ -ve +ve +ve 
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Sample 
No. 
Governorate  Vaccination 
status for 
brucellosis 
RBPT ICA iELIS
A 
cELISA 
39 Dhofar Vaccinated 4+ -ve +ve +ve 
40 Dhofar Vaccinated 4+ -ve +ve +ve 
41 Dhofar Vaccinated 4+ -ve +ve +ve 
42 Dhofar Vaccinated 3+ -ve +ve +ve 
43 Dhofar Vaccinated 4+ -ve +ve +ve 
44 Dhofar Vaccinated 4+ -ve -ve +ve 
45 Dhofar Vaccinated 4+ -ve +ve +ve 
46 Dhofar Vaccinated 4+ -ve +ve +ve 
47 Dhofar Vaccinated 4+ -ve +ve +ve 
48 Dhofar Vaccinated 4+ -ve +ve +ve 
49 Dhofar Vaccinated 3+ -ve +ve +ve 
50 Dhofar Vaccinated 4+ -ve +ve +ve 
51 Dhofar Vaccinated 4+ +ve +ve +ve 
52 Dhofar Vaccinated 4+ -ve +ve +ve 
53 Dhofar Vaccinated 3+ -ve +ve +ve 
54 Dhofar Vaccinated 3+ +ve +ve +ve 
55 Dhofar Vaccinated 4+ +ve +ve +ve 
56 Dhofar Vaccinated 4+ +ve -ve +ve 
57 Dhofar Vaccinated 4+ -ve -ve +ve 
58 Dhofar Vaccinated 4+ +ve +ve +ve 
59 Dhofar Vaccinated 3+ -ve -ve +ve 
60 Dhofar Vaccinated 4+ -ve -ve +ve 
61 Dhofar Not vaccinated 4+ +ve +ve +ve 
62 Dhofar Not vaccinated 4+ +ve +ve +ve 
63 Dhofar Vaccinated 4+ +ve +ve +ve 
64 Dhofar Vaccinated 3+ -ve +ve +ve 
65 Dhofar Vaccinated 3+ -ve +ve +ve 
66 Dhofar Vaccinated 3+ -ve -ve +ve 
67 Dhofar Vaccinated 4+ -ve -ve +ve 
68 Dhofar Vaccinated 4+ +ve +ve +ve 
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Sample 
No. 
Governorate  Vaccination 
status for 
brucellosis 
RBPT ICA iELIS
A 
cELISA 
69 Dhofar Vaccinated 2+ -ve +ve +ve 
70 Dhofar Vaccinated 3+ -ve +ve +ve 
71 Dhofar Vaccinated 3+ -ve -ve +ve 
72 Dhofar Vaccinated 2+ -ve -ve +ve 
73 Dhofar Vaccinated 2+ -ve +ve +ve 
74 Dhofar Vaccinated 4+ +ve -ve +ve 
75 Dhofar Vaccinated 4+ +ve +ve +ve 
76 Dhofar Vaccinated Trace -ve +ve +ve 
77 Dhofar Vaccinated 2+ +ve +ve +ve 
78 Dhofar Vaccinated 3+ +ve +ve +ve 
 
Table 6.2 Agreement between different Tests used in cattle found positive for 
brucellosis on the RBPT (n = 78) 
Comparison Observed 
Agreement 
95% CI of 
Agreement 
SE Kappa 
Value 
95% CI of 
Kappa 
ICA vs 
iELISA 
41.0% 30-52.7 0.066 0.034 -0.095, 0.163 
ICA vs 
cELISA 
- - - - - 
iELISA vs 
cELISA 
- - - - - 
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6.3.2 Comparison of different tests used for the diagnosis of brucellosis in sheep 
All sheep samples positive on the RBPT test (n = 29) were tested with the ICA, iELISA, 
and cELISA (Table 6.3). Of these 12 (41.38%), 14 (48.27%) and 12 (41.37%) were 
positive on the ICA, iELISA and cELISA, respectively. Agreement between the results 
of ICA, iELISA and cELISA results were substantial (k = 0.72 each) (Table 6.4). A 
higher “almost perfect” agreement was found between the iELISA and cELISA results 
(k = 0.86). 
Table 6.3 Results of different tests used for testing against brucellosis in sheep 
Sample 
No. 
Govt. 
Vaccination 
status for 
brucellosis 
RBPT ICA iELISA cELISA 
1 Batinah Not vaccinated 1+ -ve -ve -ve 
2 Batinah Not vaccinated 2+ -ve -ve -ve 
3 Batinah Not vaccinated 1+ +ve +ve +ve 
4 Batinah Not vaccinated 1+ -ve -ve -ve 
5 Batinah Not vaccinated 2+ -ve -ve -ve 
6 Al Dakhiliyah Not vaccinated 2+ -ve -ve -ve 
7 Al Dakhiliyah Not vaccinated 3+ +ve +ve +ve 
8 Al Dhahirah Not vaccinated 2+ -ve +ve +ve 
9 Dhofar Vaccinated 3+ -ve -ve -ve 
10 Dhofar Vaccinated 4+ +ve +ve +ve 
11 Dhofar Vaccinated 4+ -ve -ve -ve 
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Sample 
No. 
Govt. 
Vaccination 
status for 
brucellosis 
RBPT ICA iELISA cELISA 
12 Dhofar Vaccinated 4+ +ve +ve -ve 
13 Dhofar Vaccinated 3+ +ve +ve +ve 
14 Dhofar Vaccinated 4+ +ve +ve +ve 
15 Dhofar Vaccinated 3+ -ve -ve -ve 
16 Dhofar Vaccinated 4+ -ve -ve -ve 
17 Dhofar Vaccinated 3+ -ve -ve -ve 
18 Dhofar Vaccinated 4+ +ve +ve +ve 
19 Dhofar Vaccinated 3+ -ve -ve -ve 
20 Dhofar Vaccinated 3+ +ve -ve -ve 
21 Dhofar Vaccinated 4+ -ve +ve -ve 
22 Dhofar Vaccinated 3+ +ve +ve +ve 
23 Dhofar Vaccinated 4+ +ve +ve +ve 
24 Dhofar Vaccinated 2+ -ve -ve -ve 
25 Dhofar Vaccinated 1+ -ve -ve -ve 
26 Dhofar Vaccinated 3+ +ve +ve +ve 
27 Dhofar Vaccinated 3+ +ve +ve +ve 
28 Dhofar Vaccinated 1+ -ve +ve +ve 
29 Dhofar Vaccinated 3+ -ve -ve -ve 
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Table 6.4 Comparison of different tests used for the diagnosis of brucellosis in 
sheep (n=29) positive to the RBPT 
Comparison Observed 
Agreement 
(%) 
95% CI of 
Agreement 
SE Kappa 
Value 
95% CI of 
Kappa 
ICA vs 
iELISA 
86.2 68.3-96.1 0.12
8 
0.722 0.472, 0.973 
ICA vs 
cELISA 
86.2 68.3-96.1 0.13
2 
0.716 0.457, 0.974 
iELISA vs 
cELISA 
93.1 77.2-99.2 0.09
4 
0.861 0.677, 1.045 
 
6.3.3 Comparison of different Tests used for the diagnosis of brucellosis in goats 
In total 57 goat sera were positive on the RBPT and these sera were tested with the ICA, 
iELISA and cELISA (Table 6.5). Of the 57 sera 57.89% (n=33), 43.86% (n=25) and 
35.09% (n=20) were positive on the iELISA, cELISA and ICA, respectively. 
Agreement between the rapid test, and the iELISA and cELISA was “fair” (k = 0.29 and 
0.38, respectively). Agreement between the iELISA and cELISA was “substantial” (k = 
0.65) (Table 6.6). 
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Table 6.5 Results of different tests used for testing against brucellosis in goats 
Sample 
No. 
Vaccination status for 
brucellosis 
RBPT* ICA iELISA cELISA 
1 Not vaccinated 1+ -ve -ve -ve 
2 Not vaccinated 4+ +ve +ve +ve 
3 Not vaccinated 2+ -ve -ve -ve 
4 Not vaccinated 3+ +ve +ve +ve 
5 Not vaccinated 4+ +ve +ve +ve 
6 Not vaccinated 4+ +ve +ve +ve 
7 Not vaccinated 2+ +ve +ve +ve 
8 Not vaccinated 1+ +ve +ve +ve 
9 Not vaccinated 2+ +ve +ve +ve 
10 Not vaccinated 4+ +ve +ve +ve 
11 Vaccinated 2+ +ve -ve -ve 
12 Vaccinated T -ve -ve -ve 
13 Not vaccinated 3+ -ve -ve -ve 
14 Not vaccinated 3+ -ve -ve -ve 
15 Not vaccinated 2+ -ve +ve +ve 
16 Vaccinated T -ve -ve -ve 
17 Vaccinated 4+ -ve +ve -ve 
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Sample 
No. 
Vaccination status for 
brucellosis 
RBPT* ICA iELISA cELISA 
18 Vaccinated 4+ +ve +ve +ve 
19 Vaccinated T+ -ve +ve -ve 
20 Vaccinated 2+ -ve +ve +ve 
21 Vaccinated 4+ +ve -ve -ve 
22 Vaccinated 1+ -ve +ve +ve 
23 Not vaccinated 2+ -ve -ve -ve 
24 Vaccinated 1+ -ve -ve -ve 
25 Not vaccinated 4+ -ve +ve -ve 
26 Not vaccinated 3+ -ve -ve -ve 
27 Not vaccinated 4+ -ve +ve +ve 
28 Vaccinated 4+ +ve +ve +ve 
29 Vaccinated 4+ -ve +ve +ve 
30 Not vaccinated 4+ +ve +ve +ve 
31 Not vaccinated 3+ -ve +ve +ve 
32 Vaccinated 4+ +ve +ve +ve 
33 Vaccinated 4+ -ve +ve -ve 
34 Vaccinated 4+ +ve +ve +ve 
35 Vaccinated 3+ -ve -ve -ve 
36 Vaccinated 4+ +ve -ve -ve 
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Sample 
No. 
Vaccination status for 
brucellosis 
RBPT* ICA iELISA cELISA 
37 Vaccinated 3+ -ve -ve -ve 
38 Vaccinated 2+ -ve -ve -ve 
39 Vaccinated 3+ -ve -ve -ve 
40 Vaccinated 3+ -ve +ve +ve 
41 Vaccinated 2+ -ve +ve +ve 
42 Vaccinated 4+ -ve -ve -ve 
43 Not vaccinated 4+ -ve +ve +ve 
44 Vaccinated 4+ -ve +ve -ve 
45 Vaccinated 2+ -ve +ve -ve 
46 Vaccinated 4+ +ve +ve -ve 
47 Vaccinated 4+ +ve -ve -ve 
48 Not vaccinated 4+ +ve +ve +ve 
49 Not vaccinated 4+ -ve +ve +ve 
50 Vaccinated 4+ -ve -ve -ve 
51 Vaccinated 4+ -ve -ve +ve 
52 Vaccinated 4+ -ve -ve -ve 
53 Vaccinated 1+ -ve +ve -ve 
54 Vaccinated 2+ +ve +ve -ve 
55 Vaccinated 4+ -ve -ve -ve 
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Sample 
No. 
Vaccination status for 
brucellosis 
RBPT* ICA iELISA cELISA 
56 Vaccinated 1+ -ve -ve -ve 
57 Not vaccinated 2+ -ve -ve -ve 
* Trace 
 
 
Table 6.6 Comparison of different tests used in goats (n=57) found positive for 
brucellosis after RBPT 
Comparison Observed 
Agreement 
95% CI of 
Agreement 
SE 
Kappa 
Value 
95% CI of Kappa 
ICA vs iELISA 63.2% 49.3-75.6 0.111 0.296 0.078, 0.515 
ICA vs cELISA 70.2% 56.6-81.6 0.123 0.381 0.141, 0.621 
iELISA vs 
cELISA 
82.5% 70.1-91.3 0.095 0.656 0.469, 0.842 
 
6.3.4 Comparison of different tests used for the diagnosis of brucellosis in camels 
Of the 2055 camel sera tested only 10 were found to be positive on the RBPT. All 
positive sera were tested with ICA rapid test and cELISA (Table 6.7). Upon further 
testing, only 40% (n=4/10) of samples were positive on the ICA. However, 90% of the 
RBPT positive samples were positive on the cELISA. A poor agreement was found 
between ICA and the cELISA results (k = 0.138) (Table 6.8). Due to the unsuitability of 
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the iELISA for camels, this test was not compared with the other assays (ICA and 
cELISA). 
 
 
Table 6.7 Results of different tests used for testing against brucellosis in goats 
Sample No. Governorate 
Vaccination status 
for brucellosis 
RBPT ICA cELISA 
1 Batinah Not vaccinated 4+ +ve +ve 
2 Al Sharqiyah Not vaccinated 2+ -ve +ve 
3 Dhofar Not vaccinated 3+ +ve +ve 
4 Dhofar Not vaccinated 4+ -ve +ve 
5 Dhofar Not vaccinated 4+ +ve +ve 
6 Dhofar Not vaccinated 4+ +ve +ve 
7 Dhofar Not vaccinated 3+ -ve +ve 
8 Dhofar Not vaccinated 4+ -ve +ve 
9 Dhofar Not vaccinated 1+ -ve -ve 
10 Dhofar Not vaccinated 3+ -ve +ve 
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Table 6.8 Comparison of Different Tests used in camels (n=10) found positive for 
brucellosis after RBPT 
Comparison Observed 
Agreement 
95% CI of 
Agreement 
SE Kappa 
Value 
95% CI of Kappa 
ICA vs 
cELISA 
50% 18.7-81.3 0.138 0.138 -0.133, 0.409 
 
6.4 Discussion  
A diagnostic test for an infectious disease can be used to demonstrate the presence or 
absence of a causative agent, or to detect antibodies to a particular infectious agent. 
Demonstrating the presence of the infecting organism or a surrogate marker of infection 
is often crucial for effective clinical management and for selecting other appropriate 
disease control activities such as contact tracing. The diagnostic test(s) must be 
accurate, user friendly, simple and affordable for the population for which they are 
intended. They must also provide a timely result for allowing implementation of 
effective control measures to avoid the spread of disease. For some infections, early 
diagnosis and treatment can have an important role in preventing the development of 
long-term complications or in interrupting transmission of the infectious agent. In a 
broader context, diagnostic tests help in patient management, screening latent 
infections, disease surveillance, epidemiological investigations, evaluating the 
effectiveness of interventions including verification of elimination and detecting 
infections with markers of drug resistance (Banoo et al, 2008). 
The usefulness of a diagnostic test depends on the sensitivity, specificity and predictive 
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values and field applicability of the test (Naureen et al, 2007). Determining the 
diagnostic efficiency of the test(s) in absence of a gold standard is, however, common, 
although not ideal. New tests that are compared with imperfect gold standards will have 
bias in the error rates of the new test as a result of the lack of a perfect comparative gold 
standard (Staquent et al, 1981; Valenstein 1991). This is especially true for the tests 
with a higher detection limit than the gold standard. Therefore, evaluation methods for 
diagnostic tests using maximum likelihood techniques with a latent class model have 
been described and refined (Enoe et al, 2000; Pouillot et al, 2002). The agreement 
between two tests has also been suggested as an evaluation criterion for a diagnostic test 
(Martin, 1977). The kappa measures the magnitude of agreement between 2 tests and 
ranges from -1 to 1, where 1 is perfect agreement, 0 is exactly what would be expected 
by chance and -1 is perfect disagreement (Landis and Koch, 1977; Viera and Garret, 
2005). If the kappa value of two tests is high, then any of the tests might be selected for 
a testing program because the results of both tests provide the same information 
(Martin, 1977). Kappa values are lower in a low prevalence population and higher in a 
higher prevalence population. In the disease-free population, agreement is difficult to 
calculate as little to no variation often occurs in the distribution of results. Different 
kappa values for different populations are expected, hence, before using and interpreting 
diagnostic tests, the population of interest must be characterized (Greiner and Gardner, 
2000). In the present study, agreements among all combinations of different tests for 
different animal species (cattle, sheep and goat) except camels were calculated. A very 
good agreement (k = 0.86) was observed when the two different format of ELISAs for 
sheep were compared, while ICA and ELISAs indicated a high level of agreement (0.71 
to 0.72) for sheep flocks. Substantial agreement (k=0.65) was also noted between 
ELISAs upon testing goats and a fair agreement (0.29 to 0.38) was estimated between 
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the ICA and ELISAS in this population. For cattle and camels, the agreement between 
ICA and cELISA was poor to slight. These results indicate that the ICA carries poor 
diagnostic efficiency for cattle and camels and seems unsuitable for testing of 
brucellosis in the field. 
As mentioned previously brucellosis is an important zoonotic disease and in the 
following chapter an investigation into brucellosis in humans in Oman is reported. 
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CHAPTER SEVEN 
A RETROSPECTIVE STUDY OF BRUCELLOSIS IN HUMANS IN OMAN 
7.1 Introduction  
Brucellosis in humans is widely distributed all over the world, with regions of high 
endemicity in areas of the Mediterranean, Middle East, Latin America and parts of Asia 
(López-Merino, 1989; Corbel, 1997a&b). The World Health Organization (WHO) 
biosafety manual classifies B. melitensis in Risk group III highlighting the importance 
and impact of this pathogen. Brucellosis is readily transmissible to humans and causes 
undulant fever which may progress to a chronic form (WHO, 2006b). Several 
complications have been reported in patients with brucellosis including musculo–
skeletal, cardiovascular and central nervous system problems (European Commission, 
2001). There is a significant occupational association of brucellosis in humans with 
veterinarians, abattoir workers, laboratory technicians and farmers who handle infected 
aborted fetuses and membranes of infected animals being at greater risk of contracting 
the infection (Corbel et al, 2006; Stack and MacMillan, 2006). The main route of 
infection is orally through ingestion of infected dairy products, alternatively the 
pathogen can also enter via inhalation or conjunctival routes. 
Although the true incidence of brucellosis in humans throughout the world is not known 
( European Commission, 2001), it has been reported to vary widely from < 0.01 to > 
200 per 100,000 population per year in individual countries (López-Merino, 1989). In 
2008, a total of 619 confirmed human brucellosis cases were reported in the European 
Union (EU) (0.1 cases per 100,000 inhabitants). The highest incidence was recorded in 
those member states not officially free from bovine and ovine/caprine brucellosis 
(Greece, Italy, Portugal and Spain). Although overall the incidence in the EU decreased 
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between 2004 and 2008, cases were reported more frequently in spring and summer 
(European Food Safety Agency, 2010b). 
Childhood brucellosis (B. melitensis) in the USA is an imported disease, primarily from 
Mexico. A retrospective study of 20 patients over a period of 13 years reported that 
95% had either travelled to Mexico or consumed unpasteurized milk products from 
Mexico. Fever was an initial complaint in 80% of the patients and 50% of the patients 
presented with arthritis (Shen, 2008). 
Studies conducted in North Africa and in the Middle-East reported that brucellosis in 
humans was attributed to the presence of B. melitensis in livestock ( Al-Ani et al, 2004; 
Jennings et al, 2007) whilst in sub-Saharan African B. abortus was mainly implicated 
(Hendricks et al, 1995; Swai and Schoonman., 2009). Human brucellosis is often 
misdiagnosed in developing countries resulting in underreporting (Paul et al, 1995). A 
study in Tanzania showed that medical professionals, especially those in rural areas had 
poor knowledge of zoonotic diseases (John et al, 2008). In areas where B. abortus is a 
major problem in cattle, seroprevalence levels in humans are estimated to be in the 
range of 1–5% (Schelling et al, 2003; Swai and Schoonman, 2009). In contrast in areas 
where B. melitensis is endemic higher prevalence rates are expected in humans (Pappas 
et al, 2006).  
Although Brucella can be transmitted directly and indirectly from its animal reservoir to 
humans, indirect transmission remains the highest overall risk and mainly occurs 
through the consumption of unpasteurized milk or dairy products (Godfroid et al, 2005; 
Pappas et al, 2006; Makita et al, 2008). Brucella melitensis infection in cattle has 
emerged as a serious public health problem since B. melitensis is capable of colonizing 
the bovine udder (Banai, 2002; Ashford et al, 2004; Lamontagne et al, 2010). 
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Moreover, in some South American countries, cattle are now believed to be more 
important than pigs as a source of B. suis biovar 1 infection for humans, because B. suis 
biovar 1 is also capable of colonizing the bovine udder (Corbel, 1997). The incubation 
period of the disease in humans varies greatly (Nicoletti, 1980), ranging from weeks to 
months (Ray and Steel, 1979) and often has an insidious onset. The acute stage of the 
disease is usually accompanied by bacteremia and spreading of the organism to various 
organ systems, mainly to reticuloendothelial tissues. Hence, brucellosis in humans is a 
systemic infectious disease resulting in varying clinical manifestations (Corbel, 2006). 
Acute brucellosis is characterized by nonspecific systemic signs and clinical symptoms 
consistent with a flu-like or septicemic illness. Clinical manifestations may comprise 
osteoarticular, dermal, gastrointestinal, respiratory, cardiovascular and neurologic 
disorders mimicking many other infectious and non-infectious diseases (Corbel, 2006).  
Few cases of brucellosis in humans caused by B. canis have been described (Lucero et 
al, 2010; Nomura et al, 2010). However, canine brucellosis in humans might be 
underdiagnosed due to low awareness of the disease and a lack of valid serological tests. 
Human infections by marine mammal strains have a severe course but have rarely been 
reported (Brew et al, 1999; Sohn et al, 2003; McDonald et al, 2006). The clinical 
importance of B. inopinata and the atypical Brucella strain (BO2) closely related to B. 
inopinata is still unclear despite the fact that both agents have been isolated from 
diseased humans (De et al, 2008; Scholz et al, 2010). Little is also known about the 
human pathogenicity of B. microti, although in experimental cellular and murine models 
of infection B. microti exhibited a significantly higher virulence than other Brucella 
species (De Bagues et al, 2010). 
In Oman, the disease was reported in animals in 1979 in the southern region (Nicoletti, 
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1986). Subsequently, the disease has affected both animals and humans. A higher 
number of human cases was reported in 1998 when more than 300 cases were recorded 
(MOH, 1998). During the period from 1998 until 2002 many human cases (307, 316, 
307, 162 and 133 cases, respectively) were reported in both the southern and northern 
regions of the Sultanate (MOH, 2002). The highest incidence was reported in the 
southern region with 305, 309, 302, 159 and 127 cases reported each year, respectively. 
The study reported in this chapter was designed to highlight the incidence and pattern of 
human brucellosis in Oman through examination of records and data available from the 
Ministry of Health for the period from 1995 to 2012. 
7.2 Materials and Methods 
This study primarily examined data sourced from different hospitals in Oman through 
the Department of Surveillance and Disease Control. The forms used to collect the 
information included data on the region of origin, age, gender and nationality of the 
patient and the year of the case.  
7.3 Results 
The status of brucellosis in Oman before 1984 was unknown (Idris et al, 1993). The 
study conducted by Ismaily et al, (1988) reported the first laboratory-confirmed case of 
brucellosis in animals and the prevalence varied between (0 and 1.6%) in the northern 
region and (3.3-8%) in the Southern region. Since 1985 until 1992, several human cases 
were also identified by the Serum Agglutination Test (SAT) with most of these cases 
(96.5%) being located in the Southern region (Figure 7.1). The number of human cases 
increased over the study period, especially in the southern region city of Salalah (Table 
7.1). 
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Table 7.1 Cases of human brucellosis (1985-1992) as reported by the Department 
of Surveillance and Disease Control, Ministry of Health, Oman 
Year 
Total number of 
cases in Oman 
Total number of 
cases from the 
Southern Region 
Percentage of all 
cases from the 
Southern Region 
1985 260 219 84.2 
1986 186 180 96.8 
1987 229 224 97.8 
1988 292 284 97.3 
1989 224 220 98.2 
1990 183 180 98.4 
1991 350 347 99.1 
1992 371 368 99.2 
Total 2095 2022 96.5 
 
The symptoms of the disease mainly presented as the typical undulant fever, 
musculoskeletal malaise, headache, fatigue and weakness. However two other 
prominent features were also reported: severe night sweats and the feeling of tiredness 
in the afternoon (Idris et al, 1993). 
In 1995 the 2-Mercapto-ethanol test was introduced to diagnose disease and the 
reported incidence has fluctuated since then making the interpretation of results more 
difficult. Data on the reported incidence between 1995 and 2012 in Oman are presented 
in Table 7.2 and Figure 7.2. 
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Table 7.2 Number of cases of human brucellosis reported in different governorates of Oman, 1995 -2012 
Governorate 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Total 
Batinah 0 2 1 1 3 0 1 0 1 1 0 2 5 0 3 0 1 4 25 
Al Buraimi 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0 1 4 
Al Dakhiliyah 0 1 2 0 2 0 0 1 0 1 0 1 0 1 0 2 0 0 11 
Al Dhahirah 1 1 1 0 0 2 0 0 0 1 1 0 1 0 0 0 0 0 8 
Al Sharqiyah 0 1 0 0 0 0 1 1 1 3 1 1 0 1 1 1 1 1 14 
Alwusta 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 2 4 
Dhofar 112 69 196 305 309 303 159 128 193 97 114 66 81 90 75 89 105 139 2630 
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Governorate 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Total 
Musandam 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 
Muscat 0 0 3 1 2 2 1 3 3 4 0 0 1 1 0 0 0 0 21 
Total 113 74 203 307 316 308 162 134 198 107 116 71 89 94 79 93 107 147 2718 
Incidence in Dhofar 99.1 93.2 96.6 99.3 97.8 98.4 98.1 95.5 97.5 90.7 98.3 93.0 91.0 95.7 94.9 95.7 98.1 94.6 96.8 
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In 1991, the disease monitoring programme was initiated in the sultanate by the 
Ministry of Health and all data were collected from hospitals by the Department of 
Surveillance and Disease Control. Although cases were reported in most of the 
governorates, the southern region (Dhofar) had the majority of cases (96.8%) (Table 
7.3).  
Over the period 1995 to 2012 the annual incidence of human brucellosis in Oman was 
9.79/10000 (). As expected, a highest incidence was recorded in the Dhofar governorate 
(104.23/10000) compared with 0.35/10000 per year in the other governorates. More 
than 300 cases per annum were observed for three consecutive years (1998-2000) 
although subsequent to this period the number of cases has reduced (Figure 7.1).  
In Figure 7.2 the change in the annual incidence from 1995 to 2012 is presented. At the 
start of the period of study (1995) the overall annual incidence was 0.51/10000. This 
then started increasing from 1996 (0.33/10000) and for the 4 consecutive years (1997-
2000) remained elevated (0.90 to 1.40/10000). Subsequently it started decreasing for the 
next two years (2001 to 2002) but an increase of 45.7% was observed in 2003. From 
2004 until 2012, the annual incidence of human brucellosis fluctuated between 0.51 to 
0.29 per 10,000 people.  
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Figure 7.1 The number of cases of human brucellosis reported in different 
governorates (1995-2012)  
 
 
 
Figure 7.2 Yearly Incidence/10000 of human brucellosis in Oman (1995-2012)  
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Table 7.3 Incidence of human brucellosis in Oman (1995-2012) 
Governorate Brucella Positive 
Population 
(Census, 2010) 
Incidence per 
10000 people 
Al Wusta 4 42111 0.95 
Al Sharqiyah 14 350514 0.40 
Batinah 25 772590 0.32 
 Al Buraimi 4 72917 0.55 
Al Dhahirah 8 151664 0.53 
Al Dakhiliyah 11 326651 0.34 
Musandam 1 31425 0.32 
Muscat 21 775878 0.27 
Dhofar 2630 249729 104.23 
Total 2718 2773479 9.79 
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The overall annual incidence of human brucellosis per 10000 people was recorded as 
6.31 and 6.03 in female and males, respectively between 1995 and 2012. In total 733 
(43%) females and 972 (57%) males were recorded with brucellosis in Oman. The risk 
of having brucellosis was similar for males and females (1.05; 95%CI 0.95, 1.15). The 
highest annual incidence was recorded in females (70.9/10000) and males (62.1/10000) 
residing in the Dhofar governorate (Table 7.4).  
The overall incidence of brucellosis was recorded as 8.3/10000 and 1.08/10000 in the 
native Omani and expatriate population, respectively (Table 7.5) (OR 7.66; 95%CI 
6.18, 9.50). The highest incidence for both the local (94.8/10000) and expatriate 
(9.81/10000) population was again recorded in the Dhofar governorate. 
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Table 7.4 Influence of gender on the incidence of human brucellosis in Oman 
(1995-2012) 
Region 
Female Male 
Cases Population 
Annual 
incidence 
per 10,000 
population 
Cases Population 
Annual 
incidence 
per 10,000 
population 
Al wusta 3 10117 2.97 1 31994 0.31 
Al Sharqiyah 4 160715 0.25 9 189799 0.47 
Batinah 11 338557 0.32 7 434033 0.16 
Al Buraimi 2 29713 0.67 2 43204 0.46 
Al Dhahirah 1 64220 0.16 4 87444 0.46 
Dakhilyah 2 144696 0.14 4 181955 0.22 
Dhofar 705 99358 70.96 934 150371 62.11 
Musandam 1 12960 0.77 0 18465 0.00 
Muscat 4 300732 0.13 11 475146 0.23 
Total 733 1161068 6.31 972 1612411 6.03 
.  
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Table 7.5 Incidence of human brucellosis reported in the Omani and expatriate 
population of Oman (2000-2012) 
Governorate Omani Nationals Expatriates 
No. 
Pos. 
Population Incidence 
x 10
-6 
No. 
Positive 
Population Incidence 
x 10
-6
 
Batinah 17 620950 0.27 1 151640 0.07 
Al Buraimi 4 43026 0.93 0 29891 0.00 
Al Dakhiliyah 4 269069 0.15 2 57582 0.35 
Al Dhahirah 5 118877 0.42 0 32787 0.00 
Al Sharqiyah 12 293394 0.41 1 57120 0.18 
Al Wusta 4 19043 2.10 0 23068 0.00 
Dhofar 1555 164073 94.77 84 85656 9.81 
Musandam 1 21898 0.46 0 9527 0.00 
Muscat 15 407006 0.37 0 368872 0.00 
Total 1617 1957336 8.26 88 816143 1.08 
 
Of 1705 human cases of brucellosis recorded from 2000 to 2012, 94.8% (1617) were 
Omanis, followed by expatriates from Bangladesh (1.8%), India (1.1%), Egypt (0.7%), 
Pakistan (0.5%), Yemen (0.4%), Saudi Arabia (0.3%), Sudan (0.1%) and Jordan (0.1%). 
The nationality of 0.3% of patients was not recorded (Figure 7.3). 
When analysed for age more cases (n=771, 45.2%) were observed in the youngest age 
group (0-10 years) followed by patients in the 11 to 20 year age group (23.9%). This 
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value further decreased with age and the lowest percentage was recorded in patients 
above 60 years of age (Figure 7.4). 
 
Figure 7.3 Number of cases of human brucellosis in different nationalities in Oman 
(2000-2012). 
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Figure 7.4 Percentage of human brucellosis cases found in different age groups in 
Oman (2000-2012). 
 
 
7.4 Discussion 
The number of cases of brucellosis in humans varies between Middle Eastern countries. 
Several countries have reported the occurrence of the disease since the 1980s, including 
Egypt, Ethiopia, Iraq, Iran and Jordan (Refai, 2002). The disease has also been reported 
in Gulf countries, with reports of the disease in Kuwait in 1983, Saudi Arabia in 1985 
and UAE in 1996 (Refai, 2002). In Oman, brucellosis is considered the second most 
important zoonotic disease after rabies (Personal Communication, Director of Animal 
Health). Diagnosis of the disease in Oman depends primarily on serological tests (Idris 
et al, 1993). The only biotype isolated from both humans and animals has been B. 
melitensis biovar 1 (Ismaily et al, 1988; Idris et al, 1993; Adam and El-Rashied, 2013). 
Not surprisingly most human cases have been reported among farmers and their 
families and also in veterinarians as these groups are at greater risk of exposure to the 
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pathogen through their daily activities (Refai, 2002). Unfortunately in the current study 
there were no available data recorded on the occupation of the affected individuals. In 
this study the high number of cases reported in Dhofar was also expected as the disease 
is mainly transmitted from animals (Kozukeev et al, 2006). As reported in Chapter 4 the 
highest seroprevalence of livestock brucellosis in Oman was in Dhofar and 
consequently the risk of transmission would be expected to be higher in this governorate 
than in others.  
The habit of consuming raw milk in Dhofar has played an important role in the 
dissemination of infection to humans (Idris et al, 1993). The fluctuation and big 
variation in reported cases between 1995 and 2012 does not necessarily indicate that the 
disease is being successfully controlled in the animal population in Dhofar, but may be 
artificial through changes in the diagnostic tools used (the 2-Mercapto-ethanol test was 
introduced in 1995). As the control program in animals was started in 2003 and has 
continued since then, it is not clear why the incidence has again increased in 2011 and 
2012. This may be due to the shedding of the vaccine strain through milk (Longo et al, 
2009) which, if so, will complicate the issue in Dhofar. However the data could also be 
biased and be influenced by a large number of uncontrolled factors which may have 
elevated disease reporting in recent years. However the cases discussed in this chapter 
were those presented to hospitals and are consequently likely to under-represent the real 
situation in Oman as many cases may go undiagnosed. 
Brucellosis was previously believed to be very rare in children, however it is now well 
accepted that people of all ages can be affected (Mehmet and Bilgehan, 2003). The 
higher number of cases in younger ages (0-10 years) could be related to the 
consumption of more raw milk at this age, although congenital infection has also been 
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reported (Corbel et al, 2006; Mesner et al, 2007). The chances of contact between 
children and animals or their secretions may also be possible due to the inquisitive 
nature of children. Similar findings were also reported by Idris et al, (1993) where 4 out 
of 525 school children were positive for the disease. Furthermore, an observational 
study undertaken in the Dhofar hospital for 3 years revealed that 63% of cases in 
children were due to consumption of raw milk and 83% of cases had contact with live 
animals (El-Amin et al, 2001). 
The higher incidence in males than females may be due to an increased likelihood of 
males having contact with animals and their excretions than females. In Oman men 
usually take care of animal feeding, watering, disposal of foetal membranes and 
grazing. In contrast women are mainly involved in manual milking after washing the 
udder with water and disinfectant, which may decrease the chances of contact with the 
bacterium. Furthermore females may be more careful to prevent unnecessary contact 
with animal discharges, unlike men who often have less strict personal hygienic 
standards as reported by Blackmore and Schollum (1982). 
The higher incidence among Omani’s is not surprising for a number of reasons. Firstly 
they own most of the animal farms and consequently having more chances to have 
contact with potentially infected animals. Secondly they follow traditional habits which 
include drinking raw milk which has been associated with many cases of disease. The 
relative high number of Bangladeshi’s affected may be due to their preference to work 
as farmers or farm labourers compared with other nationalities. However, the biggest 
population working on farms in Oman, after Omani’s, are the Bangladeshi’s and again 
this would explain the large number of cases in this group. 
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There was a significant correlation (Pearson’s correlation=0.925, p<0.001) between 
human and animal brucellosis in the different governorates of Oman. This study has 
demonstrated that brucellosis is a common disease in humans in Oman with the disease 
being more common in regions with high levels of brucellosis in animals. It is likely 
that implementation of a control program in animals would result in a commensurate 
decrease in brucellosis in humans. 
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CHAPTER EIGHT 
GENERAL DISCUSSION 
Brucella melitensis, the first species in the genus Brucella to be described, causes 
abortions in pregnant animals and Malta fever in humans (Alton, 1990a). The organism 
is prevalent in Mediterranean and Middle Eastern countries, through Central Asia to 
China and the southern areas of the former Soviet Union. Some areas of Africa and 
India, as well as Central and South America, are also affected (Corbel et al, 2006). 
Although the natural hosts for the organism are goats and sheep, it is considered to be 
the least species-specific organism of the Brucellae (Alton, 1990a). In Europe, small 
ruminants and their products have been reported to be the main source of infection of 
humans with B. melitensis (Díaz-Aparicio, 2013). However, other animal species have 
emerged as important carriers of the pathogen in several countries, such as cattle in 
Israel, Kuwait, and Saudi Arabia and camels in the gulf countries of Oman and UAE 
(Hashim et al, 1987; Abbas and Agab 2002; Al-Majali et al, 2009). 
During 1979, the first case of the disease in animals was reported by the Ministry of 
Agriculture and Fisheries in goats from the southern region (Dhofar) of Oman and 
subsequently human cases were reported in the same region. The consumption of 
contaminated raw milk was believed to be the source of human infection (Ismaily et al, 
1988). In contrast to the southern region, only sporadic cases have been reported from 
the northern region which was previously considered to be a free area. However, a study 
undertaken by Alrawahi et al. in 2006 (MAF, 2006) reported several cases from the 
northern region of Oman. Moreover, the number of human cases has also increased in 
the northern region, strengthening the demand for implementation of a control program 
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in this region. 
In 2003, a national program to control brucellosis in the southern region of Oman was 
approved by the government. This 12 year program was divided into four phases each 
of 3 years. The first phase concentrated on vaccination of cattle and small ruminants 
using the Rev-1 vaccine. However, the programme was not designed based on accurate 
and essential information regarding the prevalence and risk factors for the disease and 
did not take into consideration the situation of the disease in other regions.  
The specific aims of the study outlined in this thesis were to: 
1- Map the distribution of disease in Oman using geographical information systems 
(GIS). 
2- Determine the seroprevalence of brucellosis in Oman. 
3- Establish the species and types of Brucella present in Oman and their genetic 
relationship. 
4- Determine the susceptibility of Brucella to the currently available antibiotics. 
5- Evaluate different diagnostic tests for the diagnosis of brucellosis in Oman. 
6- Highlight the disease situation in humans through an examination of historical 
hospital data 
This study documented the overall herd/flock seroprevalence of brucellosis in animal 
holdings as 2.4% (95% CI 1.6, 3.4) with 30 infected holdings of 1267 holdings tested. 
As expected, the southern governorate (Dhofar) had significantly more seropositive 
flocks (n= 20, 8.6%) than the northern governorates (n= 10, 0.97%), χ2 (2df) 
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=47.74, p<0.001. Possible reasons for this might be the endemic nature of the disease, 
the previous importation of live animals from other countries in the Horn of Africa 
without prior monitoring of their brucellosis status, more inter-species contact, sharing 
of common pastures, a larger herd size and the presence of low biosecurity and 
unhygienic conditions in farms from the southern governorate. This finding of a higher 
seroprevalence in Dhofar is supported by the reports of other researchers (Alton et al, 
1988; Grilló et al, 1997; European Commission, 2001; WHO, 2006b).  
The containment of disease and lower seroprevalence observed in the northern 
governorates may be explained by the restriction of the exportation and movement of 
female animals from Dhofar to other regions in Oman and the approved importation of 
castrated males only. Furthermore, the practice of tethering animals in the northern 
region may help reduce spread within and between herds by reducing animal to animal 
contact. 
Although there were no significant differences in the seroprevalence between cattle 
herds of different governorates, the herd level seroprevalence in cattle herds from 
Dhofar (4.9%) was higher and comparable to that reported by the BDU in 2003 prior to 
the implementation of a vaccination campaign (6.5%). However the seroprevalence 
found was lower than that reported in 2010 (24%) (MAF, 2003b; 2010). There are 
several reasons for the higher seroprevalence reported in 2010. Firstly, the vaccination 
protocol was not followed as recommended. Secondly, the veterinarians were not 
trained in handling and delivering the vaccine properly. There was the potential for 
contamination of the vaccine vials which may have led to infections or a failure to 
develop protective immunity. Finally, ear tagging was not implemented as planned and 
differentiation between the vaccinated and non-vaccinated herds was not obvious. 
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Therefore, the higher percentage of 2010 study may reflect a lower vaccination 
coverage, inadequate protection and false positive animals in case of unidentified 
vaccinated herds. In the current study the vaccination history of the herd was taken into 
consideration, and samples were predominantly from non-vaccinated animals/herds to 
minimise the probability of false positive results. 
Among small ruminants, seropositive sheep were detected in only three flocks (0.6%; 
95% CI 0.1, 1.7) and there was no significant difference in the herd level seroprevalence 
between districts. In contrast 2.3% (95% CI 1.2, 3.9) of goat herds were seropositive 
and the herd prevalence was significantly higher in Dhofar (16.2%) than in the other 
governorates. The higher number of seropositive goat holdings were expected in Dhofar 
as more goats are kept per herd as opposed to few farmers keeping sheep. The higher 
seroprevalence in goats could also be associated with the reported higher susceptibility 
for B. melitensis in this species. In contrast, sheep are reported to be more resistant to 
infection and may eliminate infection (Alton, 1990a; Durán-Ferrer, 1998; European 
Commission, 2001). Secondly, the sheep are mainly used for meat purposes in Oman 
and these breeds also may have enhanced resistance to infection as reported by Corbel 
and Brinley-Morgan (1984). The fact that vaginal excretions of goats are more copious 
and last for at least 2 to 3 months post-partum and approximately two thirds of the 
naturally acquired infections result in an infection of the udder with excretion of 
Brucella in the milk during subsequent lactations in goats, increases the probability of 
infection in this species (Alton, 1990a). In contrast, shedding of organisms from 
infected sheep may last for a maximum of three weeks post-abortion or post-partum ( 
European Commission, 2001). In Oman, small ruminants (sheep and goats) are usually 
treated as one group and the results of most previous studies did not separate out the 
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prevalence for the two species. Given the different epidemiological pattern and 
susceptibility, data for these species should be analysed separately in future studies. 
The herd prevalence of disease among small ruminants in Dhofar was also determined 
by BDU at 16.9 and 7.9% in 2003 and 2010, respectively (MAF, 2003b, 2010). 
However, in the current study 16.2% of sampled goat herds contained seropositive 
animals, while no sheep flock contained seropositive animals in Dhofar. The difference 
in the prevalence in 2003 and the results of the current study could be due to failure of 
the vaccination campaign or may reflect the failure in differentiation between infected 
and vaccinated herds as identifying ear tagging was not widely adopted in earlier 
studies. The high percentage in small ruminants may also be related to the higher 
number of goats when compared to sheep, especially in Dhofar, which as discussed 
previously, are more likely to be seropositive. 
In camels, the overall herd seroprevalence was (1.4%, 95% CI 0.6, 2.8) and infection 
was detected in only eight herds. There was also no significant difference in the herd 
prevalence between the northern (0.5%) and southern (3.7%) regions of Oman. Dhofar, 
where brucellosis would appear endemic, contains approximately 50% of the total 
camel and cattle population in Oman. Consequently most cases of brucellosis in humans 
have also been recorded in this region. In 2009, the BDU conducted a pilot study to 
determine the herd prevalence among camel holdings (4.3%), however the study was 
limited to only one area of Dhofar (Salalah). 
This study found serological evidence of infection in camels, especially in those having 
contact with small ruminants. Similar observations have been reported in other studies ( 
European Commission, 2001; Musa and Shigidi, 2001; Abbas and Aqab, 2002). 
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However, clinical signs, especially abortions, were rarely reported by veterinarians or 
by the owners of camels in positive camel holdings. The low exhibition of clinical 
disease in camels infected with B. melitensis was also in agreement with the findings of 
others (Abbas and Aqab, 2002; Teshome et al, 2003). Although clinical disease is 
seldom observed in camels, the role of milk from infected camels plays a major role in 
the transmission of disease to humans (Ismaily et al, 1988). 
The overall individual animal seroprevalence of brucellosis in Oman was generally at a 
low level (< 1%). The animal level seroprevalence of cattle in Dhofar in 2003 was 
reported to be 3.7% and this increased to 8% in 2010 (MAF, 2003b, 2010). However, in 
the current study, the individual animal seroprevalence of cattle in Dhofar was only 
1.5% (95% CI 0.3, 4.4). The overall low animal level prevalence in the current study 
may be explained by the low prevalence in the northern region which contains the 
highest number of susceptible animals (goats). The high number of sheep throughout 
the northern regions may also have resulted in a reduction in the individual level 
prevalence as sheep have been reported to be more resistant to infection. Cases in sheep 
and goats were also reported in Dhofar with the individual seroprevalence reported by 
the BDU dropping from 4.5% in 2003 to 1.3% in 2010. However in the current study 
the individual seroprevalence of brucellosis in goats in Dhofar was only 1% (95% CI 
0.6, 1.8) and was significantly higher than that found in other governorates. In contrast 
the individual animal seroprevalence in camels was only 0.8% (95% CI 0.3, 1.6). 
However, there was no significant difference between the seroprevalence in camels 
from the southern (0.14%) and northern regions (0.77%). In Dhofar, the individual 
seroprevalence in camels was 0.8% which was comparable to the 1% reported in 2009 
(MAF, 2010).  
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The individual animal seroprevalence was compared with other studies from countries 
in the region. However, other countries in the Middle East are not isolated, as trade in 
animals and animal products are significant (Al-Majali et al, 2005). The southern 
governorate of Dhofar shares a border with the Republic of Yemen while the northern 
region of Oman shares borders with UAE and Saudi Arabia. The individual level 
seroprevalence in cattle (0.4%) was higher than that reported in Yemen (0.06%), whilst 
lower than that reported in UAE (1.3%), Saudi Arabia (18.7%), Iraq (3%) and Iran 
(0.8%) (Gul and Khan, 2007). This finding is probably associated with the lower 
number of goats and cattle imported from the Horn of Africa into Oman for 
consumption and breeding purposes when compared with Saudi Arabia and the UAE. 
However the numbers imported into Oman would be expected to be higher than that 
into Yemen and this is likely to explain the higher prevalence in Oman compared to 
Yemen. 
The individual animal seroprevalence in sheep sampled in this study (0.1%) was also 
slightly lower than that reported in Yemen (0.6%) (AlShamahy et al, 2000) and 
significantly lower than that reported from the UAE (3.4%), Saudi Arabia (9.7%) and 
Iran (10.8%) (Gul and Khan, 2007). This may partly be explained by the overall lower 
number of sheep in Oman, compared to these other countries. Unlike goats, the limited 
numbers of sheep imported mainly go directly to slaughter houses and very few are 
imported for breeding purposes. Generally Omanis prefer the meat of goat and cattle to 
that of sheep, and this accounts for the low number of sheep imported into the country 
which would be associated with a reduced probability of disease introduction. 
Although goats comprise approximately 70% of the total livestock population of Oman 
(Agriculture Census, 2004), the animal level seroprevalence for brucellosis in goats was 
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lower than that reported in neighboring Middle Eastern countries. For instance, the 
prevalence of disease among goats in Jordon was reported at 27% (Al-Majali, 2005) and 
9.7% in Saudi Arabia. These values are markedly higher than that of Oman (0.4%) and 
Yemen (1.3%) (Gul and Khan, 2007). Good quarantine measures, along with limited 
importation of goats into Oman, when compared with Saudi Arabia, may play a role in 
accounting for these differences. 
In camels, the individual prevalence found in this study (0.4%) was much less than that 
reported in Iraq, Saudi Arabia and the UAE (17.2, 8 and 2%, respectively) (Gul and 
Khan, 2007). In Oman, the importation of camels has been banned for a long time (> 20 
years) with the exception of camels entering for competitive races (MAF, 2013). The 
main purpose of rearing camels in the southern region of the country is for meat 
production and there is limited transfer of live camels to the northern region, where 
camels are kept mainly for racing. 
Several studies have investigated factors associated with the presence of brucellosis ( 
European Commission, 2001; Al-Majali, 2005). This study is believed to be the first 
study to investigate the risk factors associated with the disease in Oman. The logistic-
regression analysis indicated an association of breed, age, herd size and production 
system with the presence of disease. The higher seroprevalence found in imported 
animals in this study may be due to their susceptibility to infection as they were 
imported from disease-free-areas. Alternatively this may be due to false positive 
reactions as they may have previously been vaccinated against brucellosis in their 
country of origin (Thrusfield, 2005). The higher prevalence reported in crossbred cattle 
may be attributed to the susceptibility of such breeds to infection or to differences in 
regions where crossbred cattle are commonly found (Dhofar) where they are primarily 
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reared under a semi-intensive system which facilitates transmission of infection 
(Haileselassie et al, 2010). 
Generally in this study, the seroprevalence increased with age, possibly because of the 
higher risk of contracting the disease after puberty due to increased contact with 
potentially infected animals ( European Commission, 2001; Kebede et al, 2008; Tolosa 
et al, 2008; Dinka and Chala, 2009) and due to the massive excretion of pathogens 
during active infection (Durán-Ferrer et al, 2004). However, the similar prevalence in 
males and females is not unexpected due to the similar management practices these 
animals are subjected to, especially in Dhofar. Nevertheless, males are usually kept for 
a shorter period of time than females which may reduce the chance of interaction with 
infected females or other herds and hence the probability of infection could be expected 
to be lower in males (Kebede et al, 2008; Dinka and Chala, 2009; Teklue et al, 2013). 
Diagnosis of brucellosis is usually made by antigen detection or through serological 
assays, however no test is 100% sensitive or specific (Martin, 1977). Only B. melitensis 
biotype 1 was cultured from the different species sampled in the Dhofar governorate. 
The molecular characterization of the isolates in this study suggested a closely related 
strain has existed in all governorates over the past three decades. Others (Verger et al, 
1985; Hill and Cook, 1994) have also reported that Brucella are genetically similar 
elsewhere. 
In the current study although there were no significant differences observed in the 
prevalence as determined by the cELISA (sensitivity >97%, specificity >99%) (Perrett 
et al, 2010), the iELISA and the RBPT, more samples were positive on the ELISAs than 
on the RBPT. This may reflect the higher sensitivity of the ELISAs as has been reported 
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by others (Burriel et al, 2004; Durán-Ferrer et al, 2004). However, the rapid test 
(Immunochromatography Assay - ICA) appears to have a lower sensitivity. Both the 
cELISA and iELISA seem to be the preferred tests for investigating the seroprevalence 
in herds and for evaluating control and eradication programs, especially in a country 
where vaccination is undertaken. In an experimental infection study in pregnant ewes by 
Durán-Ferrer et al, (2004), large differences in the immune response of previously 
vaccinated and non-vaccinated groups were observed. Most of serological techniques 
were able to detect antibodies in the non-vaccinated group two weeks post infection and 
this immunity was detected until the end of the experiment (30 weeks). In contrast, 
although most tests were able to detect weak antibodies before experimental challenge, 
the response post-inoculation was variable and few tests were capable of consistently 
detecting the antibody responses in previously protected animals.  
The control of brucellosis has been a subject of debate among scientists for several 
decades and no one specific program is recommended for every country/territory or 
region. To plan a program and action plan, several considerations for each situation 
have to be undertaken. Firstly it is very important to specify whether the goal of the 
program is the control or eradication of the disease and this mainly depends upon the 
financial situation of the country and the impact of the disease. Secondly, it is critical to 
have accurate information about the factors associated with the disease. These factors 
include the location and environment where the disease is distributed, the animal 
population and the management and husbandry practices adopted, the expected 
prevalence, the culture of the owners in each region and their willingness to cooperate 
in a control program. Once the situation with respect to the disease is known, the 
country may go for a specific strategy or a combination of strategies. Ideally, 
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identification of animals by ear tagging or another method and screening of animals 
with a suitable test, such as the RBPT or ELISA, is recommended before selecting a 
specific control program. In situations where the prevalence is low, a test and slaughter 
program could be adopted using the simple, rapid and inexpensive RBPT. However, the 
same test may not be ideal in populations with a high prevalence or in a country with a 
low prevalence but with limited financial resources. Therefore, a confirmatory process 
using more accurate tests and different controlling methods has been adopted in many 
countries (Mylrea, 1991). 
The failure of a vaccination program (2003 until 2012) with strain Rev-1 vaccine in the 
Dhofar governorate could be explained by several reasons. Firstly, several factors were 
not taken into consideration as have been mentioned previously. One of the major 
factors was the absence of accurate data about the real situation among the different 
species in the regions of Dhofar. Limited funds for the project were reported by a 
number of teams and staff, resulting in low vaccination coverage and a poor level of 
animal identification. As a consequence it was difficult to differentiate the serological 
response from vaccinated and infected animals by the laboratory. Adopting a 
vaccination strategy without adequate staff training and without receiving owner 
cooperation is likely to have hindered the progress of the program. Furthermore the 
project had poor management and the vaccination strategy adopted was altered by 
different managers. Initially all species and all ages of animals were vaccinated, 
however this was changed to one where only younger animals were vaccinated and 
subsequently it was decided to vaccinate all animals except for camels. 
With the information gathered in the current study, it is possible to develop a strategy to 
control brucellosis in Oman. However, the problems with previous programs need to be 
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considered when developing such a program. The country could be treated as two 
regions (the higher prevalence area in the south - Dhofar Governorate and the lower 
prevalence area in the north). In the southern region, initially implementing a 
vaccination campaign with animal identification and screening is the preferred control 
procedure; however, it is essential to include all animal species in this program after 
evaluation of the use of Rev-1 vaccine in camels. Subsequently a test and slaughter 
method with vaccination of young, disease-free animals could be implemented. 
According to Alton (1977b), it is likely that vaccination would need to be continued for 
at least 10 years to reduce the level of infection to a low level. On the other hand, as the 
prevalence is already low in the northern region, a test and slaughter program could be 
implemented immediately. Lastly the animals that are actually vaccinated in a herd is 
controversial. Several alternatives exist including vaccinating all animals in a herd (both 
adults and young animals), or vaccinating only adults or only young animals. Although 
vaccinating both young and adult animals would appear easier than repeated vaccination 
of calves, several authors have highlighted that vaccination of sexually mature cattle 
induced higher levels of immunity in cattle than vaccination of calves (Alton et al, 
1980; Corner and Alton, 1981). 
In conclusion, the work described in this thesis has demonstrated that B. melitensis, 
biotype (biovar) 1 is the sole cause of animal brucellosis in the Sultanate of Oman. 
Serological testing using different assays revealed evidence of the infection in different 
animal species. This study also highlighted that brucellosis is a serious zoonosis in the 
endemic region (Dhofar). It is recommended that both a vaccination program and a test 
and slaughter policy be adopted to control the disease. These control measures would 
result in significant benefits to the economy as well as to public health. 
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APPENDICES 
Appendix 1  
Questionnaire for recording epidemiological data at farm level 
Epidemiological study of Brucellosis in the Sultanate of Oman 
Farmer Questionnaire – Management and economic evaluation - English translation 
Region:    Area    Village:  
Farmer Name:   Herd Number:  Date: 
1-1 How many animals are in the herd (      ) 
1-2 please fill in the following 
 
sheep  Goats  
> 48 
mo 
25-48 
mo 
13-
24 
mo 
6-12 
mo 
< 6 
mo 
> 48 
mo 
25-
48 
mo 
13-24 
mo 
6-12 
mo 
< 6 
mo 
Age 
          Number 
of 
females 
          Number 
of males 
          Total 
 
Cattle  Camels  
> 48 
mo 
25-48 
mo 
13-24 
mo 
6-12 
mo 
< 6 
mo 
> 48 
mo 
25-48 
mo 
13-24 
mo 
6-12 
mo 
< 6 
mo 
Age 
          Number of 
females 
          Number of 
males 
          Total 
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1-3 Please complete the following table (enter all available information): 
Are animals confined in the farm - or do they go outside for grazing? 
 
If confined-Are they fed together in the same place? 
 
 
What are the animals used to go for grazing? 
 
 
When do these animals go for grazing and when do they return? 
 
 
Are animals separated from other species on the farm or are all species together? 
 
 
Are any animals tied up? If so, which animals (species/type) and how many? 
 
 
Are sheep and goats kept together or are they separated? Are they grazing freely or are 
they tied up? 
 
 Is AI used on cattle on the farm? 
 
 
How many offspring have been produced over the last 3 years (approximate)? 
 
 
How many abortions have occurred during the last three years and in which animals 
(species and groups)? 
 
 
Did all the abortions result in the birth of dead fetuses or did some survive for a period 
of time? 
How many of the aborted fetuses died immediately after birth according to species for 
the last three years? 
 
 At what stage (month) of the pregnancy did the abortion occur? If unsure of the age 
what size were the aborted fetuses? 
 
 Did any animals have a retained placenta after delivery? If so in which species? 
 
 
How did you dispose of aborted fetuses and/or placenta (Burn- bury- leave it where it 
was-gave to dogs, other please specify)? 
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Have you sold any animals from your farm/herd during the last three years? If yes 
please specify the species-numbers sold and their gender and price received? 
 
 What type of food do you give to your animals? Is the same ration (type of food) given 
to the animals throughout the year or is it changed? 
 
 In the past year, did you buy any extra food, medicine or vitamins for your animals? If 
yes approximately how much did you spend each month? Please provide details of extra 
food that you gave? 
 
 
What is the source of water for your animals? Have you ever had to buy in water from 
outside for the animals for drinking? If so how much did the water cost, how often did 
you do it and how long did it last? 
 
 Do you take the animals for drinking outside the farm? How many times daily and how 
far is the source? What is the time needed? 
 
 Is there any electricity used in farm? Is it private or governmental? How much does it 
cost per month? 
 
 Are there any expatriate workers in the farm? How many and what are their salaries? 
 
 
How many diseased animals were there last year? Who treated them? How many 
veterinarians visited the farm last year? 
 
 If a private veterinarian did the treatment, how much does it usually cost? What was the 
total cost last year? 
 
 Was the herd vaccinated-who did it- how many times annually? 
 
 
If you sold animals last year, who bought them (Market-farmers-meat consumers-
abattoir)? 
 
 Did you introduce any animals in last three years? What was the source? What was their 
age? How much did they cost? 
 
 Do you isolate newly purchased animals before mixing with your herd? If yes for how 
long? 
 
 Have you ever purchased animals from neiboring countries especially during the Eid 
celebration? What were their species, sex and age? 
 
 What have been the major health problems in the herd for the last two years? 
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Was the herd vaccinated against Brucella? Which species? When was the last 
vaccination performed? 
 
 What kind of camels are there (Racing-breeding or meat)? Where are they from? How 
are they fed? 
 
 
Do you take your camels to neiboring countries? Why? When? For how long? 
 
What other expenses does the farmer have? 
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Appendix 2 
 Excel based proforma for recording of epidemiological information  
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